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Breast cancer incidence and prevalence 
In 2006, there were an estimated 3,191,600 new
 
diagnoses of cancer in Europe. 
Breast cancer (BC) is currently the most common form of malignancy in women. 
In the Netherlands, 11% of all women will develop BC during their life span [1]. 
Moreover, BC is the leading cause of death in women [2]. 
Increasing age is a major risk factor for BC. In addition, higher 
socioeconomic status, a family history of BC, early menarche, late menopause, 
lengthy exposure to postmenopausal estrogens, childlessness, and first childbirth 
at late age are also associated with an increased risk of BC [3]. 
Partly due to advances in early detection (BC screening) and medical 
treatment (new adjuvant systemic and/or hormone therapies), women with BC 
will have an increased chance to survive for a longer period of time [4]. As 
survival time increases, the group of BC survivors is gradually growing. 
Therefore, it becomes important to address the impact of BC and its treatment on 
long-term psychosocial outcomes. Before describing any of the psychosocial 
outcomes found in the literature, an overview will be provided on breast cancer 
treatment. 
 
Breast cancer treatment 
Most women in developed countries diagnosed with early stage BC will have 
surgical treatment [5]. In recent decades, treatment for BC has become more 
complex. Breast conserving therapy (BCT) has become an alternative to 
mastectomy (MTC) in early stage BC due to its potential for better cosmetic 
results and its equivalent survival rate compared with mastectomy [6, 7]. Both 
surgical treatments may be chosen, when BC is diagnosed in an early stage (i.e., 
the tumour is smaller than 5 cm in diameter and there are no apparent metastases). 
When BCT is performed, the tumour is removed with a rim of surrounding 
healthy breast tissue followed by radiation therapy to the rest of the breast. MTC 
involves complete removal of all breast tissue including the nipple. As part of this 
surgical treatment, in most patients the lymph nodes in the axilla are staged, 
preferably with the sentinel node procedure, which is an invasive method to 
identify the lymph node that is the indicator for node metastases in the axilla. If 
the sentinel lymph node appears to contain cancerous cells, a complementary 
lymph node dissection is performed during a second operation. In some cases 
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axillary lymph node dissection is performed without preceding sentinel node 
procedure [8]. 
Dependent on tumour size, degree of differentiation of the tumour, and 
the presence of axillary metastases, adjuvant treatment (chemotherapy, hormone 
therapy, radiotherapy) is recommended. Each type of adjuvant therapy can be 
used separately or in combination across time.  
 
General quality of life 
Quality of life (QOL) has been established as a primary endpoint in cancer 
medicine in recent years [9, 10]. The number of studies assessing QOL in BC has 
increased enormously.  
There is debate on how to conceptualize QOL. If one adopts a critical 
approach, then, a large number of the published studies actually have not assessed 
QOL, but have measured related concepts, such as health status (HS) and/or 
health-related quality of life (HRQOL) [11]. HS, HRQOL, and QOL are often 
considered interchangeable, but these concepts are not the same [11, 12]. In 
general, it is accepted that QOL is multi-dimensional consisting of at least three 
broad domains: physical, psychological, and social (well-being). QOL is 
conceptualized by the World Health Organization Quality of Life group 
(WHOQOL Group) as ‘an individual’s perception of his/her position in life in the 
context of the culture and value systems in which he/she lives and in relation to 
his/her goals, expectations, standards and concerns. It is a broad-ranging concept 
incorporating in a complex way the person’s physical health, psychological state, 
level of independence, social relationships, personal beliefs and  relationship to 
salient features of the environment’ (p. 1405) [13]. As a consequence, QOL is 
subjective, and, therefore, can, strictly speaking, only be judged by individuals 
themselves. Both HS and HRQOL focus more exclusively on health aspects. 
HRQOL is measured when research is focusing on satisfaction within health-
related domains, such as physical well-being, psychological well-being, and 
social relationships [12]. Thus, HRQOL is QOL but restricted to the perception of 
functioning. In general, HS instruments assess the impact of disease on health-
related functioning [14]. Patients are asked about their physical possibilities, state 
of mind, and social activities. Thus, HS instruments do not contain questions 
about the persons’ feelings concerning their functioning.  
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When the above-mentioned perspective is taken into consideration, then 
we conclude that until now in oncology most studies have focused on HS, even 
when the employed assessment instruments are labelled as HRQOL-scales or 
QOL-scales. More specifically stated: most studies have examined potential 
differences in HS between surgical options or identifying factors associated with 
HS. In general, findings have indicated that HS is better after BCT than MTC [15-
19].  
In the first part of this thesis, we will focus on overall QOL. In the 
remaining parts, the focus is on two domains of QOL: the psychological domain 
and the social domain. In the next paragraph, the literature on psychosocial 
outcomes in early stage BC will be summarized. 
 
Psychosocial outcomes 
Being diagnosed with BC and living with BC are stressful experiences that may 
have a serious impact on multiple aspects of patient’s daily life [20]. Several 
studies have found that the majority of women diagnosed with BC cope quite well 
psychosocially, for instance, with reports of renewed vigour for life or stronger 
interpersonal relationships [21, 22]. However, negative consequences in 
functioning have also been found frequently.  
Psychosocial research in the field of early stage BC has at least two 
important uses [23]. First, it can be employed to identify subgroups of patients at 
(greatest) risk of psychological morbidity. Second, it may provide information to 
guide women in making choices, for instance, to select the treatment that is least 




The emotional consequences of BC have received much attention in the scientific 
literature, especially with regard to depression. In spite of better prospects, 
receiving a BC cancer diagnosis is still very stressful. Taking this into account, it 
is quite conceivable that BC patients have a high risk of developing mood 
disorders [24]. The prevalence of depression or depressive symptoms ranges from 
1.5% to 50%, depending on the study population, the definition of depression, and 
the assessment instruments used [25]. The majority of studies have found that 
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20% to 30% of the women experience elevated depressive symptoms, although 
the prevalence of major depressive disorder may be considerably lower [25, 26]. 
Depressive symptoms are probably highest in the first 6 months after cancer 
diagnosis and will thereafter decline over time [27].  
The presence of depressive symptoms has a detrimental impact on QOL 
[28]. Furthermore, it is associated with poorer compliance [29, 30], which, in 
turn, may affect disease outcome, increased morbidity, and possibly mortality 
[31]. However, the factors associated with the presence of depressive symptoms 
are still not clearly understood. There are several reasons for this state of affairs. 
First, few studies have examined women with early stage BC prospectively. In 
addition, the majority of the studies that examine, predictors of depressive 
symptoms do not take into account a broad spectrum of factors, i.e., 
sociodemographic, clinical, and psychological. As a consequence, this is an 
important target area for research and clinical practice.  
A number of factors influence depression or depressive symptoms in BC. 
Psychosocial factors seem to be the strongest predictors of depressive symptoms 
[32-34]. In contrast, objective aspects of cancer diagnosis (i.e., disease stage) and 
cancer treatment (i.e., type of treatment, tamoxifen use) are not associated 
consistently with the presence of depressive symptoms [32, 34-36]. 
 
Quality of sexual life and sexual functioning  
Several studies have indicated that BC can negatively impact women’s sexual 
functioning [37]. Although sexuality is considered to be an important aspect of 
QOL, few studies have examined this topic extensively in BC patients. Most 
studies on sexuality in BC patients are cross-sectional [38-45]. In general, studies 
focus on the impact of surgical treatment [41, 44] or chemotherapy [41-43, 45, 
46] on sexual functioning (SF; i.e., the experience of sexual difficulties) and 
sexual activity (i.e., the frequency of sexual activities). As the effects of treatment 
can lead to premature menopause, loss of fertility, and sexual dysfunction, 
knowledge about this topic is indispensable. However, knowledge about quality 
of sexual life is also important, since there may be a discrepancy between sexual 
problems, on the one hand, and persons’ evaluation of their sexual life. In spite of 
the growing recognition that QOL is of utmost importance, we still have to admit 
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that knowledge about subjectively perceived quality of sexual life is limited [40, 
45, 47, 48].  
In general, women with BC experience a wide variety of sexual 
difficulties, including vaginal dryness, reduced sexual activity, and reduced breast 
sensitivity [49]. Furthermore, these sexual difficulties appear to be a long-term 
problem, even after 5 to 10 years following diagnosis [49, 50].  
 
Social Support 
Social support is an important resource that may improve QOL in women with 
early stage BC. Despite a growing interest in this topic, a precise definition is 
currently lacking. In general, there are two broad perspectives: social support 
concerns (i) the support that is actually received (i.e., structural support, 
functional support) or (ii) the individual’s subjective appraisal of the social 
support (perceived social support). Perceived social support can be divided into 
the perception of availability, when needed, of social support (perceived 
availability of social support; PASS) and the satisfaction with received social 
support (SRSS). The latter distinction implies that it is possible that PASS and 
SRSS have different effects on health and well-being. For instance, it has been 
suggested that perceived social support may be the most important factor 
promoting (self-reported) health [51]. 
Several studies have examined perceived social support in cancer. 
However, most of them are cross-sectional [52]. Perceived social support has 
been associated with objective determinants (i.e., network size or frequency of 
contact with network members) [53], personality [54], the presence of mood 
disorders [55], and HS [56-61]. With regard to the relationship between perceived 
social support and survival, findings are rather inconclusive. Whereas some 
studies [62-64] found a positive relationship between perceived social support and 
survival, others did not [65]. 
 
Aim and design of the study 
This thesis describes a prospective longitudinal follow-up study in women with 
early stage BC. Women with a palpable lump in the breast or an abnormality on a 
screening mammography were referred by their general practitioner to the 
Department of Surgery of the outpatient clinics of the St. Elisabeth Hospital 
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(Tilburg), the Maasland Hospital (Sittard), or the Jeroen Bosch Hospital (Den 
Bosch) in The Netherlands. These women were eligible for participation in this 
study. However, women with a medical history of breast disease (either benign or 
malignant), with signs of dementia, and women who were not able to read and 
write Dutch were excluded from participation. The data were collected from 
September 2002 to September 2006. All patients signed an informed consent. 
Before a mammography and/or a diagnostic needle biopsy were performed, the 
participating women completed a set of questionnaires. After this baseline 
measurement additional questionnaires were completed at 1, 3, 6, and 12 months 
after diagnosis (women with benign breast problems) or surgical treatment 
(women with early stage BC).  
All women completed questionnaires on personality factors (only at 
baseline), state anxiety, depressive symptoms, fatigue, and QOL. Women with 
early stage BC were also assessed on disease-specific HS (from 1 month after 
surgical treatment onwards).  
Basic personality factors were assessed with the Neuroticism-
Extraversion-Openness-Five Factor Inventory (NEO-FFI) [66, 67],
 
which has 
been translated into Dutch [68]. This self-report questionnaire
 
consists of 60 
statements covering the five broad dimensions of
 
personality that formed the 
Five-Factor Model (FFM) [66]: Neuroticism (N), Extraversion (E), Openness to 
new experiences (O),
 
Agreeableness (A), and Conscientiousness (C). Each 
statement is rated on a 5-point scale ranging from 1 (strongly
  
disagree) to 5 
(strongly agree), resulting in dimension
 
scores of 12 to 60. The psychometrics of 
the NEO-FFI have been extensively examined. The internal consistency, test-
retest reliability, as well as the convergent validity, are acceptable to good [68]. 
 
 
The State Trait Anxiety Inventory (STAI) [69, 70] consists of two 20-
item scales for measuring state anxiety and trait anxiety. Initially, the STAI was 
developed to investigate anxiety phenomena in ‘normal’ adults, but the scale has 
also proven to be useful in medical and surgical patients [71]. The STAI Trait 
scale describes how persons generally feel and conceives of anxiety as a 
personality trait. The STAI State scale is a momentary emotional condition 
characterized by subjective feelings of apprehension and tension, and heightened 
autonomic nervous system activity [69].The STAI scales have a 4-point rating 
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scale ranging from 1 (almost never) to 4 (almost always). The Dutch version of 
the STAI has good reliability and validity [70].  
The Center for Epidemiological Studies- Depression Scale (CES-D) [72] 
is a 20-item self-report scale designed to measure the presence and degree of 
depressive symptoms over the past week. The rating scale ranges from 0 (seldom 
or never) to 3 ((almost) always). Scores range from 0 to 60. For the Dutch 
population, reliability and criterion validity are good [73, 74].  
The Fatigue Assessment Scale (FAS) [75] is a 10-item questionnaire 
assessing a uni-dimensional construct of perceived fatigue and exhaustion. The 
response scale is a 5-point rating scale ranging from 1 (never) to 5 (always). 
Scores on the FAS range from 10 to 50. The psychometric properties are good 
within a general population, working population, and sarcoidosis patients [76-78].  
The World Health Organization Quality of Life assessment instrument-
100 (WHOQOL-100) [79, Dutch version 80], is a cross-culturally developed 
generic multi-dimensional quality of life (QOL) measure. This instrument covers 
24 specific facets of QOL, assessed by 96 questions, and one General Health and 
Overall Quality of Life facet. Each facet is measured with four items using 5-
point Likert scales. In general, high facet scores indicate good QOL; except for 
the facets Pain and Discomfort, Negative Feelings, and Dependence on 
Medication or Treatments, which are negatively framed. Reliability and validity 
[80-82] are adequate and sensitivity [83] is high. 
The EORTC QLQ-BR23 [84] is a 23-item disease-specific questionnaire 
measuring HS in BC patients. The BR-23 is a supplementary module of the 
EORTC QLQ C30, which covers the physical, personal, cognitive, emotional, and 
social domains [85]. The EORTC QLQ BR-23 incorporates two functional scales 
(Body Image and Sexual Functioning) and three symptom scales (Arm 
Symptoms, Breast Symptoms, and Systematic Therapy Side Effects). All scales 
are transformed to a percentile scale ranging from 1 to 100. High scores in the 
functioning scales indicate high levels of functioning, whereas high scores in the 
symptom scales indicate high levels of problems. The remaining items assess the 
degree of sexual enjoyment and being upset by hair loss. Multi-trait scaling 
analysis confirmed the hypothesized structure of four of the five scales [84]. 
Cronbach's alpha coefficients were adequate [84, 86]. In known-group 
comparisons, there were marked group differences between patients differing in 
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disease stage [84, 86], previous surgery, performance status, and treatment 
modality [84]. Additionally, selective scales detected change over time as a 
function of changes in performance status and treatment-induced change [84].  
In addition to this prospective longitudinal follow-up study, we used 
cross-sectional data. This data set consisted of women who were diagnosed with 
early stage BC four to five years previously and did not have a recurrence. These 
women completed the same questionnaires as in the prospective follow-up study. 
In addition, they completed the RAND 36-Item Health Survey 1.0. The RAND 36 
is practically identical to the Medical Outcome Study / Short Form-36. The SF-36 
[87] is a 36-item generic questionnaire for assessing HS. The domains refer to 
physical functioning, role limitations due to physical problems, bodily pain, 
general health perceptions, vitality, social functioning, role limitations due to 
emotional problems, and mental health. A higher score on a particular subscale 
signifies better health. For each of the eight subscales, scores were summed and 
transformed to a scale of 0–100, representing the percentage of the highest 
possible score achieved. Cronbach's alpha coefficients exceeded the 0.70 
criterion, except for Social Functioning in a sample of cancer patients [88]. 
Known-group comparisons yielded consistent support for the validity of the SF-
36 [88]. The two general population samples reported the highest levels of health 
status. The cancer sample yielded the lowest mean SF-36 scale scores [88]. 
 
Outline of the thesis 
Until now, the number of prospective follow-up studies examining the 
psychosocial outcomes in women with early stage breast cancer is rather limited. 
Therefore, the focus in the present thesis is on enriching the paucity of studies in 
this field. This thesis will be divided into three sections. Part A focuses on QOL. 
Part B and C focus on two domains of QOL: psychological outcomes and social 
outcomes, respectively. In Figure 1, a schematic overview of the outline of the 
present thesis is presented. 
The World Health Organization Quality of Life instrument – 100 items 
(WHOQOL-100) is a cross-cultural generic instrument. However, although 
recently used in several studies, the WHOQOL-100 was not previously tested for 
its psychometric properties in Dutch BC patients. Therefore, the psychometric 
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properties of the WHOQOL-100 were assessed in women with early stage BC, 
benign breast problems, and BC survivors (Chapter 2). 
 
Figure 1. Outline of the thesis 
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General discussion and clinical implications 
 
Chapter 3 discusses which aspects of QOL contribute the most to overall 
QOL after surgical treatment. Few studies have prospectively assessed QOL in 
early stage BC. In Chapter 4 the predictors of depressive symptoms at 12 months 
after surgical treatment will be examined. Chapter 5 will describe whether 
women who have received an additional surgical treatment have more problems 
in psychosocial functioning compared with women who were more ‘effectively’ 
treated. In chapter 6 the role of personality in the perceived availability of social 
support and satisfaction with received social support is discussed. The quality of 
sexual life and sexual functioning is the main theme of chapter 7. In the general 
discussion and summary (Chapter 8), the main findings will be summarised and 
integrated. Implications for clinical research and care will be described. In 
addition, reflections on limitations and strengths of the present study are provided. 
The Dutch summary can be found in chapter 9. 
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Objective: This prospective follow-up study examines the psychometric 
properties of the WHOQOL-100 for assessing quality of life (QOL) in women 
suspected of having breast cancer and disease-free breast cancer survivors. 
Method: The WHOQOL-100 was tested at five points in time in women with a 
palpable lump in the breast or an abnormality on a screening mammography (N = 
356) and breast cancer survivors (N = 140). Furthermore, all participants 
completed measures of anxiety (STAI) and depression (CES-D). Moreover, 
women who were diagnosed with breast cancer also completed the EORTC-QLQ-
BR-23 at time points 2 to 5. Reliability (internal consistency; test-retest 
reliability) and construct validity were tested. Results: Confirmatory factor 
analyses on the WHOQOL-100 items showed a good fit with models reflecting 
six factors (physical health, psychological health, level of independence, social 
relationships, environment, spirituality/religion/personal beliefs) or four factors 
(physical health, psychological health, social relationships, environment). Internal 
consistency was adequate. Test-retest correlations were high. The WHOQOL-100 
correlated highly with related constructs and showed low correlations with 
unrelated constructs. Conclusion: The WHOQOL-100 is a reliable and valid 
instrument for measuring QOL in women suspected of having breast cancer and 
disease-free breast cancer survivors. 






Breast cancer is the most common malignancy in women [1] and the most 
frequent cause of death in women aged 35 to 60 years in Europe [2]. In the 
Netherlands, one in every nine women will develop breast cancer before the age 
of 85 [3]. The prevalence of breast cancer increases with age from 3-4% at age 
50-69 to 6% of women older than 70 [4]. Following a breast cancer diagnosis, up 
to four in ten women is experiencing symptoms of anxiety and depression [5]. For 
this reason, and also due to the growing number of breast cancer survivors [6], it 
has become increasingly important to include in research not only medical 
endpoints (e.g., morbidity and mortality), but also patient-based outcome 
measures, such as quality of life (QOL). Therefore, the aim of this prospective 
follow-up study was to examine the psychometric properties of the World Health 
Organization Quality of Life assessment instrument (WHOQOL-100), a 
multidimensional QOL instrument. 
QOL has become a popular concept in research. However, the debate on 
how to conceptualize QOL is still ongoing. Many different conceptualizations are 
covered by numerous instruments, for instance, the Short Form Health Survey – 
36 items (SF-36) [7], and the EORTC Quality of Life Questionnaire- 30 items [8], 
and its complementary breast-cancer module (QLQ BR23) [9]. Although a gold 
standard does not exist, the majority of the literature supports the multi-
dimensional aspect of QOL, in which QOL consists of at least a physical, an 
emotional, and a social domain [10]. Another commonly accepted characteristic is 
that QOL should reflect the patient’s own evaluation of life. However, strong 
disagreement exists, regarding the exact content of the QOL concept and its 
operationalization in an assessment instrument. 
In general, QOL instruments can be divided into ‘objective’ and 
‘subjective’ QOL measures. Some authors [11-13] state that these objective 
measures, for instance, the SF-36, the EORTC Quality of Life Questionnaire 30 
items (QLQ-30), or the breast-cancer specific module (BR-23) are not reflecting 
QOL.  In their view, these objective QOL measures focus, strictly speaking, on 
health status (HS). Therefore, several authors have suggested that objective 
measures, reflecting predominantly symptoms and functioning, should not be 
used as a measure of QOL [12, 13]. 
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In 1991, The World Health Organization (WHO) acknowledged the 
importance of patient’s self-evaluation of life by initiating a project, which aimed 
to develop a generic cross-cultural QOL instrument that would be broadly 
applicable across disease types and varying severities of illness. This multi-
dimensional instrument, the World Health Organization Quality of Life 
assessment instrument (WHOQOL-100) [14], reflects the view that QOL is a 
broad-ranging concept that incorporates subjectively experienced QOL. This is 
also reflected in the definition of QOL formulated by the WHOQOL-Group [15], 
in which QOL is conceptualized as ‘an individual’s perception of his/her position 
in life in the context of the culture and value systems in which he/she lives and in 
relation to his/her goals, expectations, standards and concerns. It is a broad-
ranging concept incorporating in a complex way the person’s physical health, 
psychological state, level of independence, social relationships, personal beliefs 
and their relationship to salient features of the environment’ (p. 1405). In 
addition, the WHOQOL-100 includes both positive (e.g., having the opportunity 
to go on holiday or to perform leisure activities) and negative dimensions (e.g., 
pain and bodily discomfort) [15]. This positive approach is also reflected in the 
way the items are formulated (e.g., ‘How satisfied are you with your energy 
level?’). Each QOL facet contains both positive and negative items. In sum, the 
WHOQOL-100 is not only focusing on the manifestations of distress caused by 
disease. This is of utmost importance because it is a well-established phenomenon 
that cancer can also have positive effects on a person’s life [16, 17].  
The WHOQOL-100 is cross-culturally developed and has excellent 
psychometric properties in various populations, such as patients with a liver 
transplantation [18, 19], chronic pain patients [20], and psychiatric patients [21]. 
Tazaki and colleagues [22] reported that the WHOQOL-100 was sensitive enough 
to evaluate QOL in cancer patients. Cronbach’s alpha coefficient for the total 
scale was .97. High correlations were found between the psychological domain 
and the environmental domain (r = 0.70), the physical domain and the level of 
independence (r = 0.60) and social relations and the environment (r = 0.69). Some 
of the results suggested that mean QOL scores in cancer patients differ depending 
on the site and treatment. However, test-retest reliability and construct validity 
was not assessed.  




Therefore, in the present study, the WHOQOL-100 is extensively tested 
for its properties. We expected that a 6-factor model, consisting of Physical 
Health, Psychological Health, Level of Independence, Social Relationships, 
Environment, and Spirituality/Religion/Personal Beliefs would be confirmed in 
structural equation modeling. Furthermore, we expected that a more recently 
suggested 4-factor model, consisting of Physical Health, Psychological Health, 
Social Relationships, and Environment [23] would show an even better fit. In 
addition, it was expected that particular facets of the WHOQOL-100, such as 
Body Image and Appearance, would be highly correlated with corresponding 
facets, like the EORTC QLQ BR-23 dimensions Body Image and Upset by Hair 
Loss. Likewise, relatively high associations were predicted between scores on the 
STAI and CES-D, on the one hand, and the WHOQOL-100 facet Negative 
Feelings, on the other hand. In contrast, it was expected that relatively low 
correlations would exist between WHOQOL-100 facets, like, for instance, the 
WHOQOL-100 facet Home Environment (QOL) and rather unrelated facets like 





Two samples were used in this study. The first sample consisted of women with a 
palpable lump in the breast or an abnormality on a screening mammography who 
were referred by their general practitioner to the surgical outpatient clinics of St. 
Elisabeth Hospital (Tilburg, The Netherlands), the Maasland Hospital (Sittard, 
The Netherlands), or the Jeroen Bosch Hospital (Den Bosch, The Netherlands). 
The present study in which the WHOQOL-100 is validated, is part of a larger 
study focusing on the role of personality in patients’ QOL. The data were 
collected from September 2002 until September 2006. Of the 546 eligible women, 
356 (65.2%) completed the first set of questionnaires. The questionnaires were 
completed before the women visited the surgeon or radiologist, i.e. before the 
diagnosis, benign or malignant, was known. This is comparable to other studies 
with T1 before diagnosis (e.g., 24]. The main reasons for not participating were 
the length of questionnaires and the amount of stress women experienced at their 
first visit at the hospital. Of these 356 women, 200 subsequently appeared to have 
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benign breast problems (BBP) and 156 were diagnosed with breast cancer (BC). 
Woman who had a history of abnormalities in the breast, benign or malignant, or 
had a breast tumor that was too large (>5 centimeter) for breast conserving 
therapy, were excluded from the study. In order to participate, the women had to 
be able to write and read in Dutch. After the baseline measurement before 
diagnosis (T1), women completed questionnaires 1 (T2), 3 (T3), 6 (T4), and 12 
(T5) months after diagnosis (BBP) or after surgical treatment (BC). When women 
were asked to participate in the study and completed the first set of 
questionnaires, it was unknown whether a woman had BC or BBP. Once 
diagnosis was known, diagnosis was the reference point for subsequent 
measurement times for benign patients. For BC patients, the reference point was 
surgical treatment because otherwise follow-up measures would interfere with 
timing of treatment modalities. Participation in the study was not known by the 
surgeon in attendance and, therefore, could not have affected treatment and 
clinical follow-up. All participants gave written informed consent. 
The second group consisted of all disease-free early stage breast cancer 
survivors (BCS) who were diagnosed between January 2000 and December 2001 
(N = 272) at the Department of Surgery of the St. Elisabeth Hospital, Tilburg (The 
Netherlands). In December 2005, all patients were assessed with respect to their 
well-being. Women who did not have an operation, who were diagnosed with 
locally advanced breast cancer tumors larger than 5 centimeter, or developed 
recurrent breast cancer or systemic disease in the period of four to five years since 
treatment, were not included. One hundred and ninety-four women were eligible. 
However, three patients were diagnosed with dementia, nine women were 
deceased, and four were lost to follow-up. The remaining 178 women were all 
contacted by phone and asked whether they wanted to participate. Reasons for 
refusal were ‘not interested’ (n = 10), ‘too hard / do not want to be confronted 
with the past’ (n = 15), and ‘other reasons’ (n = 7). Of the 146 women who agreed 
to participate, 140 signed the informed consent form and returned completed 
questionnaires (78.7%).  
 
Measures 
All groups completed the following questionnaires: World Health Organization 
Quality of Life assessment instrument-100 (WHOQOL-100) [14, 15], State Trait 




Anxiety Inventory (STAI) [25], and the Center for Epidemiologic Studies 
Depression scale (CES-D) [26]. The European Organization for Research and 
Treatment Quality of Life Breast Cancer instrument (EORTC-QLQ-BR23) [9] 
was not included in the first set of questionnaires, because this is a disease-
specific questionnaire and diagnosis was unknown at T1. Therefore, the EORTC-
QLQ-BR23 was not completed by the BBP group. In addition, the BCS group 
also completed the SF-36 [7]. 
 
Quality of life 
Quality of life was measured using the WHOQOL-100 [14, 27]. This instrument 
covers 24 facets, assessed by 96 questions, and one General health and Overall 
Quality of Life facet. Each facet is measured with four items with a 5-point Likert 
scale. Twenty-four facets were initially scored in six domains of QOL: Physical 
Health, Psychological Health, Levels of Independence, Social Relationships, 
Environment, and Spirituality, Religion and Personal Beliefs [14]. Nowadays, it is 
well accepted to convert these 24 facets into four domains as described by the 
WHOQOL group [23, 28]. High facet scores indicate good QOL; except for the 
facets Pain and Discomfort, Negative Feelings, and Dependence on Medication or 
Treatments, which are negatively framed. The time frame of reference is the 
previous two weeks. Reliability and validity [23, 27] are adequate, and sensitivity 
[18] of the instrument is high. 
 
Health status 
The EORTC QLQ-BR23 [9] is a 23-item disease-specific questionnaire 
measuring health status in breast cancer patients.  The BR-23 is a supplementary 
module of the EORTC QLQ C30, which covers the physical, personal, cognitive, 
emotional, and social domains [29]. The EORTC QLQ BR-23 incorporates two 
functional scales (Body Image and Sexual Functioning) and three symptom scales 
(Arm Symptoms, Breast Symptoms, and Systematic Therapy Side Effects). The 
remaining items assess sexual enjoyment and being upset by hair loss. Multitrait 
scaling analysis confirmed the hypothesized structure of four of the five scales 
[9]. Cronbach's alpha coefficients were adequate [9, 30]. In known-group 
comparisons, there were marked group differences between patients differing in 
disease stage [9, 30], previous surgery, performance status, and treatment 
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modality [9]. Additionally, selective scales detected change over time as a 
function of changes in performance status and treatment-induced change [9].  
The SF-36 [7] is a 36-item generic questionnaire for assessing health 
status. The domains refer to physical functioning, role limitations due to physical 
problems, bodily pain, general health perceptions, vitality, social functioning, role 
limitations due to emotional problems, and mental health. A higher score on a 
particular subscale signifies better health. For each of the eight subscales, scores 
were summed and transformed to a scale of 0–100, representing the percentage of 
the highest possible score achieved. Cronbach's alpha coefficients exceeded the 
0.70 criterion, except for Social Functioning in a sample of cancer patients [31]. 
Known-group comparisons yielded consistent support for the validity of the SF-
36 [31]. The two general population samples reported the highest levels of health 
status. The cancer sample yielded the lowest mean scale SF-36 scores [31]. 
 
Mood 
The STAI [25, Dutch version by 32] consists of two 20-item scales for measuring 
state anxiety and trait anxiety. The STAI State scale was used in this study. This 
scale assesses how persons feel at a particular moment in time. The STAI has a 4-
point rating scale ranging from 1 (not at all/almost never) to 4 (very much 
so/almost always). The Dutch version of the STAI has good reliability and 
validity [32). 
The CES-D [26] is a 20-item self-report scale designed to measure the 
presence and degree of depressive symptoms over the past week. The rating scale 
ranges from 1 (seldom or never) to 4 ((almost) always). Scores can range from 0 
to 60; scores ≥ 16 are suggestive of depressive symptoms. For the Dutch 
population, reliability and criterion validity are good [33, 34]. Beekman et al. [34] 
found excellent sensitivity for major depression in a sample of elderly persons. In 
addition, the internal consistency in a large Dutch patient population was good, 
Cronbach's alpha was .91 [33]. In breast cancer survivors with a recurrence and 
disease-free survivors, the internal consistency was .90 and .91, respectively [35].  
 
Socio-demographic variables 
Patients were asked to report age, marital status, education, and paid work 
(yes/no).  





Calculation of frequencies was used to present the demographic data before 
diagnosis. Student t-tests and Chi-square tests were used to compare (i) the 
participants and non-participants and (ii) the BBP group and the BC group. In 
general, statistical analyses were performed in all groups (BBP, BC, and BCS). 
However, for the confirmatory factor analysis (CFA) and test-retest reliability, we 
performed the analyses in respectively the BCS group and the BBP group, 
because for these analyses we hypothesized that it was important to have 
relatively stable groups. For this reason, test-retest reliability was calculated for 
T2 and T3. Correlations of at least 0.80 were seen as indicative for good test-
retest reliability. A CFA was conducted in BCS to test whether the original six-
domain structure and the recently revised four-domain structure are suited to a 
population with (former) breast problems. The hypothesized models are presented 
in Figures 1 and 2. Goodness of fit was verified by the following fit indices: the 
Comparative Fit Index (CFI) and the Root Mean Square Error of Approximation 
(RMSEA). The models have a satisfactory to good fit when: CFI > .90 and 
RMSEA < .06 [34]. Concerning construct validity, Pearson correlations were 
calculated between the WHOQOL-100, on the one hand, and the EORTC QLQ 
BR-23, STAI-state, and CES-D, on the other hand. Moderate correlations (r = .30 
to .49) are indicative for convergent validity, while small correlations (r = .10 to 
.29) are indicative for divergent validity [37, 38]. With regard to the reliability of 
the WHOQOL-100, two types of reliability were examined: internal consistency 
(all groups) and test-retest reliability (BBP group). Cronbach’s alpha coefficients 
were computed to estimate the internal-consistency reliability of the QOL 
domains and facets [39]. Depending on the number of questions in a (sub)scale, 
Cronbach’s alpha should be at least .70. The data were processed by means of the 
Statistical Package for the Social Sciences (SPSS, version 14.0 for Windows), 




Patient characteristics of the three groups (BC, BBP, and BCS group) are shown 
in Table 1. Of the 356 included patients, 156 had breast cancer, and 200 women 
appeared to have benign breast problems. Women who participated in the study 
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were significantly younger [t (1, 546) = 2.96, p < 0.01] and more often appeared 
to have breast cancer (χ² = 6.01, p = 0.014) than the non-participants. After 
diagnosis, the participating women were divided in two groups: women with BBP 
and women with BC. Women with BBP were younger [t (1, 354) = 6.25, p < 
0.001) and more often employed (χ² = 9.25, p = 0.002) compared with the BC 
group. In both subgroups, the majority of the women lived with a partner and had 
one or more children. Women who participated in the BCS were significantly 
younger [t (1, 270 = 2.13), p < 0.05)] than non-participants.  
 
Table 1. Patient characteristics (T1) 








Age (mean, SD, range) 54.9 ± .56  
(19-87) 
58.7 ± 9.5  
(34-87) 




Living with a partner 
(yes/no/missing) 
277/60/19 116/31/9 161/29/10 101/37/1 
Children 
(yes/no/missing) 




114/156/59/27 57/64/25/10 57/92/34/17 56/59/24/0 
Paid work 
(yes/no/missing) 
165/182/0 56/96/4 109/86/5 45/93/1 
Note: *Low = up to 10 years of education; middle = 10 to 14 years of education; high = 
more than 14 years of education 
 
Confirmatory factor analysis 
In order to test the six-domain and four-domain structure of the WHOQOL-100 
(See Fig. 1 and Fig. 2, respectively), structural equation modelling (SEM) 
analyses were conducted. Careful inspection of modification indices as provided 
by AMOS 7 suggested a number of modifications to improve the initial model 
six-domain model without correlated errors which did not meet our criteria for an 
acceptable fit (CFI = 0.81; RMSEA = .0089). Adding error covariances between 
Facet 4 (Positive Feelings) and the Social Relationships Domain, Facet 4 
(Positive Feelings) and the Environment Domain, and between the Facets 4 




(Positive Feelings) and 5 (Cognitive Functions), 4 (Positive Feelings) and 11 
(Dependence/Medication), 14 (Social Support) and 19 (Health and Social Care), 6 
(Self-Esteem) and 24 (Spirituality/Religion/Personal Beliefs), 10 (Activities of 
Daily Living) and 16 Physical Safety/Security), 7 (Body Image/Appearance) and 
19 (Health and Social Care) improved model fit significantly: CFI = 0.90 and 
RMSEA = 0.068. For the associations between the latent variable Quality of Life 
and the six domains the following standardized regression weights were obtained: 
1.0 (Physical Health), .93 (Level of Independence), .83 (Psychological Health), 
.68 (Environment), .52 (Social Relationships), and .43 (Spiritual Domain). Table 
2 contains the standardized regression weights for the 24 facets of the WHOQOL-
100. Inspection of these parameter estimates reveals that in case of Physical 
Health, Facet 1 (Pain and Discomfort) and Facet 2 (Energy and Fatigue) had 
higher loadings on their corresponding latent factor than Facet 3 (Sleep and Rest). 
With respect to Psychological Health, Level of Independence, Social 
Relationships, and Environment the highest loadings were found, respectively, for 
Facet 8 (Negative Feelings), Facet 10 (Activities of Daily Living), and Facet 13 
(Personal Relationships), and Facet 19 (Health and Social Care).  
Also in case of the testing of the four-factor structure, similar fit indices 
were found in case of the present population, compared with the corresponding 
analysis on the original field trial data set of the WHOQOL-100 [28]. When seven 
pairs of error variances were allowed to covary a fair to good fit was obtained: 
CFI = 0.90 and RMSEA = 0.065. Correlated error variances had to be added 
between the Facets 4 (Positive Feelings) and 5 (Cognitive Functions), 4 (Positive 
Feelings) and 11 (Dependence/Medication), 7 (Body Image/Appearance) and 11 
(Dependence/Medication), 6 (Self-Esteem) and 24 (Spirituality/Religion/Personal 
Beliefs), 16 (Physical Safety/Security) and 17 (Home Environment), 17 (Home 
Environment) and 22 (Physical Environment), and 16 (Physical Safety/Security) 
and 22 (Physical Environment). For the associations between the latent variable 
Quality of Life and the four domains the following standardized regression 
weights were obtained: .97 (Psychological Health), .87 (Environment), .76 (Social 
Relationships), and .71 (Physical Health). Table 3 presents the standardized 
regression weights for the 24 facets of the WHOQOL-100. 
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Table 2. Standardized regression weights of the facets on their latent variables (Domains): 
Six-domain model 
Domain Facet I II III IV V VI 
1 Pain and Discomfort -.72      
2 Energy and Fatigue  .87      
I Physical 
Health 
3 Sleep and Rest  .35      
4 Positive Feelings   .67     
5 Cognitive Functions   .46     
6 Self-Esteem   .68     




8 Negative Feelings  -.70     
9 Mobility    .48    
10 Activities of Daily Living    .97    
11 Dependence/Medication   -.56    
III Level of 
Independence 
12 Working Capacity    .79    
13 Personal Relationships      .88   
14 Social Support      .70   
IV Social 
Relationships 
15 Sexual Activity      .60   
16 Physical Safety/Security       .52  
17 Home Environment       .61  
18 Financial Resources.      .59  
19 Health and Social Care      .53  
20 New Information/Skills      .84  
21 Participation Recreation      .69  
22 Physical Environment      .45  
V Environment 
23 Transport      .55  
VI Spiritual 
Domain 
24 Spirituality/ Religion/ 
Personal Beliefs 
      .35 
 




Table 3. Standardized regression weights of the facets on their latent variables (Domains): 
Four-domain model 
Domain Facet I II III IV 
1 Pain and Discomfort -.71    
2 Energy and Fatigue  .86    
3 Sleep and Rest  .33    
9 Mobility  .49    
10 Activities of Daily Living  .95    
11 Dependence/Medication -.59    
I Physical Health 
12 Working Capacity  .79    
4 Positive Feelings   .83   
5 Cognitive Functions   .47   
6 Self-Esteem   .67   
7 Body Image/Appearance   .43   





  .22   
13 Personal Relationships   .90  
14 Social Support   .70  
III Social 
Relationships 
15 Sexual Activity   .59  
16 Physical Safety/Security      .51 
17 Home Environment      .60 
18 Financial Resources.     .56 
19 Health and Social Care     .53 
20 New Information/Skills     .83 
21 Participation Recreation     .74 
22 Physical Environment     .42 
IV Environment 
23 Transport     .53 
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These parameter estimates show that in case of Physical Health, facet 10 
(Activities of Daily Living) and Facet 2 (Energy and Fatigue) had the highest 
loadings. 
For the other three domains, Psychological Health, Social Relationships, 
and Environment, the highest regression weights were, respectively: Facet 4 




The EORTC- QLQ BR 23, CES-D and STAI (T2) scores were correlated with the 
25 facets and the four domains of the WHOQOL-100 in the BC group. The results 
are presented in Table 4. Only significant correlations (2-tailed tested) are 
reported. In accordance with our expectations, scores on the EORTC QLQ-BR23, 
the CES-D, and the STAI-state scale correlated highly (r >.49) with related facets 
of the WHOQOL-100. For instance, the EORTC-QLQ-BR23 scale Body Image 
was highly correlated with the WHOQOL-100 facet Body Image and Appearance. 
The EORTC-QLQ-BR23 scales Sexual Functioning and Sexual Enjoyment 
(EORTC-QLQ) were highly correlated with the WHOQOL-100 facet Sexual 
Activity. The EORTC-QLQ-BR23 facets Breast Symptoms and Arm Symptoms 
were predominantly correlated with facets in the Physical Health domain of the 
WHOQOL-100. Much lower correlations (r < .29) were found between, for 
example, the WHOQOL-100 facets Financial Resources and Transport, on the 
one hand, and EORTC QLQ-BR 23 dimensions, on the other hand. Finally, the 
global QOL/General Health facet demonstrated low to moderate associations with 
the related EORTC QLQ BR-23 dimensions.  The EORTC-QLQ-BR scale Future 
Prospective was most strongly correlated with the global QOL/General Health 
facet of the WHOQOL-100.  
 
Table 4. Construct validity of the WHOQOL-100 (BC group) 
EORTC-QLQ-BR23 
WHOQOL-100 facets 
BI SF SE FP SS BS AS HL 
CESD STAI 
Overall QOL/General Health .22   .48 -.26    -.64 -.63 
Physical Health  .35  .46 -.28 -.40 -.51  -.60 -.50 
Pain and discomfort -.21   -.44  .44 .45  .56 .47 
Energy and fatigue     .37 -.31 -.38 -.28 -.53 -.39 
Sleep and rest     .31  -.16 -.34 -.45 -.45 
Mobility  .37  .28   -.45  -.35 -.34 
Activities of daily living  .31  .39 .27 -.52 -.42  -.50 -.36 
Dependence/medication    -.27    .25 .38 .31 
Working capacity  .27  .32 -.21 -.30 -.46 .61 -.38 -.27 
Psychological Health .29 .26  .41     -.67 -.70 
Positive  feelings  .29  .41     -.66 -.69 
Cognitive functions  .24  .33     -.49 -.55 
Self-esteem  .29  .26     -.53 -.56 
Body image/appearance .58    -.24 -.22   -.50 -.36 
Negative feeling -.29   -.60     .77 .71 
Spirituality/religion/ 
Personal beliefs 
          
Social Relationships  .40  .37     -.54 -.56 
Personal relationships  .27  .37     -.57 -.57 
Social support  .25  .32   -.25  -.48 -.46 
Sexual activity  .50  .23     -.36 -.43 
Environment  .30  .25     -.33 -.44 
Physical safety/security  .24  .26 -.31    -.39 -.46 
Home environment    .23     -.32 -.37 
Financial resources           
Health and social care          -.30 
New information/skills    .26     -.22 -.39 
Participation recreation  .33  .36   -.25  -.56 -.63 
Physical environment    .21    .65 -.25 -.21 
Transport      -.21  .64   
Abbreviations: BI =Body Image, SF = Sexual Functioning, SE = Sexual Enjoyment, FP = Future Perspective, SS = Systemic therapy Side effects, BS = Breast 
Symptoms, AS = Arm Symptoms, HL = upset by Hair Loss.  
Note: Non-significant results are not shown. All correlations are significant at 0.01 (2-tailed tested), except for the correlations in bold (significant at 0.05; 2-tailed 
tested).  The relatively high associations between HL and Working Capacity, Physical Environment, and Transport are probably due to small number of participants 
who filled in this subscale (n≈25) 
Table 5. Construct validity of the WHOQOL-100 (BCS group)  
SF-36 
WHOQOL- 100  facets 
GH PF SF RLF RLM MH V BP HC 
CESD STAI 
Overall QOL/General Health .65 .45 .54 .51 .43 .60 .57 .51 .29 -.48 -.56 
Physical Health .70 .53 .62 .67 .39 .55 .71 .64 .25 -.58 -.49 
Pain and discomfort -.60 -.36 -.50 -.48 -.33 -.52 -.60 -.68 -.22 .48 .40 
Energy and fatigue .59 .49 .60 .64 .35 .60 .83 .56 ..21 -.59 -.49 
Sleep and rest .20  .34 .20 .21 .35 .33 .24  -.31 -.31 
Mobility .39 .34 .31 .39 .24 .34 .40 .37 .19 -.28 -.24 
Activities of daily living .72 .59 .61 .71 .41 .51 .60 .63 .23 -.57 -.44 
Dependence/medication -.58 -.42 -.41 -.40 -.34 -.35 -.40 -.51  .37 ..34 
Working capacity .65 .47 .61 .67 .42 .44 .54 .51 .19 -.58 -.41 
Psychological Health .49 .32 .43 .43 .36 .69 .57 .41 .25 -.63 -.62 
Positive  feelings .46 .30 .37 .37 .36 .47 .43 .33  -.56 -.52 
Cognitive functions .35 .17 .30 .25  .38 .40 .31 .19 -.37 -.32 
Self-esteem .35 .24 .23 .32 .19 .50 .35 .35 .21 -.44 -.42 
Body image/appearance .22 .17 .21 .20 .26 .39 .30 .19  -.30 -.31 
Negative feeling -.47 -.29 -.51 -.44 -.41 -.71 -.52 -.40 -.21 -.63 -.62 
Spirituality/religion/personal  
Beliefs 
           
Social Relationships .23  .24 .23  .24 .26   -.35 .34 
Personal relationships .32 .20 .31 .24 .19 .39 .34 .32  -.47 -.47 
Social support .23     .18 .22   -.23 -.29 
Sexual  activity .28 .18 .26 .30 .20 .34 .30 .22  -.42 -.30 
Environment .42 .39 .42 .41 .35 .36 .43 .32  -.43 -.43 
Physical safety/security .23  .24 .18  .30 .26  .17 -.30 -.32 
Home environment .23 .21  .22  .19 .24   -.23 -.28 
Financial resources .26 .25 .30 .26 .21 .21 .28 .22  -.28 -.27 
Health and social care .22  .19    .20 .19    
New information/skills .43 .35 .33 .34 .30 .32 .41 .31  -.40 -.41 
Participation recreation .39 .32 .47 .43 .37 .51 .44 .34 .30 -.54 -.55 
Physical environment .19     .22 .20 .20  -.30 -.19 
Transport .34 .45 .38 38 .32 .20 .40 .27    
Abbreviations: GH = General Health, PF = Physical Functioning, SF = Social Functioning, RLF = Role Limitations Physical, RLM = Role Limitations Mental, MH = 
Mental Health, V = Energy / fatigue, BP = Bodily Pain, HC = Health Changes 
Note: Non-significant results are not shown. All correlations are significant at 0.01 (2-tailed tested), except for the correlations in bold (significant at 0.05; 2-tailed 
tested). 




The CES-D and STAI-state correlated significantly with all domains and 
facets of the WHOQOL-100, except for the WHOQOL-100 facets Spirituality, 
Religion and Personal Beliefs, Financial Resources, and Transport. 
The SF-36, CES-D and STAI scores were correlated with the domains 
and facets of the WHOQOL-100 in the BCS group. The results are presented in 
Table 5. Related subscales of the SF-36 were highly correlated with the 
WHOQOL-100 domains and facets, while low correlations were found between 
non-related domains and facets. For instance, the SF-36 subscales General Health 
and Physical Functioning were highly correlated with the WHOQOL-100 
Physical Domain. Low correlations were found between the SF-36 Bodily Pain 
and the WHOQOL-100 Financial Resources. 
 
Reliability 
Cronbach’s alpha coefficients were calculated separately for the BBP group, the 
BC group, and the BCS group (See Table 6). In all groups, all alpha coefficients 
exceeded .70. In the BC group, they ranged for the domains from .76 (Social 
Relationships) to .88 (Environment). The alpha coefficients in the BBP group 
ranged from .78 (Social Relationships) to .91 (Physical Health). At the facet level, 
the internal consistency exceeded .72 for all facets in all groups.  
Table 7 presents test-retest correlations. Correlations were all strong and 
significant at the 0.01 level (2-tailed tested), ranging from .58 (Self-esteem) to .90 
(Financial Resources). 
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WHOQOL-100 domains and facets 
BBP (T2) BC (T2) BCS 
Overall QOL and General Health .88 .87 .87 
Physical Health .91* .85* .85* 
Pain and discomfort .77 .77 .87 
Energy and fatigue .90 .91 .88 
Sleep and rest .93 .92 .91 
Mobility .90 .91 .92 
Activities of daily living .91 .90 .90 
Dependence/medication .92 .85 .87 
Working capacity .94 .94 .87 
Psychological Health .83* .84* .68* 
Positive feelings .81 .82 .77 
Cognitive functions .82 .84 .81 
Self-esteem .83 .84 .74 
Body image and appearance .91 .99 .84 
Negative feelings .85 .86 .81 
Spirituality/religion/personal beliefs .92 .90 .73 
Social Relationships .78* .76* .71* 
Personal relationships .74 .78 .57 
Social support .89 .88 .80 
Sexual activity .82 .82 .86 
Environment .85* .88* .83* 
Physical safety and security .72 .78 .68 
Home environment .75 .74 .74 
Financial resources .93 .91 .87 
Health and social care .81 .84 .80 
Opportunities for New Information and 
Skills 
.84 .84 .84 
Participation recreation .81 .80 .74 
Physical environment .72 .75 .66 
Transport .92 .92 .88 
1
 Cronbach’s alpha coefficients were calculated at item level, except for the values marked 
with *, which were calculated at facet level.  




Table 7. Test-retest correlations T2 en T3 (BBP group) 
WHOQOL-100 
Domains and facets Correlations (r) 
Overall QOL and General Health .85 
Physical Health .92 
Pain and discomfort .73 
Energy and fatigue .85 
Mobility .83 
Activities of daily living .81 
Dependence/medication .87 
Working capacity .84 
Psychological Health .91 
Positive feelings .84 
Cognitive functions .83 
Self-esteem .58 
Body image and appearance .87 
Negative feelings .84 
Spirituality/religion/personal beliefs .72 
Social Relationships .86 
Personal relationships .81 
Social support .81 
Sexual activity .77 
Environment .85 
Physical safety and security .77 
Home environment .79 
Financial resources .90 
Health and social care .69 
Opportunities for new information and skills .73 
Participation recreation .82 
Physical environment .77 
Transport .85 
Note: All correlations (Pearson r product-moment correlations) were significant at the 
0.01 level (2-tailed tested). 
 





The aim of the present study was to examine the psychometric properties of the 
WHOQOL-100 in a population of women with breast abnormalities (benign or 
malignant) and breast cancer survivors. Before examining the reliability and 
validity of the WHOQOL-100, confirmatory factor analyses (CFA) were 
conducted to test whether the original six-domain structure and the in more recent 
publications suggested four-domain structure were suited to a population with 
(former) breast problems. Both models fitted well, although in both cases some 
modification in specification was needed in order to determine a model that better 
represented the sample data. In case of both models some measurement error 
covariances appeared to be systematic rather than random. It is difficult to 
indicate whether they derive predominantly from item characteristics (e.g., a high 
degree of overlap in item content), or respondent characteristics (e.g., response 
bias), or interactions between item and respondent features. The four-domain 
model, however, demonstrated to a lesser extent such possible areas of misfit. 
Therefore, we prefer the four-domain structure and conclude that the WHOQOL-
100 is a truly generic instrument, which is also applicable to women with breast 
problems. 
The WHOQOL-100 seemed to be a reliable instrument for the use in 
women with breast problems. That is, the internal consistencies were more than 
satisfactory, with all Cronbach’s alpha coefficients exceeding .70 for all domains 
and facets, demonstrating homogeneity of item content. This is consistent with the 
finding of Tazaki et al. [22] who also reported an adequate Cronbach’s alpha for 
the total scale. Test-retest reliability was high. 
With regard to validity, we expected that the WHOQOL-100 would 
correlate moderately with related components of the EORTC – QLQ BR 23 and 
the CES-D. The associations that were found between the WHOQOL-100 and the 
other instruments confirmed the hypothesis regarding the EORTC-QLQ-BR 23 
scale Body Image, high correlations were found with the WHOQOL-100 facet 
Body Image and Appearance. The global WHOQOL-100 facet correlated most 
strongly with the EORTC-QLQ-BR 23 scale Future Prospective. In addition, the 
CES-D, and STAI-state correlated significantly with all domains and facets of the 
WHOQOL-100. Pearson correlations between both questionnaires ranged 




between -.21 and .77. The highest correlation between the WHOQOL-100 and the 
EORTC-QLC-BR23 was .65 for QOL Physical Environment and HS Upset by 
Hair Loss, indicating that outcome measures are not interchangeable. Other 
studies also indicated that QOL and HS are distinct concepts [41-43]. 
A limitation of the present is study is that women with breast problems 
(BBP and BC) were asked to participate and to fill in questionnaires, while they 
were under great stress. Therefore, we needed several groups in order to establish 
the psychometric evidence for the WHOQOL-100. For instance, test-retest 
reliability was checked in relatively stable persons (BBP) at T2.  
In conclusion, the results of the present study showed that the WHOQOL-
100 had good reliability and validity, and, therefore, is a suitable instrument for 
measuring QOL in a population of women who have (had) abnormalities (benign 
or malignant) of the breast. 
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Objective: Scores on quality of life (QOL) domains and facets are probably 
subject to fluctuations across time due to the course of breast cancer (BC) 
treatment. Existing QOL studies have been cross-sectional. Therefore, this 
prospective follow-up study is the first to examine whether QOL domains 
(physical health, psychological health, social relationships, and environment) and 
QOL facets contributed differentially across time to overall QOL in women with 
early stage BC. Methods: From the 608 participating women, 225 women had 
early stage BC. Before diagnosis (Time-1) and one (Time-2), three (Time-3), six 
(Time-4), and 12 months (Time-5) after surgical treatment, women with early 
stage BC were assessed on QOL (WHOQOL-100). Results: Psychological Health 
and Social Relationships were the QOL-domains that predicted overall QOL most 
consistently at the various time points. Environment contributed to a lesser extent 
to overall QOL compared with Physical Health, Psychological Health, and Social 
Relationships. Almost at all measurement points, the facets Positive Feelings and 
Personal Relationships were important factors in the process of maintaining a 
good overall QOL. Conclusions: QOL domains and facets contributed differently 
to overall QOL at various time points across treatment in women with early stage 
BC. 





In the Netherlands, over 11,500 women were diagnosed with breast cancer (BC) 
in 2003 [1]. In 2005, there were an estimated number of 119,000 BC patients or 
BC survivors in the Netherlands. Due to advances in cancer screening and 
medical treatment, this number might increase to about 194,000 within ten years 
[2]. In recent decades, breast conserving therapy has become an alternative to 
mastectomy. Most women with early stage BC have a choice between these two 
treatment options, which have equivalent survival rates [3, 4]. However, this 
decision is not easy to make. Therefore, concepts like quality of life (QOL) are 
important because they can inform surgeons and patients in the decision-making 
process of determining which treatment options to use [5].  
In general, definitions of QOL emphasize that QOL is multidimensional 
[6] and in the eye of the beholder [7]. QOL represents subjective evaluations of 
oneself, one’s social and material world, and reflects the extent to which the 
individual is satisfied with them or is bothered by problems in those areas [7]. In 
line with this principle, the World Health Organization Quality of Life Group 
(WHOQOL Group) defined QOL as “an individual’s perception of his/her 
position in life in the context of the culture and value systems in which he/she 
lives and in relation to his/her goals, expectations, standards and concerns. It is a 
broad-ranging concept incorporating in a complex way the person’s physical 
health, psychological state, level of independence, social relationships, personal 
beliefs and relationship to salient features of the environment” (p. 1405) [8]. In 
line with this conceptualization, the WHOQOL Group has developed the 
WHOQOL-100 instrument. This questionnaire assesses three levels of QOL: (i) 
the first level corresponds with overall QOL, (ii) the second level consists of the 
separate domains of QOL, and (iii) the third level is formed by the specific 
aspects within each domain. This approach is consistent with Spilker’s 
hierarchical model of QOL [9]. Moreover, Spilker’s model assumes that QOL 
variables at a lower level determine QOL variables at a higher level. This 
“pyramid model” containing lower and higher QOL levels has practical relevance 
because it gives insight in the consequences of an illness for patients in terms of 
valuation of life [10].  
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Few studies have examined the contribution of physical, psychological, 
and social well-being to patient’s evaluations of overall QOL [10-12]. One study 
found that the domain of psychological functioning contributed to overall QOL in 
healthy subjects as well as patients with chronic disorders [11]. However, this 
study did not include breast cancer patients. Another study described the role of 
fatigue and QOL domains on overall QOL in lung and breast cancer patients 
preceding radiotherapy [10]. These studies have major limitations because of 
small sample size, the employment of a cross-sectional design, and the assessment 
of the first and second level of QOL only. Little research has been conducted to 
assess quantitatively the relationships between QOL domains in breast cancer 
patients [10]. Differences in the contribution of specific QOL domains and QOL 
facets can be expected between different diseases [10]. However, differences can 
also be expected across time. According to Leventhal and Colman [13], there is a 
“need to assess the importance assigned to various experiential domains in 
making quality of life judgments, and the need to understand that people observe, 
and then integrate, experienced events into quality of life judgments” (p.758). 
Recently, Lu et al. [14] stated that it is important to acquire detailed information 
regarding the contributions of separate domains and facets of QOL to overall 
QOL judgments. It is quite conceivable that the salience, meaning, and 
importance of the domains and their consistent facets as well as the ways they are 
integrated will change over time.   
To the best of our knowledge, the present prospective follow-up study is 
the first to examine the relationships between QOL domains (second level: 
Physical Health, Psychological Health, Social Relationships, and Environment) 
and facets (third level), on the one hand, and overall QOL (first level), on the 
other hand, at several moment in time in women with early stage BC. In addition, 
this study examined which baseline assessments of QOL domains and facets 
contributed substantially to overall QOL at one-year after surgical treatment. 
From a theoretical point of view, knowledge about the relationships between 
lower level assessment of QOL and higher level assessment is important, since it 
provides insight in the process underlying overall QOL judgments [11]. 
Moreover, as several clinicians and researchers prefer to use composite scores in 
QOL assessments in clinical practice, we now gain a better understanding of the 
usefulness of this preference for combining subtest scores.  For instance, “it is the 
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patient’s view of the disease and its treatment, and his or her view as to how they 
affect the physical, psychological, and social self, that holds the key to 
understanding quality of life” (p.670) [13]. We hypothesized that the association 
between different QOL-domains and facets, on the one hand, and overall QOL, on 
the other hand, in early stage BC patients would differ across time. For instance, 
facets of physical health and social relationships were expected to be more 
important during the first months after surgical treatment, while it is quite 
conceivable that facets of psychological health would be rated as most important 
in later time periods. Furthermore, we hypothesized that the Environment-domain 
would contribute to a lesser extent to the prediction of overall QOL compared 
with Physical Health, Psychological Health, and Social Relationships. Finally, it 
was expected that facet scores belonging to the domains of Social Relationships 
and Psychological Health assessed at baseline, would play a significant role in the 




Women with a palpable lump in the breast or an abnormality on a screening 
mammography were referred by their general practitioner to the surgical 
outpatient clinics of the St. Elisabeth Hospital (Tilburg, The Netherlands), the 
Maasland Hospital (Sittard, The Netherlands), or the Jeroen Bosch Hospital (Den 
Bosch, The Netherlands). The present study, in which the predictors of overall 
QOL are examined, is part of a larger prospective follow-up study focusing on the 
role of personality in early stage BC patients’ QOL.  
The data were collected from September 2002 until September 2006.  Of 
the 799 eligible women, 609 (76.2%) completed the first set of questionnaires 
before diagnosis was known. The main reasons for not participating were the 
length of questionnaires and the amount of stress women experienced at their first 
visit at the hospital. Of these 609 women, 223 were subsequently diagnosed with 
early stage breast cancer (BC). Women who had a history of abnormalities in the 
breast, benign or malignant, or had a breast tumor that was too large (>5 
centimeter) for breast conserving therapy, were excluded from the study. In order 
to participate, the women had to be able to write and read in Dutch. The 
questionnaires were completed before the women visited the surgeon and 
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radiologist, i.e. before the diagnosis, benign or malignant, was known. After the 
baseline measurement (Time-1), women completed questionnaires at one (Time-
2), three (Time-3), six (Time-4), and 12 (Time-5) months after surgical treatment. 
The reference point was surgical treatment because otherwise follow-up measures 
would interfere with the timing of treatment modalities. Participation in the study 
was not known to the surgeon in attendance and, therefore, did not affect 
treatment and clinical follow-up. All participants gave written informed consent. 
 
Measurements 
QOL was measured at all time points using the WHOQOL-100 [15, 16], a cross-
culturally developed generic multidimensional instrument. This instrument covers 
24 facets, assessed with 96 questions, and one General Health and Overall Quality 
of Life facet (4 questions). In this study, we used this General Health and Overall 
Quality of Life facet as the dependent variable. Because this scale also included 
one item on general health, we decided to exclude this particular item from the 
analysis. Each facet of the WHOQOL-100 is measured with four items using a 5-
point Likert scale. The 24 facets were initially scored in six domains of QOL: 
Physical Health, Psychological Health, Levels of Independence, Social 
Relationships, Environment, and Spirituality, Religion and Personal Beliefs [15]. 
Nowadays, it is well accepted to convert these 24 facets into four domains as 
described by the WHOQOL group [17-19]. In general high facet scores indicate 
good QOL, except for Pain and Discomfort, Negative Feelings, and Dependence 
on Medication or Treatments. The time frame of reference is the previous two 
weeks. Reliability and validity [16, 17, 19] are adequate, and sensitivity [20] is 
high. Recently, the WHOQOL-100 is validated in a group of BC patients, women 
with benign breast problems, and BC survivors [19]. Cronbach’s alpha 
coefficients ranged for the domains from .76 (Social Relationships) to .88 
(Environment) in the BC group. At the facet level, the internal consistency 
exceeded .72 for all facets in all groups [19].  
 
Socio-demographic and clinical variables 
Information on sociodemographic data (age, partner status, educational 
background, and employment status) was obtained by self-report at Time-1. 
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Clinical information (diagnosis, disease stage, type of surgery, tumor size, 
adjuvant therapy) was obtained from the medical files.  
 
Statistical procedure 
Student t-tests and Chi-square tests were used to examine the potential differences 
between participants and non-participants. Multiple linear regression analyses 
(method: enter) were used to examine the associations of QOL domains and 
facets, on the one hand, and overall QOL at the various time points, on the other 
hand (Time-2 to Time-5). In order to preserve statistical power, two preliminary 
multiple linear regression analyses were run. First, we determined which QOL 
domains (Physical Health, Psychological Health, Social Relationships, 
Environment) were significantly associated with overall QOL at a given time 
point. Second, those QOL facets of a significant contributing domain were 
entered in a subsequent regression analysis. For instance, if Psychological Health 
(Time-2) was associated with overall QOL (Time-2), the facets belonging to that 
particular domain (Positive Feelings, Cognitive Functions, Self-esteem, Body 
Image and Appearance, Negative Feelings, and Spirituality Religion Personal 
Beliefs) were entered in the regression analysis. Thus, dependent and independent 
variables entered in the regression analyses were measured at the same time point. 
The final analysis included all facets that were significantly associated with 
overall QOL for a given time point. In order to determine whether QOL domains 
and facets assessed at baseline predict overall QOL at Time-5, multiple linear 
analyses were used. Again, preliminary analyses were used (as described above). 
However, different time points were now used. Statistical significance was 
designated at a p-value of .05 or smaller. In addition, we examined which QOL 
facets as measured at Time-1 predicted overall QOL at Time-5. All statistical 
analyses were performed using the Statistical Package for the Social Sciences 
(SPSS Chicago, IL, USA; version 14.0). 





Demographic and clinical characteristics are presented in Table 1. Participants 
were significantly younger than non-participants (p =.002). They did not differ on 
other sociodemographic or clinical characteristics. Figure 1 presents the flow 
chart of this study.  
 
Table 1. Socio-demographic and characteristics of the participants at baseline 
 BC group (n = 225) 
Age at diagnosis (mean ± SD) 58.7 (9.4) 
Living with a partner (yes/no/missing) 180 (80.3) / 38 (16.6) / 7 (3.1) 
Having children (yes/no/missing) 191 (84.9) 29 (13.1) /  3 (1.3) 
Educational level 
(0-9 yrs / 10-14 yrs / >14 years /missing) 
86 (38.2) / 95 (42.2) / 38 (16.9) / (4.0) 
Paid work (yes/no/missing) 86 (38.2) / 136 (60.4) / 3 (1.3) 
Diameter of tumor  
<1 cm / 1-3 cm /  >3 cm 49 (22.0) / 146 (65.5) / 25 (11.2) 
Type of surgery  
BCT/ MTC/ No surgical treatment 106 (47.1) / 115 (51.1) / 4 (1.8) 
Adjuvant therapy  
Yes / No  171 (75.9) / 54 (24.1)  
Disease stage  
Stage 0 26 (11.6) 
Stage I 92 (40.9) 
Stage IIa 68 (30.2) 
Stage IIb 35 (15.6) 
Indefinable 2 (  0.9) 
Abbreviations: MTC = modified radical mastectomy; BCT = breast conserving therapy; 
Note: For the socio-demographics, percentages are between brackets (except for age).  
 




N = 799 
Breast Cancer 
N = 225 (Time-1) 
 
Time-2: 
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Time-3: 
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Refused to participate: 
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Time-4: 
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Associations between QOL domains and overall QOL 
Preliminary analysis showed that the Physical Health-domain (only Time-2) and 
Environment-domain (only Time-3 and Time-5) did not significantly contribute to 
overall QOL. Therefore, facets belonging to Physical Health and Environment 
were left out of further analyses at these time points (Table 2). At all time points, 
overall QOL was associated with the domains Psychological Health and Social 
Relationships. Compared with the Physical Health domain and Social 
Relationships domain, the facets of the Psychological Health-domain explained 
the largest proportion of variance in the association with overall QOL across time 
(adjusted R
2
 > .63). 
Facets belonging to the physical domain, for instance, Sleep and Rest, 
Mobility, Activities of Daily Living, and Working capacity turned out to be 
relevant at some point(s) in time. The facets Sleep and Rest and Mobility, for 
instance, predicted overall QOL especially in the first month after surgical 
treatment, while Working Capacity became significantly associated with overall 
QOL one year after surgical treatment. This also applies for the facets Cognitive 
Functions, Self-esteem, and Negative Feelings (Psychological Health). However, 
the facet Positive Affect was significantly associated with overall QOL across al 
time points. All facets belonging to the Social Relationships domain were 
associated with overall QOL at some time points. However, Personal 
Relationships was positively associated with overall QOL across all time points. 
Several facets, for instance, Body Image and Appearance and Spirituality 
Religion Personal Beliefs, were not significantly associated with overall QOL 
throughout all analyses (Table 3). 
 
Table 2. Beta weights for preliminary multivariate regression analyses of overall QOL 
after surgical treatment 
Predictor variables QOL 
domains (level 2) 
Time-2 Time-3 Time-4 Time-5 
Physical Health .09 ns .27 *** .20 ** .16 * 
Psychological Health .46 *** .42 *** .35 *** .45 *** 
Social Relationships .26 *** .22 *** .28 *** .23 ** 
Environment .15* .07 ns .17 **  .14 ns 
Note: *** p<.0001, ** p < .001, * p < .05, ns = not significant 
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Table 3. Beta weights for preliminary multivariate regression analyses of overall QOL 
after surgical treatment 
Predictor variables  
QOL facets (level 3) 
Time-2 Time-3 Time-4 Time-5 
Physical Health     
Pain and Discomfort  -.04 ns -.16 ns -.14 ns 
Energy and Fatigue  .18 ns .07 ns -.13 ns 
Sleep and Rest  .19 ** .10 ns .13 ns 
Mobility  .26 ** .13 ns .14 ns 
Activities of Daily Living  .23 ns .28 * .28 * 
Dependence of Medication  .04 ns -.11 ns -.01 ns 
Working Capacity  -.00 ns -.00 ns .27 * 
Psychological Health     
Positive Feelings .25 ** .30 *** .40 *** .47 *** 
Cognitive Functions .14 ns .16 * .23 ** .24 *** 
Self-esteem .27 ** .18 ns .19 * .13 ns 
Body Image and Appearance .02 ns  .09 ns .04 ns .04 ns 
Negative Feelings -.20 ** -.19 ** -.08 ns -.12 ns 
Spirituality, Religion, Personal 
Beliefs 
.10  ns .09 ns .03 ns .06 ns 
Social Relationships     
Personal Relationships .62 *** .54 *** .43 *** .54 *** 
Social Support .07 ns .10 ns .30 *** .14 ns 
Sexual Activity .12 ns .16 * .17 ** .15 * 
Environment     
Physical Safety and Security .17 *  .22 *  
Home Environment .12 ns  .12 ns  
Financial Resources .00 ns  .04 ns  
Health and Social Care .02 ns  .13 ns  
Opportunity for Acquiring 
Skills 
.12 ns  -.08 ns  
Participation in Leisure .57 ***  .49 ***  
Physical Environment -.16 *  -.02  ns  
Transport -.10 ns  .00 ns  
Note: *** p<.0001, ** p < .001, * p < .05, ns = not significant 
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In the final analyses, the most consistent facets contributing to overall 
QOL were Positive Feelings and Personal Relationships. Other facets, for 
instance, Self-esteem (Time-2) and Cognitive Functioning (Time-3), contributed 
only once to the prediction of overall QOL. Table 4 presents the standardized beta 
weights, confidence intervals, ANOVAs and Adjusted R
2 
for the multivariate 
regression analyses. 
 
Predictors of overall QOL 
Preliminary analyses showed that the domains Physical Health (ß = .24, p < 
.0001), Psychological Health (ß = .13, p = .037), Social Relationships (ß = .19, p= 
.001), and Environment (ß = .22, p < .0001), assessed at baseline (Time-1), 
contributed significantly to overall QOL (Time-5). The Physical Health facets 
Sleep and Rest (ß = .14, p = .006) and Mobility (ß = .15, p = .014) predicted 
overall QOL at Time-5. Positive Affect (ß = .18, p = .004), Cognitive Functioning 
(ß = .18, p < .003), and Self-esteem (ß = .25, p < .0001) belonging to the 
Psychological Health domain predicted overall QOL at Time-5. Personal 
Relationships (ß = .38, p < .0001) and Sexual Activity (ß = .19, p < .0001) were 
significantly associated with overall QOL. Finally, the facets Health and Social 
Care (ß = .15, p = .009), Opportunity for Acquiring Skills (ß = .15, p = .021), and 
Participation in Leisure (ß = .25, p < .0001) predicted overall QOL.  
The final analysis showed that: Mobility (ß = .17, p < .0001), Personal 
Relationships (ß = .19, p = .003), Sexual Activity (ß = .12, p = .013), and 
Opportunity for Acquiring Skills (ß = .13, p = .038) were significantly 
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Table 4. Final multivariate linear regression analyses 
 Predictor variables QOL facets  
(level 3) 
ß p-value  
Positive Feelings .15 ns F = 42.48*** 
Self-esteem .17 .046  
Negative Feelings -.12 ns Adjusted R
2
= .67 
Personal Relationships .30 <.0001  
Physical Safety .08 ns  
Participation in Leisure .21 .012  
Time-2 
Physical Environment -.09 ns  
Sleep and Rest -.06 ns F = 51.11*** 
Mobility .27 <.0001  
Positive Feelings .22 .004 Adjusted R
2
= .66 
Cognitive Functioning .13 .047  
Negative Feelings -.13 ns  
Personal Relationships .32 <.0001  
Time-3 
Sexual Activity .02 ns  
ADL .16 .004 F = 46.02*** 
Positive Feelings .28 .001  
Cognitive Functioning .05 ns Adjusted R
2
= .74 
Self-esteem  .11 ns  
Personal Relationships  .01 ns  
Social Support  .20 .001  
Sexual Activity .11 .038  
Physical Safety  .17 .007  
Time-4 
Participation in Leisure  .05 ns  
ADL .05 ns F = 46.02*** 
Working Capacity .06 ns  
Positive Feelings .46 <.0001 Adjusted R
2
= .68 
Cognitive Functions .02 ns  
Personal Relationships .32 <.0001  
Time-5 
Sexual Activity .07 ns  
Note: *** p<.0001, ns = not significant; Abbreviations: ADL, Activities of Daily Living 
 





The aim of this prospective follow-up study was to examine which QOL domains 
and facets contribute significantly to overall QOL in women with early stage BC 
during the first year after surgery. In this way, this study adds knowledge to our 
understanding of what determines the overall QOL scores of women with early 
stage BC. 
Two domains of QOL, i.e., Psychological Health and Social 
Relationships, were significantly associated with overall QOL at all time points, 
which is in line with the findings of a previous cross-sectional study [11]. It was 
also found in the latter study that psychological functioning was important in 
people with a broad range of chronic diseases as well as in healthy subjects, while 
social functioning was contributing to overall QOL in only some of the chronic 
diseases (i.e., back problems, rheumatoid arthritis, and migraine). Thus, findings 
indicate that there may be differences between disease populations. As a 
consequence, future studies should examine the role of second and third level 
aspects in different samples. 
Our hypothesis that different QOL facets would determine overall QOL at 
a given time point after BC diagnosis was partly confirmed. That is, two facets, 
namely Positive Feelings and Personal Relationships predicted overall QOL 
across all time points. However, other predictors did turn out to be relevant at 
some point(s) in time, except for the facet Body Image and Appearance. This 
factor remained non-significant throughout all analyses. This is in line with, for 
instance, Andritsch et al. [21] who found that body image did not play a 
substantial role after 1 to 5 years after BC diagnosis. Energy and Fatigue, 
Dependence on Medication, or Spirituality Religion Personal Beliefs predicted 
QOL the first month after diagnosis, while Working Capacity significantly 
predicted QOL 12 months after surgical treatment. Between 3 and 6 months, 
Sleep and Rest, and Sexual Activity contributed to the prediction of overall QOL. 
Facets belonging to the Psychological Domain were the predominant 
determinants of overall QOL in early stage BC. Physical Health contributed to a 
lesser extent to the explanation of overall QOL. This finding is in line with an 
earlier study [11]. 
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The WHOQOL-100 contains a facet Overall QOL and Health consisting 
of four items. Three of these items refer to QOL, while the other item explicitly 
refers to how satisfied the individual is with his/her health. Therefore, in this 
study, we have used the three items that all explicitly refer to overall QOL. 
However, additional analysis showed that the results remained quite similar when 
the original facet Overall QOL and Health was used (results not shown), which is 
in line with earlier findings [10]. 
Knowledge about the factors contributing to overall QOL at a given time 
point will allow health professionals to adjust follow-up management to the needs 
of women with early stage BC.  For instance, our results show that women with 
early stage BC may benefit from a more multidisciplinary treatment: not only 
focussing on the medical aspects, but also discussing the psychological, social, 
and environmental aspects of BC [11]. Our findings have also methodological 
implications for the use of composite scores in (HR)QOL studies. Composite 
scores are often obtained by averaging scores across domains. Our study clearly 
shows that different aspects of life are important at different points in time. This 
kind of information is lost, when a composite score is used. 
Some caution is needed, when interpreting our results. In this study, we 
only included women with early stage BC (disease stage ≤ 2). Therefore, it is 
possible that women with more advanced BC will show a different pattern of 
QOL facets predicting overall QOL across time. In addition, this sample consisted 
of women only, possibly affecting the results. It is conceivable that in men other 
aspects, such as financial resources are more important determinants of overall 
QOL than in women.  A major strength of this study is the longitudinal follow-up 
design. Due to this design, it provides insight into the longitudinal effects of QOL 
domains and facets on overall QOL [11]. Besides the inclusion of patients in 
different disease stages, it would be interesting to further extend the follow-up 
period in future studies. BC patients may experience a number of different stages 
of survival during their lives and their specific needs at these stages may differ 
[14]. 
Information regarding changes in the prediction pattern of overall QOL 
over time may have important implications for clinical practice. In particular this 
information may help to provide psychological interventions that have a positive 
impact on QOL. This study identified variables that play a major role in 
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predicting overall QOL across time. The outcomes suggest that clinicians and 
caregivers should focus on different domains and facets of QOL in order to 
improve QOL of BC patients. To paraphrase George Orwell: all domains and all 
facets are important, but some of them are more important than others. Some of 
the time! 
In conclusion, our results indicate that in early stage BC positive feelings 
and personal relationships are the predominant contributors to overall QOL 
during the first year after surgical treatment.  
 





1. Netherlands Cancer Registry. Most prevalent cancer types [Meest 
voorkomende kankersoorten]. In: http://www.ikcnet.nl/page.php? 
id=1868&nav_id=114; 2005. 
2. SignaleringscommissieKanker. Cancer in the Netherlands. Trends, 
prognosis, and implications for care demands [Kanker in Nederland. 
Trends, prognoses en implicaties voor zorgvraag]. KWF 
Kankerbestrijding; 2004. 
3. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et 
al. Twenty-year follow-up of a randomized trial comparing total 
mastectomy, lumpectomy, and lumpectomy plus irradiation for the 
treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241. 
4. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. 
Twenty-year follow-up of a randomized study comparing breast-
conserving surgery with radical mastectomy for early breast cancer. N 
Engl J Med 2002;347:1227-1232. 
5. Van der Steeg AF, De Vries J, Roukema JA. Quality of life and health 
status in breast carcinoma. Eur J Surg Oncol 2004;30:1051-7. 
6. Cella D, Tulsky DS. Measuring quality of life today: Methodological 
aspects. Oncology 1990;5:29-38. 
7. Orley J, Saxena S, Herrman H. Quality of life and mental illness. 
Reflections from the perspective of the WHOQOL (editorial). Br J 
Psychiatry 1998;172:291-293. 
8. WHOQOL group. The World Health Organization Quality of Life 
assessment (WHOQOL): position paper from the World Health 
Organization. Soc Sci Med 1995;41:1403-1409. 
9. Spilker B. Introduction to the field of Quality of Life trials. In: Spilker, B 
(Ed.). Quality of Life Assessments in Clinical Trials. New York: Raven 
Press; 1990. 
10. Dagnelie PC, Pijls-Johannesma MC, Lambin P, Beijer S, De Ruysscher 
D, Kempen GI. Impact of fatigue on overall quality of life in lung and 
breast cancer patients selected for high-dose radiotherapy. Ann Oncol 
2007;18:940-944. 
 Chapter 3 
 
72 
11. Arnold R, Ranchor AV, Sanderman R, Kempen GI, Ormel J, Suurmeijer 
TP. The relative contribution of domains of quality of life to overall 
quality of life for different chronic diseases. Qual Life Res 2004;13:883-
896. 
12. Beijer S, Kempen GI, Pijls-Johannesma MC, de Graeff A, Dagnelie PC. 
Determinants of overall quality of life in preterminal cancer patients. Int J 
Cancer 2008;123:232-235. 
13. Leventhal H, Colman S. Quality of life: a process view. Psychology and 
health 1997;12:753-767. 
14. Lu W, Cui Y, Chen X, Zheng Y, Gu K, Cai H, et al. Changes in quality of 
life among breast cancer patients three years post-diagnosis. Breast 
Cancer Res Treat 2009;114:357-369. 
15. WHOQOL Group. The World Health Organization Quality of Life 
Assessment (WHOQOL): development and general psychometric 
properties. Soc Sci Med 1998;46:1569-1585. 
16. De Vries J, Van Heck GL. The World Health Organization Quality of 
Life assessment instrument (WHOQOL-100): validation study with the 
Dutch version. Eur J Psychol Assess 1997;13:164-178. 
17. Power M, Harper A, Bullinger M. The World Health Organization 
WHOQOL-100: tests of the universality of Quality of Life in 15 different 
cultural groups worldwide. Health Psychol 1999;18:495-505. 
18. WHOQOL Group. Development of the World Health Organization 
WHOQOL-BREF quality of life assessment. The WHOQOL Group. 
Psychol Med 1998;28:551-558. 
19. Den Oudsten BL, Van Heck GL, Van der Steeg AF, Roukema JA, De 
Vries J. The WHOQOL-100 has good psychometric properties in breast 
cancer patients. J Clin Epidemiol 2009;62:195-205. 
20. O'Carroll RE, Smith K, Couston M, Cossar JA, Hayes PC. A comparison 
of the WHOQOL-100 and the WHOQOL-BREF in detecting change in 
quality of life following liver transplantation. Qual Life Res 2000;9:121-
124. 
21. Andritsch E, Dietmaier G, Hofmann G, Zloklikovits S, Samonigg H. 
Global quality of life and its potential predictors in breast cancer patients: 
an exploratory study. Support Care Cancer 2007;15:21-30. 
Chapter 4 
Predictors of depressive symptoms 12 months after surgical 
























                                                   
∗
  Den Oudsten BL, Van Heck GL, Van der Steeg AFW, Roukema JA, De Vries J. 
Predictors of depressive symptoms 12 months after surgical treatment of early 
stage breast cancer. Psycho-oncology (in press). 





Objective: Nearly half of the women with breast cancer (BC) show depressive 
symptoms in the first year after diagnosis. This has a major impact on patients’ 
lives. Therefore, the aim of this study was to identify predictors of depressive 
symptoms 12 months after surgical treatment. Furthermore, the stability of 
depressive symptoms across 12 months was investigated for persons scoring high 
versus low/moderately on agreeableness, trait anxiety, and neuroticism. Methods: 
From the 609 women with an abnormality in the breast, 223 appeared to have 
early stage BC. A depressive symptoms questionnaire (CES-D) was completed 
before diagnosis and 1, 3, 6, and 12 months after surgical treatment. In addition, 
patients completed questionnaires on personality (STAI, NEO-FFI), fatigue 
(FAS), and aspects of quality of life (WHOQOL-100). Results: Before diagnosis 
and one year later, 40.9% and 27.8% of the women, respectively, scored above 
the established cut-off score for depressive symptoms. Depressive symptoms 
significantly improved in this period. Patients reported higher scores, when they 
had a breast conserving therapy (BCT), scored low on agreeableness, scored high 
on neuroticism, or reported higher scores on depressive symptoms or fatigue 
before diagnosis. Other clinical and sociodemographic factors did not predict 
depressive symptoms. Conclusions: Besides BCT, fatigue, and depressive 
symptoms, personality, especially neuroticism and agreeableness, predicted 
depressive symptoms one-year after surgical treatment. Therefore, it is important 
to screen patients on these characteristics in order to prevent long-term depressive 
symptoms.  
 





Breast cancer (BC) is the most common type of malignancy among women in 
Europe. BC was responsible for 17.6% of all deaths in 2006 [1]. In the 
Netherlands, one in every nine women will develop carcinoma in situ or invasive 
carcinoma of the breast during her life [2]. Nowadays, a lot of women survive BC 
due to early detection of cancer by screening programmes [3].  
BC patients have a high risk of developing mood disorders. There is a 
growing body of studies demonstrating this. Studies examining clinically 
significant depression, however, show a wide array of estimated depression rates 
due to differences in study population (e.g., disease stage, treatment stage), study 
design (e.g., the criteria used to define depression) and choice of measures [4, 5]. 
In spite of these discrepancies the overall picture is that during the first year 
following a BC diagnosis, nearly 50% of the women with early stage BC scored 
high on depression and/or anxiety [6]. Compared with the general female 
population, the prevalence of depression in women with early stage BC is twice 
as high [6].  
Depression has a detrimental impact on patients’ lives [7-9], adversely 
affects compliance with medical treatment [10], significantly influences recovery 
from treatment [11], and may reduce survival length [12-14]. In addition, women 
with depression experience more side-effects of treatment [15]. Major depression 
and depressive symptoms are frequently underrecognized and undertreated among 
breast cancer patients [4, 16]. Therefore, the identification of predictive factors 
for depressive symptoms in patients is important. In this way, screening tools 
including items assessing these predictive factors can be developed. Then, the 
detection of women at risk of developing symptoms can be improved in early 
stage and consequently more adequate support can be provided. 
Various risk factors fitting the biopsychosocial model have been 
examined in the literature. However, previous studies differ substantially with 
respect to their study design, sample size, concepts assessed, and populations 
examined, as well as factors under consideration. Due to these discrepancies, 
there are striking inconsistencies regarding the role of clinical factors and their 
association with clinical depression (i.e., DSM-IV) or depressive symptoms (i.e., 
self-report). Some studies have shown that clinical factors, such as type of 
 Chapter 4 
 
76 
surgery, disease stage or adjuvant therapy, were not associated with depressive 
symptoms [17, 18]. Other studies, in contrast, found that higher levels of 
depressive symptoms were predicted by axillary lymph node involvement [5] or 
the presence of pain [18].  
With regard to socio-demographics, younger age was negatively 
associated with depressive symptoms [6, 18, 19]. The lack of a confiding intimate 
relationship appeared to be a determinant for clinical depression and anxiety at 4 
to 12 months after diagnosis [6]. Furthermore, perceived adequacy and network 
characteristics were significantly associated with less depression [18, 20, 21], 
however, only in young female patients [18, 21]. Greater risk for depressive 
symptoms was associated with more stressful life events, less optimism, 
ambivalence concerning the expression of negative emotions, sleep disturbance, 
and poorer social functioning [17]. Some studies have examined the role of 
personality factors with regard to psychological distress in BC. For instance, trait 
anxiety predicted psychological distress in BC patients on average 21 months 
after surgery [18]. Women with psychological distress were, in general, 
characterized by an increased level of anxiety, intrusive thoughts, serious health 
complaints, and sleeping problems. Pessimists, compared with optimists, had a 
three times greater risk of experiencing depressive symptoms one year after BC 
surgery [22]. Recently, it was found that neuroticism may increase the risk for 
developing depressive symptoms in women with BC [23].  
In sum, the existing literature shows that socio-demographic, clinical, and 
personality factors predict depressive symptoms in breast cancer. Although, a 
wide range of predictors of depressive symptoms has been found, until now each 
study has focussed on rather limited sets of predictors. Consequently, there is a 
need for studies examining a broad range of factors reflecting socio-demographic, 
clinical, social as well as psychological variables, including personality traits. 
Given the scarcity of studies and the many inconsistencies in the outcomes of 
these studies, the current study is rather exploratory.  
Thus, the aim of this prospective follow-up study was to explore these 
factors in depressive symptoms one year after surgical treatment. Furthermore, 
the stability of depressive symptoms across 12 months was investigated in 
relation to personality. Concerning personality, we hypothesized that, in addition 
to clinical predictors like adjuvant therapy and type of surgery, trait anxiety and 
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neuroticism would predict depressive symptoms 12 months after surgery. In 





Women with a palpable lump in the breast or an abnormality on a screening 
mammography were referred by their general practitioner to the Department of 
Surgery of the outpatient clinics of the St. Elisabeth Hospital (Tilburg, The 
Netherlands), the Maasland Hospital (Sittard, The Netherlands), or the Jeroen 
Bosch Hospital (Den Bosch, The Netherlands). The present study is part of a large 
research program focusing on the role of personality in quality of life of BC 
patients who had a choice between breast conserving therapy (BCT; i.e. removal 
of the tumor by means of a lumpectomy and axillary lymph node dissection 
followed by radiation of the breast) or mastectomy (MTC; i.e. removal of all 
breast tissue including the nipple). The data were collected from September 2002 
until September 2006. From the 799 eligible women, 609 (76.2%) completed the 
first set of questionnaires before they visited the surgeon or radiologist, i.e. before 
the diagnosis, benign or malignant, was known (Time-1). In this group (N = 609), 
223 appeared to have early stage BC of whom 144 women (63.7%) also 
completed the depressive symptoms questionnaire one year after surgical 
treatment (Time-5). The main reasons for not participating were the length of the 
questionnaires and the amount of experienced stress. Women who had a history of 
abnormalities in the breast, either benign or malignant, or were suspected of 
having a breast tumor that was too large (>5 centimeter) to allow a choice 
between both types of surgery, were not included in the study. In order to 
participate, the women had to be able to read Dutch. After the baseline 
measurement (Time-1; N = 223), women completed questionnaires at 1 (Time-2; 
N = 178), 3 (Time-3; N = 171), 6 (Time-4; N = 167), and 12 (Time-5; N = 164) 
months after surgical treatment. Participation in the study was not known to the 
treating surgeon. The local ethics committee approved the study. All participants 
gave written informed consent. 
 




Questionnaires assessing socio-demographic factors (marital status, children, paid 
work, and education level), psychological factors (depressive symptoms, fatigue, 
sleep and rest, self-esteem, body image, subjective cognitive functioning, pain 
and discomfort, social support), and personality were completed at Time-1. At the 
other time points women again completed a depressive symptoms questionnaire.  
Basic personality factors were assessed with the Neuroticism-
Extraversion-Openness-Five Factor Inventory (NEO-FFI) [24, 25, 26] and the 
State Trait Anxiety Inventory [27, 28]. The NEO-FFI is a self-report 
questionnaire
 
consisting of 60 statements covering five broad dimensions of
 
personality: neuroticism (i.e., the tendency to experience distressing emotions, 
such as fear, guilt, and frustration), extraversion (i.e., the disposition towards 
cheerfulness, sociability, and high activity), openness to new experiences (i.e., the 
tendency to have a receptive orientation towards varied experiences and ideas),
 
agreeableness (i.e., the inclination towards interpersonal trust and consideration of 
others), and conscientiousness (i.e., the tendency towards persistence, sense of 
duty, organizing, planning, and self-discipline). Each statement is rated on a 5-
point scale ranging from 1 (strongly disagree) to 5 (strongly agree), resulting in 
dimension
 
scores between 12 and 60. The internal consistency, test-retest 
reliability, as well as the convergent validity, are acceptable to good [26].
 
 
The STAI consists of two 20-item scales for measuring state anxiety and 
trait anxiety. In the present study, only the Trait Anxiety scale was used, which 
describes how persons generally feel and conceives of anxiety as a personality 
disposition. The STAI trait scale has a 4-point rating scale (1 (almost never) to 4 
(almost always)). The Dutch version of the STAI-Trait scale has good reliability 
and validity [28]. 
The Center for Epidemiological Studies- Depression Scale (CES-D) [29] 
is a 20-item self-report scale measuring the presence and degree of depressive 
symptoms over the past week. The rating scale ranges from 0 (seldom or never) to 
3 ((almost) always). Scores can range from 0 to 60. The CES-D has been 
established as a valid and reliable measure of depressive symptoms in BC patients 
30. Reliability and criterion validity are good [31, 32].  
The Fatigue Assessment Scale (FAS) [33] is a 10-item questionnaire 
assessing perceived fatigue and exhaustion. The response scale is a 5-point rating 
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scale (1 (never) to 5 (always)). Scores on the FAS range from 10 to 50. The 
psychometric properties are good [34-36].  
The World Health Organization Quality of Life assessment instrument-
100 (WHOQOL-100) [37, 38], is a cross-culturally developed generic multi-
dimensional quality of life (QOL) measure. This instrument covers 24 specific 
facets of QOL, assessed by 96 questions, and one General Health and Overall 
Quality of Life facet. Each facet is measured with four items using 5-point Likert 
scales. High facet scores indicate good QOL; except for the facets Pain and 
Discomfort, Negative Feelings, and Dependence on Medication or Treatments, 
which are negatively framed. In the present study, six facets (Pain and 
Discomfort, Cognitive Functions, Sleep and Rest, Self-esteem, Body Image, and 
Social Support) were used. Reliability and validity [38-40] are adequate and 
sensitivity [41] is high. 
 
Medical records 
Data concerning type of surgery (BCT or MTC), disease stage, tumor size after 
pathological examination (mm), and adjuvant treatment (chemotherapy, 




Frequencies were used to present the available sociodemographic and clinical 
data. Student t-tests and chi-square tests were used to examine differences 
between participants and non-participants. As a first step, aiming at minimizing 
the number of independent variables in the final regression analysis, linear 
regression analyses (method: stepwise) were performed separately with socio-
demographic factors (i.e., age, partner, children, educational level, paid job), 
clinical factors (i.e., chemotherapy, hormone therapy, radiotherapy, tumor size, 
disease stage, type of surgery), symptoms (fatigue, pain and discomfort, 
subjective cognitive functions, sleep and rest), psychological factors (i.e., 
depressive symptoms (Time-1), self-esteem, body image), personality factors 
(trait anxiety, neuroticism, extraversion, openness to new experiences, 
agreeableness, conscientiousness) and social support, as independent variables 
and depressive symptoms at 12 months as the outcome measure. Subsequently, 
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the significant predictors of depressive symptoms at 12 months were entered in 
the final regression analyses (method: stepwise).  
General linear model analyses for repeated measures were used to 
investigate the course of depressive symptoms over the various assessment points. 
In addition, stability was examined with respect to those factors that proved to be 
most prominent in the present study: type of surgery, agreeableness and 
neuroticism. For this purpose, we divided the total scores of agreeableness and 
neuroticism into two groups. The first group consisted of the stanines ≤5; the 
second group of stanines ≥6. Partial eta squared (effect size) was derived from the 
general linear model. An effect size between 0.01 and 0.06 is considered as a 
small effect by Cohen’s definition, while effect sizes between 0.06 and 0.13 and 
greater than 0.14 are considered as moderate and strong effect sizes, respectively 
[42]. Multiple post hoc comparisons were corrected with Bonferroni’s method. 
Analyses were performed with SPSS (version 14.0). 
 
Results 
Sociodemographic and clinical characteristics of the participants are shown in 
Table 1. Participants were significantly younger compared with non-participants 
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Table 1. Sociodemographic and clinical characteristics of the participants at baseline 
 BC group (n=223) 
Sociodemographic variables  
Age at diagnosis (mean  ±  SD) 58.7 (9.4) 
Living with a partner (yes/no/missing) 179 (80.3) / 37 (16.6) / 3 (1.3) 
Having children  (yes/no/missing 191 (85.7) / 29 (13.0) / 3 (1.3) 
Educational level 
0-9 yrs/10-14 yrs/> 14 yrs/missing) 
 
85 (38.1) / 95 (42.6) / 37 (16.6) 2 (0.9) 
Paid work (yes/no/missing) 85 (38.1) / 135 (60.5) / 1 (0.4) 
Diameter of tumor  
< 1cm / 1-3 cm / > 3 cm 49 (22.0) / 146 (65.5) /25 (11.2) 
Type of surgery  
BCT/MTC/no surgical treatment 107 (48.0) / 114 (51.1) / 2 (0.9) 
Adjuvant therapy (yes/no) 169 (75.8) / 54 (24.2) 
Disease stage  
Stage 0 24 (10.8) 
Stage I 93 (41.7) 
Stage IIa 69 (30.9) 
Stage IIb 35 (15.7) 
Indefinable 2 (0.9) 
Note: For the sociodemographics, percentages are between brackets (except for age).  
Abbreviations: MTC = modified radical mastectomy; BCT = breast conserving therapy 
 
None of the sociodemographic factors predicted depressive symptoms 
scores at Time-5. The only clinical factor that predicted depressive symptoms at 
Time-5 was type of surgery (β= -.205, p= .017). Fatigue (β= .492, p<.0001) and 
sleep and rest (β= -.162, p= .032), and depressive symptoms (β= .354, p< .0001) 
at Time-1 contributed significantly to the prediction of depressive symptoms at 
Time-5. In addition, social support (β= -.223, p= .008) also predicted depressive 
symptoms. Furthermore, neuroticism (β= .218, p= .020), agreeableness (β= -.155, 
p= .047), and trait anxiety (β= -.155, p < .0001) predicted depressive symptoms at 
Time-5 (see Table 2). In the final analysis, depressive symptoms at Time-5 was 
predicted by type of surgery, depressive symptoms at Time-1, fatigue at Time-1, 
neuroticism, and agreeableness, explaining 39.8% of the variance (F = 18.71, p < 
.0001; see Table 3). 
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Table 2. Regression analyses (stepwise) for depressive symptoms (Time-5) in women 
with early stage BC 
Predictors Beta p-value 
Adjusted R2 
(F-value, p-value) 
Age at baseline  ns  
Children (yes/no)  ns  
Partner (yes/no)  ns  
Paid work (yes/no)  ns  
Educational level  ns  
Disease stage  ns  
Chemotherapy  ns  
Hormone therapy  ns  
Radiotherapy  ns  
Tumor size  ns .035 
Type of surgery -.205 .017 (F = 5.880, p = .017) 
Fatigue (Time-1) .492 <.0001  
Pain and discomfort  (Time-1)  ns  
Cognitive functions  (Time-1)  ns .306 
Sleep and rest  (Time-1)  .032 (F = 31.434, p <.0001) 
Depressive symptoms  (Time-1) .519 <.0001  
Self-esteem  (Time-1)  ns .264 
Body image  (Time-1)  ns (F = 51.501, p <.0009) 
Social support  (Time-1) -.223 .008 .043  
(F = 7.186, p = .008) 
Neuroticism .218 .020  
Extraversion  ns  
Openness to experience  ns  
Agreeableness -.155 .047  
Conscientiousness  ns .298 
Trait anxiety .331 <.0001 (F = 19.787, p <.0001) 
Note. ns = not significant 
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Table 3. Final regression analysis (stepwise) for depressive symptoms (Time-5) in women 











Fatigue (Time-1) .276 .003 .292  
Neuroticism .163 .050 .055  
Type of surgery -.169 .013 .028  
Depressive symptoms .219 .018 .024 .398 
Agreeableness -.154 .034 .021 (F = 18.710, p <.0001) 
 
Before diagnosis and one year later, 40.9% and 27.8% of the women, 
respectively, scored above the established cut-off score for depressive symptoms. 
Concerning the stability of depressive symptoms across assessment points 
(Figure 1), an effect for time was found (Wilks’ Lambda = .78, F(4,101) = 7.30, 
p<.0001, partial eta squared = .224, observed power = .995). Mean scores of 
depressive symptoms at Time-1 (14.78 ± 9.74) were statistically different from 
scores at Time-4 (11.45 ± 10.24; p = .002) and the mean scores of depressive 
symptoms at Time-5 (10.33 ± 8.35) were statistically different from scores at 
Time-1 (14.78 ± 9.74), Time-2 (12.97 ± 9.77), and Time-3 (12.58 ± 10.15).  
With regard to agreeableness, no significant improvements were found in 
depressive symptoms across time (Figure 2). In addition, no significant 
interaction effect between time and agreeableness was found. 
With regard to neuroticism, a significant improvement in depressive 
symptoms across time was found (Wilks’ Lambda = .80, F(4,93) = 5.66, p<.0001, 
partial eta squared = .196, observed power = .975; see Figure 3).  
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Figure 2. Course of depressive symptoms across 12 months in women with early stage 
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Figure 3. Course of depressive symptoms across 12 months in women with early stage 
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Figure 4. Course of depressive symptoms across 12 months in women with early stage 
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Mean scores of depressive symptoms at Time-5 (10.19 ± 8.22) were 
statistically different from scores at earlier time points (p<.05). No interaction 
effects between time and neuroticism were found. 
With regard to type of surgery, a significant improvement in depressive 
symptoms across time was found (Wilks’ Lambda = .79, F(4,100) =6.61, p < 
.0001, partial eta squared = .209, observed power = .990; see Figure 4). Mean 
scores of depressive symptoms at Time-5 (10.33 ± 8.35) were statistically 
different from scores at earlier time points (p < .05), except for Time-4. In 
addition, Time-1 (14.78 ± 9.74) differed significantly from Time-4 (11.45 ± 





The aim of the present prospective follow-up study was to examine predictors of 
depressive symptoms 12 months after surgical treatment in women with early 
stage BC. In addition, we examined the stability of depressive symptoms. As 
such, this study adds knowledge to describing those patients who are at risk of 
developing depressive symptoms, so that screening and interventions can be 
aimed at high-risk patients in order to reduce subsequent morbidity. Depressive 
symptoms at Time-5 were predicted by lower scores on agreeableness, higher 
scores on neuroticism, depressive symptoms at Time-1, fatigue at Time-1, or type 
of surgery. Socio-demographic factors did not play a significant role.  
Existing studies are inconclusive regarding the association between 
clinical variables and depressive symptoms [5, 6, 17, 18], i.e. studies have shown 
no differences between types of surgery [6, 17, 43] or slightly favored BCT [43, 
44]. We found that women with MCT had less chance to experience depressive 
symptoms one-year after surgical treatment compared to women who had 
received BCT. This result cannot be easily explained. It should be emphasized 
that in the present study women had a choice between BCT and MTC. To what 
extent women feel that they had received the ‘wrong’ type of surgery is unknown. 
However, one could argue that a subtype of women would worry about whether 
the surgeon had removed enough tissue [45]. For instance, women scoring high 
on trait anxiety and / or neuroticism might perceive BCT as a greater threat than 
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women scoring low or moderately on these traits. Consistent with the literature 
[17, 18], women who received adjuvant therapy and were relatively satisfied with 
their level of social support were not at risk for developing depressive symptoms 
in our study. Previous identified risk factors, like, self-esteem and bodily pain, 
were not contributing significantly to the prediction of depressive symptoms in 
our study [18]. 
To the best of our knowledge no previous study has longitudinally 
examined the relationship between several broad personality characteristics and 
depressive symptoms in early stage BC patients. Following the findings of 
Golden-Kreutz and Andersen [23], we hypothesized that neuroticism would be 
positively associated with depressive symptoms at Time-5. We found that in the 
multivariate analysis agreeableness and neuroticism contributed significantly to 
the prediction of depressive symptoms. With regard to neuroticism, this finding is 
consistent with the study of Golden-Kreutz and Andersen [23]. In spite of the fact 
that, a strong positive association between trait anxiety and depressive symptoms 
at Time-5 could be demonstrated, trait anxiety did not provide a substantial 
increment of explained variance on top of neuroticism, presumably due to the 
overlapping content of both variables. Neuroticism is characterized by a general 
disposition to experience distressing emotions, such as fear, guilt, and frustration 
[25]. Costa and McCrae [25] distinguish six aspects of neuroticism: Vulnerability 
to Stress, Impulsiveness, Self-Consciousness, Depression, Hostility, and Anxiety. 
Theoretically, neuroticism only shows a minor overlap with trait anxiety [46]. In 
this study, trait anxiety accounts for 34.3% of the variability in neuroticism. 
Consequently, trait anxiety can also be defined individually. Trait anxiety refers 
to the tendency to respond to situations perceived as threatening with a rise in 
anxiety intensity [27]. Agreeableness represents the inclination towards 
interpersonal trust and consideration of others. Persons scoring high on 
agreeableness tend to be warm, sympathetic, cooperative, and are inclined to 
avoid conflict [25]. However, agreeableness is not frequently assessed in studies 
on depression [47]. An explanation for our current finding could be that persons 
who score high on agreeableness tend to have enough social support or perceive 
the actual social support as adequate. Among patients with kidney disease, Hoth 
et al. [48] tested the hypothesis that the association between social support and 
depressive symptoms would vary as a function of individual differences in 
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agreeableness. In patients high in agreeableness, greater social support was 
associated with a reduction in depressive symptoms over a period of 
approximately 18-months. In contrast, for patients low in agreeableness, social 
support had little effect on depressive symptoms. This effect was observed after 
controlling for initial level of depression and disease progression during the 
follow-up period. In the present study, no significant interactions were found, 
between time and agreeableness showing that agreeableness did not act as a 
moderator variable [49]. However, agreeableness was a mediator of depressive 
symptoms (results not shown). 
Notwithstanding the fact that personality traits are relatively stable over 
time, these women still might benefit significantly from adequate forms of 
psycho-education and consequently might learn to understand how a person’s 
characteristics interfere with labeling and perceiving situations and subsequently 
affect behavior. 
The current study consisted of a rather homogenous group of women with 
early stage BC (T1 and T2 stage). It might be that women with a more advanced 
cancer (T3 and T4 stage) would experience a greater threat to survival [18]. 
Consequently, levels of depressive symptoms may increase or depressive 
symptoms [18] may be experienced for a longer period of time. In other words, 
scores of depressive symptoms may be more stable in women with advanced 
breast cancer. However, women in this study all had early stage BC. The more 
severe cases of BC were not present in this sample. Therefore, these results 
should not be generalized to other populations, for instance, women with more 
severe cancer stages or women with recurrent breast cancer. Studies like the 
current one often show relatively high attrition [50]. Also our study had only 
63.7% of the women with early stage BC still in the study at one-year after 
surgical treatment. This might have influenced our results. In addition, the sample 
size in this study was relatively small. Furthermore, some important factors, 
including co-morbidity, possible psychiatric history, and information whether any 
of the women had received treatment for mental health problems have not been 
included. Therefore, results should be interpreted with caution and replication is 
desirable. Future studies should further examine the relationship between 
personality characteristics and the presence of depressive symptoms.  
 Breast cancer and depressive symptoms 
 
91 
In conclusion, agreeableness, depressive symptoms, fatigue (all at Time-
1), and type of surgery have a profound effect on experiencing depressive 
symptoms at Time-5. Since depressive symptoms adversely affect patients’ lives 
[8-12, 15], it is of utmost importance to screen women with early stage BC for the 
risk factors that we found and subsequently offer them psychological 
interventions focusing on dealing with stressful situations.   
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Objective: To examine the effect of multiple surgical treatments on psychological 
outcomes in women with early stage breast cancer (BC). Methods: Questionnaires 
for depressive symptoms (CES-D), fatigue (FAS), anxiety (STAI-State), physical 
health (WHOQOL-100), psychological health (WHOQOL-100), and overall 
quality of life and general health (WHOQOL-100) were completed before 
diagnosis (Time-1) and 1 (Time-2), 3 (Time-3), 6 (Time-4), and 12 (Time-5) 
months after the last surgical treatment. Results: From the 217 participating 
women with early stage BC, 78 (35.9%) needed an additional surgical treatment. 
Eight persons (10.4%) received a second operation due to complications. Twenty-
two women (28.6%) were converted from BCT to MTC in a second surgery. 
After adjusting for type of surgery, disease stage, and hormonal therapy, 
psychological outcomes did not significantly change over time, with the exception 
of anxiety [Wilks’ Lambda = .72, F(4,86) = 8.55, p<.0001, partial eta squared = 
.29, observed power = 1.00]. On average, women with one and women with two 
surgical treatments did not differ on any outcome measure. No interaction effects 
were found, indicating that changes in outcomes over time were the same for both 
groups. Conclusions: Women who had a repeat surgical treatment did not score 
differently on psychological outcome measures compared with women who were 
treated ‘efficiently’.  
 





Breast cancer (BC) is the most common malignancy in women [1] and the most 
frequent cause of death in women aged 35 to 60 years in Europe [2]. In the 
Netherlands, one in every nine women will develop breast cancer before the age 
of 85 [3]. The prevalence of BC increases with age from 3-4% at age 50-69 to 6% 
of women older than 70 [4].  
Surgical treatment is usually the initial treatment for invasive early stage 
BC. Surgical options include breast conserving therapy (i.e., lumpectomy and a 
sentinel node procedure or axillary lymph node dissection followed by 
radiotherapy; BCT) or mastectomy (i.e., removal of the breast and sentinel node 
procedure or axillary lymph node dissection; MTC). Although physicians strive to 
treat women as effectively as possible, i.e. with a minimum of surgical treatments, 
in practice this is not always possible. For instance, some of the women with early 
stage BC who initially received BCT appear to need additional surgery when the 
margin of tissue around the tumor is not cancer-free. It is estimated that of 
patients undergoing BCT 30 to 60% will require a re-excision for residual tissue 
[5]. The majority of studies examining the effects of surgical treatment in 
oncology have focused on the effects of type of surgery or adjuvant therapy on 
clinical [6, 7] or psychosocial outcomes [8-14]. Recently, several studies have 
focused on determining those clinical factors which may be associated with re-
excision after BCT [5, 15-18].  To the best of our knowledge, it remains unclear 
whether there is a relationship between the number of surgical treatments women 
receive after BC diagnosis and psychological outcomes. Therefore, the aim of this 
prospective follow-up study was to examine the relationship between second 
surgery and psychological outcomes (i.e., state anxiety, fatigue, depressive 
symptoms, and aspects of quality of life). We hypothesize that both groups will 
improve over time with regard to the selected psychological outcomes, but that 
women with re-excisions will temporarily have more negative scores. We also 
expect that differences between the groups will not be significant at 12-months 
after surgical treatment. 
 





Women with a palpable lump in the breast or an abnormality on a screening 
mammography were referred by their general practitioner to the Department of 
Surgery of the outpatient clinics of the St. Elisabeth Hospital (Tilburg), the 
Maasland Hospital (Sittard), or the Jeroen Bosch Hospital (Den Bosch) in The 
Netherlands. The present study is part of a larger study that focuses on the role of 
personality on the quality of life in women with early stage BC who could choose 
between breast conserving and ablative surgical treatment. The inclusion of 
patients took place from September 2002 until September 2006.  From the 799 
eligible women, 609 (76.2%) completed the first set of questionnaires before they 
visited the surgeon or radiologist, i.e. before the diagnosis, benign or malignant, 
was known (Time-1). In this group (N = 609), 225 appeared to have early stage 
BC; the others had a benign breast problem (BBP).  
The main reasons for not participating were the length of questionnaires 
and the amount of stress at the first visit to the hospital. Women with a history of 
abnormalities in the breast, benign or malignant, or a breast tumor that was too 
large (>5 centimeter) for BCT, were excluded from the study. Participants had to 
be able to read and write in Dutch.  
After the baseline measurement before diagnosis (Time-1), the 
participants were divided in two groups: women with early stage breast cancer 
(BC group) and women with benign breast problems (BBP group). Thereafter, 
women completed questionnaires at 1, (Time-2), 3 (Time-3), 6 (Time-4), and 12 
(Time-5) months after the last surgical treatment (BC). Only the women with a 
BC diagnosis participated in the present study. The time points were chosen in 
such a way that the follow-up measures would not interfere with the time of the 
treatment modalities. Questionnaires were filled in at home and returned in a 
stamped addressed envelope. Participation in the study was not known to the 
surgeon in attendance and, therefore, could not affect treatment and clinical 
follow-up. All the participants gave written informed consent.  
 
Measures 
Questionnaires assessing socio-demographic factors (marital status, children, paid 
work, and education level) and psychological factors (depressive symptoms, 
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fatigue, state anxiety, quality of life) were completed at Time-1. At the other time 
points women again completed questionnaires on psychological factors.  
The Center for Epidemiological Studies- Depression Scale (CES-D) [19] 
is a 20-item self-report scale measuring the presence and degree of depressive 
symptoms over the past week. The rating scale ranges from 0 (seldom or never) to 
3 ((almost) always). Scores can range from 0 to 60. The CES-D has been 
established as a valid and reliable measure of depressive symptoms in BC patients 
[20]. Reliability and criterion validity are good [21, 22].  
The Fatigue Assessment Scale (FAS) [23] is a 10-item questionnaire 
assessing perceived fatigue and exhaustion. The response scale is a 5-point rating 
scale ranging from 1 (never) to 5 (always). Scores on the FAS range from 10 to 
50. The psychometric properties are good [24-26].  
The STAI consists of two 20-item scales for measuring state anxiety and 
trait anxiety. In the present study, only the State Anxiety scale was used. This 
scale assesses how persons feel at a particular moment in time. The STAI State 
scale has a 4-point rating scale ranging from 1 (almost never) to 4 (almost 
always). The Dutch version of the STAI-State scale has good reliability and 
validity [27].  
The World Health Organization Quality of Life assessment instrument-
100 (WHOQOL-100) [28, Dutch version 29], is a cross-culturally developed 
generic multi-dimensional quality of life (QOL) measure. This instrument covers 
24 specific facets of QOL, assessed by 96 questions, and one General Health and 
Overall Quality of Life facet. In the present study, only the Overall Quality of 
Life and General Health facet, the Physical Health domain, and the Psychological 
Health domain were used. A high facet score indicates good QOL. Reliability and 
validity [29-31] are adequate and sensitivity [32] is high. 
 
Statistical procedure 
Student t-tests and Chi-square tests were used to examine the potential differences 
between participants and non-participants. To examine the influence across time 
of the number of surgical treatments on depressive symptoms, state anxiety, 
overall quality of life and general health, physical health, and psychological 
health, multivariate analysis of variance (MANOVA) with repeated measures 
were used. Partial eta squared (effect size) was derived from the general linear 
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model. An effect size between 0.01 and 0.06 is considered as a small effect, while 
effect sizes between 0.06 and 0.13 and greater than 0.14 are considered as 
moderate and strong effect sizes, respectively [33]. Multiple post hoc 
comparisons were corrected with the Bonferroni method. Subsequently, 
multivariate analysis of covariance (MANCOVA) with repeated measures was 
used, in which type of surgery (BCT/MTC), disease stage, and hormone therapy 
(yes/no) were used as covariates as women with one and two surgical treatments 
differed on these patient characteristics (see Table 1). A p-value < .05 was 
considered to be statistically significant. All statistical analyses were performed 





At baseline, 225 women completed psychological outcome questionnaires. Figure 
1 presents a flow chart of this study. Participants did not differ from non-
participants with regard to sociodemographic (i.e., age, partner status, job status, 
educational level) and clinical (i.e., chemotherapy, radiotherapy, hormone 
therapy) variables. Eight persons were removed from the analyses, because they 
did not have surgery (n = 4) or had more than two surgical treatments (n = 4). 
From the 217 participating women, 79 (36.4%) needed one repeat surgical 
treatment. Eight persons (10.4%) received a second operation due to 
complications. Twenty-two women (28.6%) were converted from BCT to MTC in 
a second surgery. No differences were found between the women who received 
one or two surgical treatments with regard to sociodemographic variables. 
However, women differed on the clinical characteristics: hormone therapy 
(yes/no), type of surgery (BCT/MTC), and disease stage (stage 0 / I / IIa / IIb) (see 
Table 1). 
Concerning fatigue, women with one or two surgical treatments did not 
score differently on symptoms of fatigue [F(1,105)=.01, p = .92]. However, an 
effect for time was found (See Table 2). Mean scores of fatigue scores at Time-1 
(20.03 ± 7.36) were statistically lower than scores at Time-2 (22.95 ± 7.52, 
p<.0001) and Time-3 (22.94 ± 8.09, p<.0001). In addition, mean fatigue scores at 
Time-5 (20.57 ± 7.11) were significantly lower than mean scores at Time-2 




N = 799 
 
Breast Cancer 
N = 217 (Time-1) 
 
Time-2: 
N = 172 
 
Time-3: 
N = 165 
 
Refused to participate: 
N = 191 
 
Benign breast diagnosis: 
N = 383 
 
Drop-out:  
N = 45 
 
Drop-out:  
N = 7 
 
Time-4: 
N = 161 
 
Drop-out:  
N = 4 
 
Time-5: 
N = 154 
 
Drop-out:  
N = 7 
 
No surgery received: 
N = 4 
 
Three surgical treatments 
received: N = 4 
 
(p=.001) and Time-3 (p<.0001). No relationship was found between time and 
number of surgical treatments. After controlling for clinical factors, the effect for 
time did not remain significant [Wilks’ Lambda = .97, F(4,99) = .89, p=.474, 
partial eta squared = .04, observed power = .27]. 
 
Figure 1. Flow chart of the participants  
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Table 1. Patient characteristics 
Number of operations  
One 
(N = 138) 
Two 
(N = 79) 
p-
value 
Sociodemographic    
Age, years (mean ± SD) 59.3 ±   9.1 57.8 ±   9.5 ns 
Living with a partner  
(yes/no/missing) 
111 (80.4)/ 24 (17.4)/  
3 (2.2) 





118 (85.5)/ 19 (13.0)/  
2 (1.4) 





53 (38.4)/ 58 (42.0)/  
25 (18.1)/ 3 (1.4) 
26 (32.9)/ 35 (44.3)/  
12 (15.2)/ 4 (5.1) 
ns 
Paid work  
(yes/no/missing) 
48 (34.8)/ 89 (64.5)/  
1 (0.7) 
37 (46.8)/ 40 (50.6)/  
2 (2.5) 
ns 
Clinical    
Type of surgery (BCT/MTC) 77 / 64 30 / 49 .017 
BCT 17 (12.3) 23 (29.1)  
MTC 41 (29.7) 23 (29.1)  
Excision and sentinel node 60 (43.5) 7     (8.9)  
Ablation and sentinel node 20 (14.5) 26 (32.9)  
Adjuvant therapy*    
Chemotherapy (yes/no) 32 (23.2)/ 105 (76.1) 28 (35.4)/ 51 (64.6)  ns 
Hormone therapy (yes/no) 45 (32.6)/ 93 (67.4)  40 (50.6)/ 39 (49.2) .003 
Radiotherapy (yes/no) 81 (58.7)/ 57 (41.3)  36 (45.6)/ 43 (54.4)  ns 
Disease stage: 0 / I / IIa / IIb 12 (8.7)/ 71 (51.4)/  
37 (26.8)/18 (13.0) 
12 (15.2)/ 20 (25.3)/  
30 (38.0)/ 17 (21.5) 
.002 
Psychological     
Overall QOL/General Health 15.5 ±   2.6 16.0 ±   2.3 ns 
Depressive symptoms 15.2 ±   9.5 14.1 ±   9.5 ns 
Fatigue 20.2 ±   6.9 18.7 ±   6.5 ns 
Anxiety  47.8 ± 13.7 47.8 ± 14.2 ns 
Abbreviations: BCT = breast conserving therapy, MTC = mastectomy, QOL = quality of life 
Note: * more than one treatment possible, percentages are presented between brackets 
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Table 2. Effects of time for psychological outcomes 
 Wilks’ 
Lambda 




Fatigue .73 F(4,102) =  9.51 <.0001 .27 1.00 
Anxiety .38 F (4, 89) = 36.05 <.0001 .62 1.00 
Depressive 
symptoms 
.78 F(4,106) =  7.51 <.0001 .22 .99 
Overall QOL and 
General Health 
.93 F(4,110) =   .07 .07 .07 .63 
Physical Health .87 F(4,110) =  4.09 .004 .13 .91 
Psychological 
Health 
.88 F(4,110) =  3.49  .01 .11 .85 
Abbreviations: QOL = Quality of Life 
 
Women with one or two surgical treatments did not differ on symptoms 
of anxiety [F(1,92) = .013, p = .91). However, an effect for time was found, 
indicating a decrease in symptoms of anxiety over time (see Figure 2). Mean 
scores of state anxiety scores at Time-1 were statistically different from scores at 
subsequent time points (p<.0001). In addition, scores on Time-2 (37.00 ± 11.26) 
were different from scores on Time-5 (34.38 ± 10.63, p = .047). No relationship 
was found between time and number of surgical treatment. After controlling for 
possible confounders, the effect for time remained significant [Wilks’ Lambda = 
.72, F(4,86) = 8.55, p<.0001, partial eta squared = .29, observed power = 1.00]. 
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Figure 2. Mean scores on state anxiety. Women were divided in two groups, according to 
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Women with one and women with two surgical treatments did not differ 
on symptoms of depressive symptoms [F(1,109)=.14, p=.71, partial eta squared = 
.001, observed power = .07). Concerning depressive symptoms, an effect for time 
was found, indicating that depressive symptoms decrease over time. Mean scores 
of depressive symptoms at Time-1 (14.54 ± 9.61) were statistically different from 
Time-4 (11.68 ± 10.25, p= .02) and Time-5 (10.31 ± 8.50, p<.0001). Mean scores 
at Time-5 were also different from Time-2 (13.08 ± 9.78, p=.001) and Time-3 
(12.63 ± 9.95, p=.003). No interaction effect was found. After controlling for 
possible confounders, the effect for time did not remain significant [Wilks’ 
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Lambda =.93, F(4,103) = 1.94, p=.11, partial eta squared =.07, observed power = 
.57]. 
Concerning Overall QOL and General Health, no effect for time was 
found. No interaction effect (time by number of surgical treatments) was found, 
showing that the number of surgical treatments exerted a stable effect on Overall 
QOL and General Health scores. Women with one or two surgical treatments did 
not differ on symptoms of Overall QOL and General Health [F(1,113)=.59, p = 
.45, partial eta squared = .01, observed power = .12]. However, the univariate 
approach produced different results. Using the Greenhouse-Geiser estimates of 
sphericity (ε = .90), an effect for time was found [F(3.59, 405.18) = 3.23, p<.05)]. 
With regard to Physical Health, women with one or two surgical 
treatments did not differ on Physical Health [F(1,113)=.36, p = .55, partial eta 
squared = .03, observed power = .09]. An effect for time was found, indicating 
that Physical Health increases over time. Mean scores of Physical Health scores at 
Time-5 (14.60 ± 2.51) were statistically different from scores at Time-2 (14.04 ± 
2.46; p=.006) and Time-4 (14.08 ± 2.42; p=.016). No interaction effect (time by 
number of surgical treatments) was found, showing that the number of surgical 
treatments exerted a stable effect on Physical Health scores. After controlling for 
possible confounders, the effect for time did not remain significant [Wilks’ 
Lambda = .97, F(4, 107) = .72, p=.58, partial eta squared = .03, observed power = 
.26]. 
Women with one or two surgical treatments did not differ on 
Psychological Health [F(1,114)= .98, p = .33, partial eta squared = .01, observed 
power = .17]. Again an effect for time was found, this time indicating that 
Psychological Health improved over time. Mean scores of Psychological Health 
scores at Time-5 (15.35 ± 2.02) were statistically different from scores at Time-1 
(14.81 ± 1.93; p<.05), Time-2 (14.89 ± 2.03; p<.01), and Time-3 (15.02 ± 2.04; 
p<.05). No interaction effect (time by number of surgical treatments) was found, 
showing that the number of surgical treatments exerted a stable effect on 
Psychological Health scores. After controlling for possible confounders, the effect 
for time did not remain significant [Wilks’ Lambda = .96, F(4, 108) = .1.21, p = 
.31, partial eta squared = .04, observed power = .37]. 
 





In the Netherlands, there is a fierce debate about the number of re-excisions in 
women with BC. The Inspection for Health Care suggested that, as a rule of 
thumb, 1 out of 10 women may get a second surgical treatment. Besides the costs 
associated with additional surgery, it is also speculated that women who get 
additional surgery will have, at least initially, more stress. However, no study has 
documented the effect of the number of surgical treatments on psychological 
outcomes. Does the group of women with more than one surgical treatment have 
more psychological problems than women who received just one operation? 
Therefore, the aim of this prospective follow-up study was to examine potential 
differences between women who received one surgical treatment and women who 
received two surgical treatments. This study showed that, in general, both groups 
did not differ on psychological outcomes, such as depressive symptoms and 
anxiety, over time. In addition, scores on depressive symptoms, anxiety, and 
fatigue initially decreased over time when we did not control for clinical factors. 
With regard to Overall QOL and General Health, the opposite trend was found. 
However, when adjuvant therapy and type of surgery were taken into account, 
these time effects disappeared. The effect for time remained present with regard 
to Physical Health.These findings may seem counter-intuitive at first glance. 
However, several explanations are suggested here. The fact that some women in 
our study needed an additional surgical treatment may not be easy for women 
initially. However, women may also realize that an extra surgery is for their own 
benefit. Irrespective of the number of surgical treatment, the aim is to remove 
malignant tissue from the body. Another explanation may be that the data set is 
somewhat biased. For instance, women with more than an additional surgical 
treatment tend to drop out more often from the study compared with women with 
one surgery. However, this suggestion was not supported by our findings (results 
not shown). Both groups did not differ on whether they drop out or the moment 
they dropped out from our study (p>.24).  
This study has several limitations. First, women who receive multiple 
surgical treatments may vary in the type of treatment performed. However, as we 
used a rather small sample, it was not possible to divide the sample and examine 
whether women who received, for instance, BCT twice or women who were 
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converted from BCT to MTC differ in psychological functioning. Thus, our 
analyses were performed on a rather heterogeneous group. It would be interesting 
for future studies to further address this issue. Second, this study focused on 
psychological outcomes after surgical treatment. Therefore, no information is 
present on whether women with a repeated surgical treatment score differently on 
clinical physical outcomes compared with women who were operated only once. 
In order to partly overcome this limitation, we have assessed women on the 
WHOQOL-100-domain Physical health. Based on this self-evaluation, no 
differences were found between women operated once and women operated 
twice. Third, the time points were chosen in such a way that the follow-up 
measures would not interfere with the time of the treatment modalities. As a 
consequence, the timing of the second measurement point is dependent of the last 
surgical treatment, which is different in both surgical groups. Thus, information 
on psychological outcomes after the first surgical treatment is lacking. However, 
since, both groups do not differ at one month after surgical treatment, we may 
conclude that potential differences at that point were not long-lasting, since no 
differences were found at all measurement points. 
In conclusion, women with early stage BC receiving multiple surgical 
treatments do not have worse psychological outcomes compared with women 
with one surgical treatment. 
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Objective: This study examines the relationships between personality, on the one 
hand, and perceived availability of social support (PASS) and satisfaction with 
received social support (SRSS), on the other hand, in women with early stage 
breast cancer (BC). In addition, this study examined whether a stressful event (i.e. 
diagnosis) is associated with QOL, when controlling for PASS and SRSS. 
Method: Women were assessed on PASS and SRSS (WHOQOL-100) before 
diagnosis (Time-1) and one (Time-2), three (Time-3), six (Time-4), 12 (Time-5) 
and 24 months (Time-6) after surgical treatment. Personality (NEO-FFI, STAI-
trait scale) and fatigue (FAS) were assessed at Time-1. Results: Agreeableness 
and fatigue predicted PASS and SRSS at Time-5 and Time-6. Trait anxiety had a 
negative effect on SRSS (ß= -.22, p<.05). In addition, having a job was negatively 
associated with SRSS (Time-6, ß= -.23, p<.001). Across time, women reported a 
decrease in PASS and SRSS. Path models, used to test whether PASS and/or 
SRSS functioned as mediators of the link between diagnosis and QOL, reached 
adequate fit. Conclusions: Besides factors, like fatigue and having a job, 
personality factors substantially influence the way women with early stage BC 
perceive social support. Knowledge about these underlying mechanisms of social 
support is useful for the development of tailor-made interventions. Professionals 
should be aware of the importance of social support. They should check whether 
patients have sufficient significant others in their social environment and be 
sensitive to potential discrepancies patients might experience between availability 
and adequacy of social support. 





In the Netherlands, over 11,500 women received a breast cancer (BC) diagnosis 
in 2003 [1]. In 2005, there were an estimated number of 119,000 BC patients or 
survivors in the Netherlands. Due to advances in cancer screening and medical 
treatment, this number might increase to about 194,000 within ten years [2]. In 
spite of these better prospects, receiving a BC diagnosis is still very stressful. For 
instance, BC patients have a high risk of developing mood disorders [3]. 
Therefore, social support from a partner, family, and/or friends is of the utmost 
importance for women with BC [4]. 
Despite a growing interest in social support, a precise definition is 
currently lacking. In general, there are two broad ideas: social support concerns 
(i) the support that is actually received (i.e., structural support, functional support) 
or (ii) the individual’s subjective appraisal of the social support (perceived social 
support). Perceived social support can be divided into the perception that social 
support is available when needed (perceived availability of social support; PASS) 
and the satisfaction with received social support (SRSS). This approach is used in 
the current study.  
Several studies have examined perceived social support in cancer. For 
instance, Hann et al. [5] reported that greater perceived adequacy of social 
support among cancer patients was negatively related to depression. With regard 
to the relationship between perceived social support and survival, findings are 
rather inconclusive. Whereas some studies [6-8] found a positive relationship 
between perceived social support and survival, others did not [9]. Social support 
is also associated with quality of life (QOL) in BC patients [10-15]. Socially 
isolated women reported more problems compared with women who were 
socially integrated with regard to physical role functioning, vitality, and physical 
functioning [15]. Thus, social support seems to fulfil an important role in 
adaptation efforts of cancer patients.  
In order to understand the underlying mechanisms of the protective role 
of perceived social support, it is important to examine its determinants or the 
factors associated with it [16]. Few studies have tested those determinants 
longitudinally [17]. Objective determinants, such as, network size or the 
frequency of contact with network members, explained about 30% of the variance 
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of perceived social support [16]. In addition, perceived social support may also be 
associated with other factors, for instance, personality. Few studies, however, 
have examined this particular relationship [18]. Research has shown that 
extraverts report higher scores on satisfaction with the social support they receive 
compared with introverts [19, 20]. A longitudinal study among alcoholics [21] 
found that extraversion and neuroticism were indirectly related to perceived social 
support through their effects on network properties during treatment. 
Furthermore, it was demonstrated that agreeableness, i.e., the tendency towards 
interpersonal trust and consideration of others, predicts actual support from others 
[20]. Recently, Hoth et al. [22] studied agreeableness in persons with chronic 
kidney disease. Persons high on agreeableness showed a substantial decrease in 
depressive symptoms across time, while support had little effect for low-scorers. 
In another study [4] dispositional optimism and perceived social support were 
substantially related to well-being. In addition, women who were not treated yet 
and scored low on dispositional optimism experienced more cancer-specific 
distress. Persons high on trait anxiety were inclined to seek more support from 
others, while they also tended to be dissatisfied with the received social support 
[23, 24]. Courtens et al. [17] found that network size decreased over time. Since 
their illness, cancer patients were relatively less able to provide support to their 
social network, which caused an imbalance between the amount of support given 
to others and the amount of help received by the network. Presumably, this 
imbalance had a negative impact on their social network. However, there is still a 
limited body of knowledge regarding the question whether, in line with a 
decreasing social network, perceived social support also diminishes across time, 
since the remaining support providers may give the support patients need. 
Therefore, the aim of this prospective longitudinal follow-up study was to 
examine the relationships between personality and PASS and SRSS in early stage 
BC patients. In addition, we examined whether PASS and/or SRSS mediates the 
link between diagnosis and QOL. Based on earlier findings, it was hypothesized 
that women scoring high on extraversion and agreeableness would experience 
higher perceived availability and higher scores on satisfaction compared with 
women scoring low or moderately on these traits. Furthermore, it was expected 
that high scores on neuroticism and trait anxiety would be negatively associated 
with PASS and SRSS. Moreover, it was hypothesized that the levels of PASS and 
 Personality and social support 
 
119 
SRSS would be high in the period around surgical treatment and then, 
subsequently, would decline. It was expected that women scoring high on trait 
anxiety would be less satisfied with their social support. It was expected that 
women scoring high on trait anxiety would be less satisfied with their social 
support at all time points, compared to women with low or moderate scores. 
Finally, it was expected that PASS and SRSS are mediators of the link between 





Women with a palpable lump in the breast or an abnormality on a screening 
mammography were referred by their general practitioner to the surgical 
outpatient clinics of the St. Elisabeth Hospital (Tilburg, The Netherlands), the 
Maasland Hospital (Sittard, The Netherlands; since August 2004), or the Jeroen 
Bosch Hospital (Den Bosch, The Netherlands; since January 2006). The present 
study, in which PASS and SRSS is examined, is part of a large study focusing on 
the role of personality in early stage BC patients’ QOL. The data were collected 
from September 2002 until September 2006.  Of the 799 eligible women, 604 
(75.6%) completed the first set of questionnaires. The main reasons for not 
participating were the length of the test battery and the amount of stress women 
experienced at their first visit to the hospital. Of these 604 women, 223 were 
diagnosed with early stage breast cancer (BC; see Figure 1). A substantial number 
of women had benign breast problems (BBP; n = 381). Women who had a history 
of abnormalities in the breast, benign or malignant, or had a breast tumor that was 
too large (>5 centimeter) for breast conserving therapy, were excluded from the 
study. In order to participate, the women had to have sufficient knowledge of the 
Dutch language. The questionnaires were completed before the women visited the 
surgeon or radiologist, i.e. before the diagnosis, benign or malignant, was known. 
After the baseline measurement (Time-1), women completed questionnaires at 
one (Time-2), three (Time-3), six (Time-4), 12 (Time-5) and 24 (Time-6) months 
after surgical treatment. The reference point was surgical treatment, because 
otherwise follow-up measures would interfere with the timing of treatment 
modalities. Participation in the study was not known to the surgeon in attendance 
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and, therefore, could not affect treatment and clinical follow-up. All participants 
gave written informed consent. 
 
Measures 
Women completed the following questionnaires: World Health Organization 
Quality of Life assessment instrument-100 (WHOQOL-100) [25, 26] at all time 
points. The Center for Epidemiological Studies-Depression Scale (CES-D) [27], 
the Fatigue Assessment Scale (FAS) [28], the Neuroticism-Extraversion-
Openness-Five Factor Inventory (NEO-FFI) [29, 30] and the State Trait Anxiety 
Inventory (STAI) [31] were assessed at Time-1. 
Social support and General Health and Overall Quality of Life were 
measured using the WHOQOL-100 [26, 32]. Each facet is measured with four 
items with a 5-point Likert scale. High scores on these facets indicate good QOL. 
Reliability and validity [32-34] are adequate, and sensitivity [35] of the 
instrument is high. For instance, Cronbach’s alpha for the facet Social Support 
exceeds .80 [34]. This facet consists of four items: (i) Do you get the kind of 
support from others that you need? (item 43), (ii) To what extent can you count 
on your friends when you need them? (item 44), (iii) How satisfied are you with 
the support you receive from your family? (item 66), and (iv) How satisfied are  
you with the support you receive from your friends (item 67)? In this study, we 
calculated two subscores by adding the scores of the first two items in order to 
measure PASS (α = .68), and the total scores of the last two items in order to 
measure SRSS (α = .73). The time frame of reference is the previous two weeks.  
The CES-D [27] is a 20-item self-report scale designed to measure the 
presence and degree of depressive symptoms over the past week. The rating scale 
ranges from 0 (seldom or never) to 3 ((almost) always). Scores can range from 0 
to 60. The CES-D has been established as a valid and reliable measure of 
depressive symptoms in BC patients [36]. For the Dutch population, reliability 
and criterion validity are good [37, 38].  
The FAS [28] is a 10-item questionnaire assessing a uni-dimensional 
construct of perceived fatigue and exhaustion. The response scale is a 5-point 
rating scale ranging from 1 (never) to 5 (always). Scores on the FAS range from 
10 to 50. The psychometric properties are good [39-41].  
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Personality was assessed with the NEO-FFI [29, 30] and the State-Trait 
Anxiety Inventory (STAI) [31, 42]. The NEO-FFI has been translated into Dutch 
[43]. This self-report questionnaire
 
consists of 60 statements covering five basic 
dimensions of
 
personality: Neuroticism, Extraversion, Openness to New 
Experiences, Agreeableness, and Conscientiousness. Each statement is rated on a 
5-point scale ranging from 1 (strongly
 
disagree) to 5 (strongly agree), resulting in 
dimension
 
scores between 12 and 60. The psychometrics of the NEO-FFI have 
been extensively examined. The internal consistency, test-retest reliability, as well 
as the convergent validity, are acceptable to good [43]. 
 
 
The STAI [31, 42] consists of two 20-item scales for measuring state 
anxiety and trait anxiety. In this study, the STAI trait scale was used. This scale 
describes how persons generally feel and refers to their inclination to experience 
anxiety in stressfull times. The STAI has a 4-point rating scale ranging from 1 
(not at all/almost never) to 4 (very much so/almost always). The Dutch version of 
the STAI has good reliability and validity [42]. 
 
Socio-demographic and clinical variables 
Patients were asked to report age, marital status, education, and paid work 




Pearson correlation coefficients were used to examine the relationship between 
PASS and SRSS, on the one hand, and the independent variables 
(sociodemographic and personality), on the other hand. Multiple linear regression 
analyses (method: enter) were performed to identify factors associated with PASS 
and SRSS at Time-5 and Time-6. First, the sets of socio-demographic, clinical, 
personality, and psychological characteristics were entered separately in the 
regression analyses. This procedure was employed to minimize the number of 
independent variables in the final regression analysis preserving statistical power. 
Subsequently, only those factors that significantly (p<.05) predicted the 
dependent variables were entered in the final analyses. General linear model 
analysis was used to examine PASS and SRSS across time. This was done until 
Time-5, due to the rather limited sample size at Time-6. However, this limited 
 Chapter 6 
 
122
sample size was not a problem in the regression analysis. Partial eta squared 
(effect size) was derived from the general linear model. An effect size between 
0.01 and 0.06 is considered as a small effect, while effect sizes between 0.06 and 
0.13 and greater than 0.14 are considered as moderate and strong effect sizes, 
respectively [44]. Multiple post hoc comparisons were corrected with the 
Bonferroni method. Path analyses were conducted to test whether PASS and/or 
SRSS are mediators of the relationship between stress and QOL [45]. In this 
study, the hypothesized models were tested at each measurement point (Time-2 to 
Time-5). In the model, the latent variable ‘stress’ was linked to the diagnosis 
women had received. Therefore, only in these analyses women with BC and BBP 
were used. As outlined above, the PASS and SRSS latent variables were both 
measured with two observed indicators. In the hypothesized models, stress was 
specified as the predictor, PASS and SRSS were conceived as mediators, and 
QOL was specified as the outcome. To evaluate the model, multiple indices of fit 
were used, including: an overall chi-square statistic, the comparative fit index 
(CFI), and the root mean square error approximation (RMSEA). The models have 
a satisfactory to good fit when: CFI > .90 and RMSEA < .06 [46]. All statistical 
analyses were performed using the Statistical Package for the Social Sciences 
(SPSS Chicago, IL, USA; version 14.0), except for the path analyses. These 





In total, 799 patients were eligible for this study. Before diagnosis was known, 
609 (76.2%) completed the first set of questionnaires before they visited the 
surgeon or radiologist. Participants were significantly younger compared with 
non-participants (p =.002). Participants and non-participants did not differ on 
other sociodemographic or clinical characteristics. Figure 1 shows the flow chart 
of this study. The outcomes regarding the socio-demographic, clinical, and 
psychological characteristics are presented in Table 1. Women with BBP were 
younger [t (1, 603) = -6.81, p < 0.001) and more often employed (χ² = 11.46, p = 
0.001) compared with the BC group.  
 
 Personality and social support 
 
123 
Table 1. Demographic, clinical, personality, and psychological characteristics at baseline 
 BC group (n = 223) 
Sociodemographic factors  
Age at diagnosis (mean ± SD) 58.7 (9.4) 
Living with a partner (yes /no /missing) 179 (80.3) / 37 (16.6) / 3 (1.3) 
Having children (yes / no / missing) 191 (85.7) / 29 (13.0) / 3 (1.3) 
Education level:  
0-9 yrs / 10-14 yrs / > 14 years /missing 
 
85 (38.1) / 95 (42.6) / 37 (16.6) / 2 (0.9) 
Paid work (yes / no / missing) 85 (38.1) / 135 (60.5) / 1 (0.4)  
Clinical factors  
Disease stage  
Stage 0 / Stage I 24 (10.8) / 93 (41.7) 
Stage IIa / Stage IIb 69 (30.9) / 35 (15.7) 
Undefinable  2 (  0.9) 
Type of surgery:  
BCT / MTC / No surgical treatment 
 
107 (48.0) / 114 (51.1) / 2 (  0.9) 
Adjuvant therapy (yes / no) 169 (75.8) / 54 (24.2) 
Personality factors  
Neuroticism 30.2   (7.0) 
Extraversion 41.1   (5.5) 
Openness to New Experiences 35.4   (6.0) 
Agreeableness 43.5   (4.1) 
Conscientiousness 45.5   (5.4) 
Trait Anxiety 39.4 (11.0) 
Depressive symptoms 14.9   (9.5) 
Fatigue 19.8   (9.5) 
Abbreviations: MTC = modified radical mastectomy; BCT = breast conserving therapy 
Note: For the sociodemographics, percentages are presented between brackets (except for age). For 
the personality and psychological factors the means and standard deviations (SD) are presented.  
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Figure 1. Flow chart for the recruitment of women with breast problems. 




Neuroticism and trait anxiety were negatively associated with both PASS 
and SRSS, while extraversion, conscientiousness, and agreeableness were 
positively associated with these aspects of social support (Table 2). Correlation 
coefficients in Table 2 relate to Time-1. 
 
Eligible: 
N = 799 
Refused: 
N = 195 
Included: 
N = 604 
Time-5:  
N = 228 
Time-5:  
N = 167 
 
Time-4:  
N = 170 
 
Time-3:  
N = 174 
 
Time-2:  
N = 181 
 
Time-1:  
N = 223 
 Drop-out:  
N = 109 
 
Drop-out:  
N = 22 
 
Drop-out:  
N = 15 
 
Drop-out:  
N = 7 
 
BBP group BC group 
Drop-out:  
N = 43 
 
Drop-out:  
N = 6 
 
Drop-out:  
N = 4 
 
Drop-out:  
N = 3 
 
Time-4:  
N = 235 
Time-3:  
N = 250 
 
Time-2:  
N = 272 
 
Time-1:  
N = 381 
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Table 2. Pearson correlation coefficients between perceived social support, age, and 
personality characteristics  
Variables PASS (Time-1) SRSS (Time-1) 
Age .01  -.06 
Neuroticism -.19** -.22** 
Extraversion .20** .30** 
Openness to New Experiences .08 .17     
Agreeableness .26** .26** 
Conscientiousness .16 * .12 * 
Trait anxiety -.18** -.22** 
Note: * p<.05, ** p <.01 (2-tailed tested) 
 
Trait anxiety (ß = -.22, p = .021), agreeableness (ß = .29, p < .0001), and 
fatigue (ß = -.21, p < .008) predicted SRSS at Time-5. These factors also 
contributed significantly to the prediction of PASS at Time-5, except for trait 
anxiety. At Time-6, agreeableness as well as fatigue predicted PASS and SRSS. 
In addition, having a job was negatively associated with SRSS (ß = -.23, p < .001) 
(Table 3).  
 








Agreeableness .219 .274** PASS Time-5 
Fatigue  -.263 * 
13.594 † 
Trait anxiety .278 -.221 * 
Agreeableness  .291 † 
SRSS Time-5 
Fatigue  -.206 * 
18.351† 
Agreeableness .280 .313** PASS Time-6 
Fatigue  -.272 *  
12.14† 
Agreeableness .375 .337 † 
Fatigue  -.299** 
SRSS Time-6 
Paid job (yes/no)  -.232** 
13.76† 
Abbreviations: PASS, perceived availability of social support; SRSS, satisfaction with  
received social support. 
Note: †= p < .0001; ** = p < .001: * = p < .05 
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There was no effect of time on PASS scores for women scoring low or 
moderately on agreeableness versus high-scorers on this trait (p =.28). In addition, 
no interaction effect was found between time * agreeableness, showing that 
agreeableness exerted a stable effect on PASS over time (p = .73). However, low-
scorers on agreeableness reported significantly poorer PASS (p = .001) compared 
to high-scorers (Figure 2).  
In contrast, a significant effect across time was found with regard to 
SRSS scores and agreeableness (Wilks’ Lambda = .88, F(4,93) = 3.16, p = .017, 
multivariate partial eta squared = .12; see Figure 3). No interaction effect was 
found between time * agreeableness, showing that agreeableness exerted a stable 
effect on SRSS over time (p = .47). The mean scores of social support at Time-2 
were statistically different from the scores obtained at Time-4 (p = .027), 
indicating a significant decline. Women high on agreeableness had significantly 
higher scores on SRSS compared with women low or moderately on this trait (F = 
9.24, p = .003, partial eta squared = .088).  
Concerning trait anxiety, there was also a significant effect across time, 
indicating that SRSS decreased over time (Wilks’ Lambda = .86, F(4,137) = 4.14, 
p = .004, multivariate partial eta squared = .14; see Figure 4). The mean scores of 
SRSS at Time-2 were statistically different from the scores obtained at Time-4 (p 
= .008) and Time-5 (p = .005), indicating a sizeable decline. In addition, women 
high on trait anxiety had significantly lower scores on SRSS compared with 
women low or moderately on trait anxiety (F = 34.66, p < .0001, partial eta 
squared = .25).  
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Figure 2. PASS scores of patients before diagnosis and one, three, six, and 12 months 
after surgical treatment. Women with early stage BC were divided in two groups, 
























































agreeableness low or 
moderately versus high
Perceived availability of social support
 
 
 Chapter 6 
 
128
Figure 3. SRSS scores of patients before diagnosis and one, three, six, and 12 months 
after surgical treatment. Women with early stage BC were divided in two groups, 




















































agreeableness low or 
moderately versus high
Satisfaction with received social support
 
 
 Personality and social support 
 
129 
Figure 4. SRSS scores of patients before diagnosis and one, three, six, and 12 months 
after surgical treatment. Women with early stage BC were divided in two groups, 
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Figure 5 presents the path diagrams of the mediational models. These 
models were used to test whether PASS and/or SRSS functioned as a mediator of 
the relationship between diagnosis and overall QOL at different time points. To 
reach a better fit, the model required two correlations of two error terms for PASS 
from Time-2 to Time-4 (‘estimation of QOL’ with ‘stress’; ‘satisfaction with 
health’ with ‘stress’). Adding constrains was not necessary for reaching an 
adequate fit with regard to PASS at Time-5. To reach a better fit, the SRSS model 
required at least two correlations of two error terms (Time-2: ‘estimation of QOL’ 
with ‘stress’, ‘satisfaction with health’ with ‘stress’, ‘satisfaction with QOL’ with 
‘satisfaction with support from family, Time-3: ‘satisfaction with life in general’ 
with ‘satisfaction with health’, ‘satisfaction with health’ with ‘stress’, ‘satisfaction 
with QOL’ with ‘stress’, ‘diagnosis’ with ‘satisfaction with support from friends’, 
 Chapter 6 
 
130
‘Time-4: satisfaction with QOL’ with ‘stress’ and ‘satisfaction with health’ with 
‘stress’, Time-5: ‘satisfaction with health’ with ‘satisfaction with support from 
family’, ‘satisfaction with health’ with ‘satisfaction with support from friends). A 
summary of the overall goodness-of-fit statistics of the path models and the added 
error variances are presented in Table 4. These models have a satisfactory fit. 
 





df CFI RMSEA Number of 
constraints 
PASS, Time-1 to Time-2 8.877 .449 9 1.000 .000 2 
PASS, Time-1 to Time-3 8.877 .449 9 1.000 .000 2 
PASS, Time-1 to Time-4 9.483 .394 9 1.000 .000 2 
PASS, Time-1 to Time-5 11.567 .481 12 1.000 .000 0 
SRSS, Time-1 to Time-2 11.404 .180 8 .997 .038 3 
SRSS, Time-1 to Time-3 12.132 .096 7 .995 .053 4 
SRSS, Time-1 to Time-4 6.087 .731 9 1.000 .000 2 
SRSS, Time-1 to Time-5 16.912 .076 10 .992 .054 2 
Note: PASS, perceived availability of social support; SRSS, satisfaction with received 
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Figure 5. The path models for PASS and SRSS as mediator variables in the link between 
stress at diagnosis of early stage breast cancer and general quality of life across time. 
Ovals represent latent variables. In the interest of clarity, error terms are not shown. PASS 
= perceived availability of social support, SRSS = satisfaction with social support, QOL = 











The aim of this study was to examine the role of personality factors in PASS and 
SRSS in BC patients. Agreeableness was positively associated with perceived 
social support at Time-5 and Time-6. Several explanations can be given for this 
finding: (i) persons who are more agreeable may be more strongly motivated to 
maintain positive relationships with others compared with persons who are less 
agreeable [47); (ii) high-scores on agreeableness tend to interpret the behaviors 
of others more positively and also tend to react more positively upon them [48]. 
A consequence could be that persons scoring high on agreeableness tend to 
receive more support from others [49] compared with persons scoring low on this 
trait. At Time-5 and Time-6, trait anxiety was negatively associated with 
perceived social support. Persons scoring high on trait anxiety in general are 
more anxious. As a result, high-scorers will presumably seek more support from 
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significant others [23]. However, Hobson, Slade, Wrench, and Power [24] found 
that persons scoring high on trait anxiety tend to score lower on perceived social 
support, compared with persons scoring low on trait anxiety. In contrast with 
persons scoring high on agreeableness, persons scoring high on trait anxiety 
might interpret the behaviors of others more negatively and also tend to react 
more negatively upon others. Another explanation may be that high-anxious 
women are not easily reassured by others. Therefore, they never receive enough 
social support to feel at ease. At first glance, it seems a paradox that having a job 
(Time-6) is negatively associated with perceived social support, because women 
who work are usually surrounded by others. An explanation for this finding, 
however, may be that the environment tends to provide less support or provide 
support differently due to the fact that women who are working after two years of 
surgical treatment seem to pick up their ‘normal’ life. In this way, women with 
(former) BC present themselves to others as ‘doing fine’. Although it may seem 
that women are fully functioning, they perceive the regular check-ups as stressful 
[50]. Across time, women with early stage BC report a decrease in perceived 
social support. Women scoring low or moderately on agreeableness or high on 
trait anxiety tend to score lower on perceived social support compared with 
women scoring high on agreeableness or low or moderately on trait anxiety 
across all time points.  
Across time, scores of perceived social support significantly declined 
with respect to trait anxiety and agreeableness. High-scorers on trait anxiety or 
low-scorers on agreeableness tend to score lower on perceived social support. To 
what extent, however, social support is actually lower is not clear. To the best of 
our knowledge, no studies have related personality characteristics to perceived 
social support longitudinally. However, Courtens et al. studied social support 
across time and found that the size of the networks as well as the amount of 
emotional support showed some decrease over time [17].   
The path models reached an adequate fit when examining the role of 
PASS and SRSS as mediating variables of the link between diagnosis and QOL. 
To the best of our knowledge, no existing studies examined the abovementioned 
relationship. In fact, few studies have examined relationships between social 
support and QOL. Recently, Lim and Zebrack [51] found that network diversity 
indirectly affected QOL through perceived social support.  
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As social support is an aspect of QOL, it seems important to try to 
increase its level. Potential problems with regard to perceived social support 
could be improved by, for instance, trying to involve the partner or family in the 
treatment plan. In this way, significant others are aware of the problems women 
with early stage BC are facing during and after the treatment process. Another 
option is to try to educate women with early stage BC and their families about 
the importance of social support, i.e., to teach women to ask for help, when they 
need support, or to learn how they can best discuss their needs, when they are not 
satisfied. Nevertheless, it is important to keep in mind that personality traits are 
quite stable. Also, the way persons encounter and perceive social situations is not 
easily altered.  
The current study has a couple of limitations. For instance, the study 
population at Time-6 was rather small (n = 92). Therefore, we should be careful, 
when interpreting and generalizing the results based on this particular sample. 
Another limitation is that we only assessed perceived social support. As a 
consequence, it was not possible to examine whether the same or other 
sociodemographic and personality factors were related to more quantitative 
aspects of social support, for instance, network size or frequency of 
appointments. Information concerning the type of support (i.e., instrumental 
support and emotional support) women received and needed from significant 
others was also lacking. Thus, future studies should further examine the role of 
potential factors which play a role in social support and combine these findings 
with assessing the needs of women with early stage BC. In this way, screening 
and treatment can be geared to one another.  
In conclusion, personality traits are important determinants of perceived 
social support. Understanding the underlying mechanisms of perceived social 
support will be useful in the development of interventions for women with BC. 
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Background: Few studies have prospectively assessed the impact of breast cancer 
(BC) on women’s sexual lives. Therefore, this study examines the determinants of 
quality of sexual life (QOSL), sexual functioning (SF), and sexual enjoyment 
(SE) at six and 12 months after surgical treatment. Methods: All participants 
completed a measure of QOSL (WHOQOL-100-facet Sexual Activity) before 
diagnosis (Time-1), and one (Time-2), 3 (Time-3), 6 (Time-4) and 12 months 
(Time-5) after surgical treatment. At Time-1, women also completed 
questionnaires on personality (STAI-trait, NEO-FFI), body image and self-esteem 
(WHOQOL-100), depressive symptoms (CES-D), and fatigue (FAS). 
Furthermore, SF and SE (EORTC-QLQ-BR23) were measured from Time-2 
onwards. Results: At baseline, the analysis included 223 women with early stage 
BC. Clinical factors did not predict QOSL, SF or SE. In the final analyses, trait 
anxiety predicted QOSL and SF at Time-4 (ps<.01). At Time-5, agreeableness 
predicted QOSL and SE (ps<.05). Having a partner and age predicted SF, while 
SE was predicted by educational level (Time-4).  In addition, fatigue predicted SE 
at Time-4 (p<.05). With regard to type of surgery, QOSL diminished across time, 
while SF improved. However, women with a mastectomy did not differ from 
women with breast conserving therapy. Conclusions: Mainly personality and 
psychological factors affect patients’ sexuality after surgical treatment. Clinical 
factors did not predict QOSL, SF or SE. More knowledge in this field will help 
professionals to identify women who are at risk of experiencing sexual problems 
and consequently will contribute to provide adequate support.  





In Europe, breast cancer (BC) is the predominant type of malignancy among 
women. Although studies have shown that about two-third of women with a 
partner will remain sexually active after cancer diagnosis or at the end of 
treatment [1-3], research also indicates that BC can negatively impact women’s 
sexual functioning (SF) [4]. As sexuality is considered to be an important aspect 
of quality of life [5, 6], research is needed to better understand long-term sexual 
problems in order to be able to adequately provide support to women with early 
stage BC.  
Most studies on sexuality in BC are cross-sectional [7-14]. In general, 
studies focus on the impact of surgical treatment [10, 13] or chemotherapy [10-
12, 14] on sexual functioning (i.e., the experience of sexual difficulties) and 
sexual activity (i.e., the frequency of sexual activities). In addition, some studies 
reported on sexual satisfaction [9, 14-16].  
In 1998, Ganz et al. [9] have proposed a broad conceptual model in which 
sexual health, encompassing sexual interest, sexual dysfunction and sexual 
satisfaction, were determined by sociodemographic and personal characteristics, 
medical variables, body image, partner relationship, and health-related quality of 
life. Since then, various determinants have been examined prospectively [1, 15-
18]. Several clinical factors, for instance, vaginal dryness [9, 16, 17], 
chemotherapy [9, 18], disease stage [18], distant recurrence [15], and sexual 
functioning before diagnosis [16], seem to be associated with sexual problems. 
Furthermore, research has demonstrated that marital status [17], age [15, 18], 
mental health [17], and body image [17] predicts SF. Women tend to be more 
sexually active if they had an unmarried relationship, had two or more children at 
home, experienced more vitality, and reported vaginal dryness [17]. Burwell et al. 
[16] found no significant changes in satisfaction with sex life across time. 
Prospective studies examining the determinants of sexuality, however, are rather 
scarce. Furthermore, the fact that several related concepts have been used as 
endpoints makes it difficult to compare the various studies.  
Few cross-sectional studies have examined the relationship between 
fatigue and depression, on the one hand, and sexuality, on the other hand. 
However, the limited body of studies has shown sizeable associations between 
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fatigue and depression, on the one hand, and sexuality, on the other hand [19, 20]. 
However, prospective data are lacking. Therefore, the associations between 
depressive symptoms and fatigue and QOSL, SF, and SE were examined in this 
longitudinal study, using a prospective design.  
Besides the necessity to include control groups, recently, Fobair et al. [17] 
also stressed the need for longitudinal studies, examining the relationships 
between body image and sexual functioning, interactions between side effects of 
BC treatment and mental health, self-esteem, and difficulties with relationships. 
In line with the Ganz et al. position that personal characteristics could 
play a role in sexual health, we focused in the current study on basic personality 
factors. Despite the known influences of personality traits on quality of life-
related concepts, no extensive studies have been conducted on the role of 
personality in relation to quality of sexual life, SF, and sexual enjoyment. In 1992, 
Costa et al. [21] conducted a study incorporating personality factors. They have 
shown that, for instance, neuroticism was related to lowered body image and 
sexual functioning.  
The present prospective, longitudinal study examined the determinants of 
the quality of sexual life (QOSL), SF, and sexual enjoyment (SE) at six and 12 
months in women with early stage BC after surgical treatment. In this research, 
the role of sociodemographic, clinical, psychological, and personality factors 
were examined. Concerning personality factors, we hypothesized that trait anxiety 






Women with a palpable lump in the breast or an abnormality on a screening 
mammography were referred by their general practitioner to the Department of 
Surgery of the outpatient clinics of the St. Elisabeth Hospital (Tilburg), the 
Maasland Hospital (Sittard), or the Jeroen Bosch Hospital (Den Bosch) in The 
Netherlands. The present study is part of a larger study focusing on the role of 
personality in early stage BC patients’ quality of life. The data were collected 
from September 2002 until September 2006. From the 799 eligible women, 604 
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(75.6%) completed the first set of questionnaires before they visited the surgeon 
or radiologist, i.e. before the diagnosis, benign or malignant, was known (Time-
1). In this group (N = 604), 223 appeared to have early stage BC; the others had a 
benign breast problem (BBP).  
The main reasons for not participating were the length of questionnaires 
and the amount of stress at the first visit at the hospital. Woman with a history of 
abnormalities in the breast, benign or malignant, or a breast tumor that was too 
large (>5 centimeter) for BCT, were excluded from the study. Participants had to 
be able to read and write in Dutch.  
After the baseline measurement before diagnosis (Time-1), the 
participants were divided in two groups: women with early stage breast cancer 
(BC group) and women with benign breast problems (BBP group). Thereafter, 
women completed questionnaires at 1, (Time-2), 3 (Time-3), 6 (Time-4), and 12 
(Time-5) months after diagnosis (BBP) or surgical treatment (BC). Once 
diagnosis was known, this was the reference point for subsequent measurement 
times for BBP. For BC patients, the reference point was surgical treatment. This 
was chosen, because otherwise the timing of treatment modalities would interfere 
with follow-up measures. Participation in the study was not known by the surgeon 
in attendance and, therefore, could not affect treatment and clinical follow-up. All 




All participants completed a measurement of QOSL (WHOQOL-100-facet Sexual 
Activity) at all time points. At Time-1, women also completed questionnaires on 
personality (STAI-trait, NEO-FFI), body image and self-esteem (WHOQOL-
100), depressive symptoms (CES-D), and fatigue (FAS). Furthermore, women 
with BC completed a disease-specific measurement (EORTC-QLQ-BR23) of SF 
and SE from Time-2 onwards.  
The World Health Organization Quality of Life assessment instrument-
100 (WHOQOL-100) [22] is a, cross-culturally developed, generic multi-
dimensional QOL measure. It covers 24 specific QOL facets, assessed by 96 
questions, and one General Health and Overall Quality of Life facet. Each facet is 
measured with four items using 5-point Likert scales. Facet scores range from 4 to 
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20. Reliability and validity are adequate [23-25] and sensitivity is high [26]. In the 
present study, three facets were used (Self-esteem, Body Image and Appearance, 
and Sexual Activity). Higher scores on these facets indicate good QOL. The facet 
Sexual Activity (α = .83) captures general satisfaction with sex life and contains 
the following items: ‘How would you rate your sex life?’, ‘How well are your 
sexual needs fulfilled?’, ‘How satisfied are you with your sex life?’, and ‘Are you 
bothered by any difficulties in your sex life?’. In the general population, the mean 
value of this facet was 14.10 (SD = 3.93). As Sexual Activity assesses the 
qualitative aspects of sex life, we will use the term QOSL in the remaining text. 
The European Organisation for Research and Treatment of Cancer 
Quality of Life Questionnaire Breast Cancer module (EORTC QLQ BR-23) [27, 
28] is a supplementary module of the EORTC QLQ C30. The EORTC QLQ BR-
23 incorporates two functional scales (Body Image and Sexual Functioning) and 
three symptom scales (Arm Symptoms, Breast Symptoms, and Systematic 
Therapy Side Effects). The remaining items assess sexual enjoyment and distress 
related to hair loss. Each item is rated on a scale ranging from 0 (not at all) to 4 
(very much). All scores of the QLQ-BR23 were transformed linearly so that all 
scales ranged from 0 to 100. Reliability, validity and sensitivity are adequate [28, 
29]. In the present study, two scales were used: Sexual Functioning and Sexual 
Enjoyment). Higher scores represent higher levels of functioning. The subscale 
Sexual Functioning (α = .88) captures interest and activity and contains the 
following items: ‘To what extent were you interested in sex?’ and ‘To what extent 
were you sexually active?’ (with or without intercourse). Sexual Enjoyment is 
assessed by: ‘To what extent was sex enjoyable for you?’. 
Basic personality factors were assessed with the Neuroticism-
Extraversion-Openness-Five Factor Inventory (NEO-FFI) [30-32]. This self-
report questionnaire
 
consists of 60 statements covering the five broad dimensions 
of
 
personality that formed the Five-Factor Model FFM) [33]: Neuroticism, 
Extraversion, Openness to New Experiences,
 
Agreeableness, and 
Conscientiousness. Each statement is rated on a 5-point scale ranging from 1 
(strongly
 
disagree) to 5 (strongly agree), resulting in dimension
 
scores between 12 
and 60. The psychometrics of the NEO-FFI have been extensively examined. The 
internal consistency, test-retest reliability, as well as the convergent validity, are 
acceptable to good [32]. 
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The State Trait Anxiety Inventory (STAI) [34, 35] consists of two 20-
item scales for measuring state anxiety and trait anxiety. In the present study, only 
the Trait Anxiety Scale was used. This scale describes how persons generally feel. 
The STAI trait scale has a 4-point rating scale ranging from 1 (almost never) to 4 
(almost always). The Dutch version of the STAI Trait Anxiety scale has good 
reliability and validity [35]. 
 
Medical records 
Data concerning type of surgery (breast conserving therapy; BCT or mastectomy; 
MTC), disease stage, and adjuvant treatment were obtained from the medical 
records of the patients.  
 
Statistical procedure 
Frequencies were used to present the available sociodemographic and clinical 
data. Student t-tests and chi-square tests were used to examine differences 
between (i) participants and non-participants and (ii) the BC group and the BBP 
group. Sexual Functioning, Sexual Enjoyment, and Quality of Sexual Life are 
partially overlapping constructs. In spite of this relatedness, they should be 
conceived of as separate variables. Therefore, using the Time-2 scores, the 
intercorrelations between Sexual Functioning, Sexual Enjoyment, and Quality of 
Sexual Life were calculated. As a first step, aiming at minimizing the number of 
independent variables in the final regression analysis, separate preliminary 
regression analyses (method: Enter) were performed with sociodemographic (age, 
having children, partner status, educational level, work status), clinical (disease 
stage, type of surgery, chemotherapy, radiotherapy, hormone therapy), 
psychological (body image, self-esteem, depressive symptoms, fatigue), and 
personality factors (neuroticism, extraversion, agreeableness, openness to new 
experiences, conscientiousness, trait anxiety) as independent variables. These 
variables were used to predict QOSL, SF, and SE at two measurement points: 
Time-4 and Time-5 (BC group). Subsequently, significant predictors (p <.05) 
were entered in the final regression analyses (method: Enter). General linear 
model analysis for repeated measures was used to examine QOSL scores across 
time with regard to diagnosis (BC and BBP group) and trait anxiety 
(low/moderate versus high scores). In addition, QOSL across time was examined 
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with regard to BCT or MTC. Women with BBP were included as a reference 
group. In addition, we examined the interaction between age and type of 
diagnosis for the QOSL measure. Therefore, the sample was stratified by age, 
according to the menopausal status of these women. All analyses were performed 





In total, 799 patients were eligible for this study. Before diagnosis was known, 
609 (76.2%) completed the first set of questionnaires before they visited the 
surgeon or radiologist. Participants were significantly younger compared with 
non-participants (p =.002). Participants and non-participants did not differ on 
other sociodemographic or clinical characteristics. A flow chart is presented in 
Figure 1. 
At baseline, the BC group (n =223) was significantly older compared with 
the BBP group (n=486; p<.0001). Participants in the BC group were less often 
employed (p=.001). In addition, the BBP group scored higher on Neuroticism (p 
=.048) and Openness to New Experiences (p=.001). Concerning the remaining 
personality characteristics, the BBP and BC group were not statistically different 
(Table 1). 
At baseline, 83.4% of the women with BC and 81.5% of the women with 
BBP reported on the QOSL-scale that they were not bothered or only a little 
bothered by the presence of sexual difficulties.  
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N = 799 
Refused: 
N = 195 Included: 
N = 604 
Time-5:  
N = 228 
Time-5:  
N = 167 
Time-4:  
N = 170 
Time-3:  
N = 174 
Time-2:  
N = 181 
Time-1:  
N = 223 
Drop-out:  
N = 109 
 
Drop-out:  
N = 22 
 
Drop-out:  
N = 15 
 
Drop-out:  
N = 7 
 
BBP group BC group 
Drop-out:  
N = 43 
 
Drop-out:  
N = 6 
 
Drop-out:  
N = 4 
 
Drop-out:  
N = 3 
 
Time-4:  
N = 235 
Time-3:  
N = 250 
Time-2:  
N = 272 
Time-1:  
N = 381 
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Table 1. Baseline characteristics of women with early stage BC and BBP  
 BC group (n =  223) BBP group (n = 383) p-value 
Age at diagnosis   
(mean ± SD; range) 
58.7 ± 9.4; 34-87  52.9 ± 10.4; 19-83 <.0001 
Living with a partner  
(yes /no /missing) 
179 (80.3)/ 37 (16.6)/   
3 (1.3) 
325 (84.9)/ 51 (13.3)/  
7 (0.6) 
ns 
Having children  
(yes / no / missing) 
191 (85.7)/ 29 (13.0)/  
3 (1.3) 
323 (84.3)/ 57 (15.9)/ 
 3 (0.8) 
ns 
Education level 
0-9/ 10-14/ > 14 years/ missing 
85 (38.1)/ 95 (42.6)/  
37 (16.6) / 2 (0.9) 
133 (34.7)/ 171 (44.6)/ 
72 (18.8) / 4 (1.0) 
ns 
Paid work  
(yes / no / missing) 
85 (38.1)/ 135 (60.5)/  
1 (0.4) 
199 (52.0)/ 178 (46.5)/ 
6 (1.6)  
.001 
Diameter of tumor:  
< 1 cm / 1-3 cm / > 3 cm 
49 (22.0)/ 146 (65.5)/ 
25 (11.2) 
  
Type of surgery: 
BCT / MTC / No surgical 
treatment 
 
107 (48.0)/ 114 (51.1)/ 
2 ( 0.9) 
  
Adjuvant therapy*:Yes / No 169 (75.8)/ 54 (24.2)   
Chemotherapy: 
(yes / no / missing) 
60 (26.8)/ 162 (72.3) /  
2 (0.9)  
  
Radiotherapy:  
(yes / no / missing) 
117 (52.2)/  106 (47.3)/ 
1 (0.4) 
  
Hormone therapy:  
(yes / no / missing) 
87 (38.8)/  136 (60.7)/  
1 (0.4) 
  
Disease stage:    
Stage 0 24 (10.8)   
Stage I 93 (41.7)   
Stage IIa / Stage IIb 69 (30.9)/ 35 (15.7)   
Indefinable 2 ( 0.9)   
Neuroticism (mean ± SD) 30.2 ±   7.0 31.4 ±   7.1 .048 
Extraversion (mean ± SD) 41.1 ±   5.5 40.2 ±   5.8 ns 
Openness to New Experiences 
(mean ± SD) 
 
35.4 ±   6.0 
 
37.1 ±   5.8 
 
.001 
Agreeableness (mean ± SD) 43.5 ±   4.1 43.4 ±   4.4 ns 
Conscientiousness (mean ± SD) 45.5 ±   5.4 45.0 ±   5.3 ns 
Trait Anxiety (mean ± SD) 39.4 ± 11.0                            38.8 ± 10.6 ns 
Quality of Sexual Life  
(mean ± SD) 
 
15.0 ±   3.1 
 
14.9 ± 3.3  
 
ns 
Sexual Functioning  
(Time-2; mean ± SD) 
 
29.5 ± 21.9 
  
Sexual Enjoyment  
(Time-2; mean ± SD) 
 
55.7 ± 22.2 
  
Depressive symptoms  
(mean ± SD) 
 
14.9 ±   9.5                      
 
14.6 ± 10.5 
 
ns 
Fatigue (mean ± SD) 19.8 ±   6.9 20.9 ±   7.1 ns 
Self-esteem (mean ± SD) 14.8 ±   2.3 14.4 ±   2.1 .035 
Body Image (mean ± SD) 16.5 ±   2.9 6.0 ±   3.3 ns 
Abbreviations: BCT = Breast Conserving Therapy, MTC = Mastectomy  
Note: * = more than one treatment possible. 
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At Time-4 and Time-5, these percentages in the BC group dropped 
significantly: 75.4% and 71% (p<.0001), respectively. About 10% of the women 
with BC and BBP rated their sex life as bad or pretty bad. These percentages 
remained stable across time. A minority of the women is initially very unsatisfied 
or unsatisfied with their sex life.  
However, these percentages significantly rise in the group of women with 
BC, 4.3% (at baseline), 11% (Time-4), and 11.4% (Time-5; p<.0001). About a 
quarter of the women with BC and 18.4% of the women with BBP felt that their 
sexual needs were not or almost not fulfilled at Time-5 (p>.05).  
 
Predictors of sexual health 
Correlation coefficients between the subscales assessing SF, SE, and QOSL 
ranged from .49 (QOSL and SE) to .57 (SE and SF; p<.0001; 2-tailed).  
Preliminary linear regression analyses (Table 2 to Table 4) revealed that 
none of the clinical factors predicted QOSL, SF, or SE. Thus, type of surgery or 
adjuvant therapy did not substantially contribute to the prediction of QOSL, SF or 
SE. Therefore, clinical factors were not entered in the final analyses. Regarding 
QOSL, Trait-Anxiety (ß=-.30) and Extraversion (ß=.21) predicted QOSL at Time-
4. QOSL at Time-1 was a predictor of QOSL measured at Time-4 (ß=.65) and 
Time-5 (ß=.62). Other psychological factors did not play a substantial role. With 
regard to SF, Age (ß=-.25) predicted SF at Time-5. Partner Status predicted SF at 
Time-5 (ß=.27). Trait-Anxiety (ß=-.21) predicted SF at Time-4. Regarding SE, 
Agreeableness (ß=.28) predicted SE at Time-5. Fatigue (ß=-.34) was negatively 
associated with SE at Time-4. 
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Table 2. Beta weights for preliminary multivariate analyses of Quality of Sexual Life 
(QOSL) after surgical treatment  
Time-4 Time-5 
Predictors 
Beta p-value Beta p-value 
Age -.07 .49 -.86 .47 
Children -.09 .31 -.13 .15 
Partner status .21 .02 .23 .02 
Education .00 1.00 .05 .58 
Work status .02 .86 -.05 .66 
Adjusted multiple R .03  .03  
F-value 1.77 .12 1.83 .11 
Disease stage .07 .53 .01 .94 
Type of surgery .03 .85 .16 .26 
Chemotherapy -.05 .66 -.08 .52 
Radiotherapy -.03 .84 .03 .83 
Hormone therapy -.10 .35 -.02 .88 
Adjusted multiple R -.03  -.02  
F-value .30 .91 .53 .75 
QOSL (Time-1) .65 .000 .62 .000 
Body Image -.04 .55 -.05 .51 
Self-Esteem -.12 .15 -.03 .72 
Depressive symptoms -.14 .10 -.03 .76 
Fatigue -.09 .31 -.05 .63 
Adjusted multiple R .47  .37  
F-value 25.28 <.0001 15.69 <.0001 
Neuroticism -.07 .53 -.14 .22 
Extraversion .21 .03 .12 .25 
Agreeableness .17 .06 -.26 .005 
Openness to New Exp. -.12 .16 -.05 .573 
Conscientiousness -.06 .54 -.15 .124 
Trait Anxiety -.30 .003 -.16 .131 
Adjusted multiple R .20  .15  
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Table 3. Beta weights for preliminary multivariate analyses of Sexual functioning (SF) 
after surgical treatment  
Time-4 Time-5 
Predictors 
Beta p-value Beta p-value 
Age -.12 .25 -.25 .02 
Children -.12 .15 .09 .29 
Partner status .24 .01 .27 .003 
Education -.11 .22 -.08 .35 
Work status .03 .81 -.04 .72 
Adjusted multiple R .07  .15  
F-value 3.06 .02 5.32 <.0001 
Disease stage .08 .52 -.03 .83 
Type of surgery .09 .53 .04 .81 
Chemotherapy -.13 .26 .07 .56 
Radiotherapy .12 .39 .11 .46 
Hormone therapy -.11 .31 -.05 .66 
Adjusted multiple R -.01  -.03  
F-value .66 .66 .33 .89 
Body Image -.05 .65 -.01 .93 
Self-Esteem -.03 .76 .13 .29 
Depressive symptoms .10 .41 .03 .81 
Fatigue -.19 .11 -.09 .47 
Adjusted multiple R .03  -.01  
F-value 1.92 .11 .83 .51 
Neuroticism -.12 .31 -.07 .56 
Extraversion .15 .15 .14 .20 
Agreeableness .06 .51 .05 .63 
Openness to New Exp. .03 .75 .03 .76 
Conscientiousness -.03 .74 -.19 .09 
Trait Anxiety -.21 .05 -.17 .13 
Adjusted multiple R .11  .04  
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Table 4. Beta weights for preliminary multivariate analyses of Sexual Enjoyment (SE) after 
surgical treatment  
Time-4 Time-5 
Predictors 
Beta p-value Beta p-value 
Age -.16 .28 -.12 .43 
Children -.13 .29 -.04 .76 
Partner status .05 .68 .20 .13 
Education .12 .34 .08 .51 
Work status -.01 .98 -.19 .21 
Adjusted multiple R -.01  -.01  
F-value .82 .54 .89 .49 
Disease stage .15 .36 .05 .75 
Type of surgery -.01 .94 .09 .64 
Chemotherapy -.05 .77 -.18 .26 
Radiotherapy .12 .54 .10 .62 
Hormone therapy -.15 .29 -.10 .51 
Adjusted multiple R -.03  -.04  
F-value .55 .73 .50 .78 
Body Image -.16 .24 .01 .92 
Self-Esteem .04 .80 -.07 .67 
Depressive symptoms .06 .72 .01 .95 
Fatigue -.34 .03 -.28 .08 
Adjusted multiple R .05  .01  
F-value 1.99 .11 1.16 .33 
Neuroticism -.05 .74 -.07 .65 
Extraversion -.01 .95 .09 .54 
Agreeableness .06 .65 .28 .04 
Openness to New Exp. -.08 .51 .02 .86 
Conscientiousness -.04 .80 -.08 .55 
Trait Anxiety -.20 .19 -.06 .71 
Adjusted multiple R -.03  .04  
F-value .69 .66 1.51 .19 
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The results of the final multivariate regression analyses are shown in 
Table 5. QOSL at Time-1 was the strongest predictor of QOSL at Time-4 and 
Time-5. Trait-Anxiety and Extraversion predicted QOSL at Time-4, while at 
Time-5 Agreeableness contributed significantly to the prediction of QOSL. QOSL 
was not predicted by any of the sociodemographic factors. SF was predicted by 
Partner Status (Time-4 and Time-5) and Age (Time-5). Trait-Anxiety predicted 
SF at Time-4. Regarding SE, Fatigue was a predictor at Time-4. Agreeableness 
(Time-5) contributed to the prediction of SE.  
The significant predictors in QOSL (Adjusted R
2 
>.42) explained more 
variance compared with SF (Adjusted R
2 





Table 5. Beta weights for the final multivariate regression analyses of QOSL, SF, and SE 
after surgical treatment 
Dependent 
variable 
Predictors Time-4 p-value Time-5 p-value 
QOSL Partner (Time-1) .07 ns .08 Ns 
 QOSL (Time-1) .57 *** .56 *** 
 Trait anxiety (Time-1) -.15 * -  
 Agreeableness (Time-1) -  .21 ** 
 Extraversion (Time-1) .11 ns -  
 Adjusted multiple R .48  .42  
 F-value 32.77 *** 30.22 *** 
SF Age (Time-1) -  -.23 ** 
 Partner (Time-1) -  .30 ** 
 Trait anxiety (Time-1) -.33 *** -  
 Adjusted multiple R  .10  .16  
 F-value 15.32 *** 12.26 *** 
SE Fatigue (Time-1) -.28 * -  
 Agreeableness (Time-1) -  .33 ** 
 Adjusted multiple R .07  .09  
 F-value 6.20 * 8.04 ** 
Abbreviations: QOSL = Quality of Sexual Life; SF = Sexual Functioning; SE = Sexual 
Enjoyment.  
Note: *** = p<.0001; ** = p < .001; * = p < .05; ns = not significant; - = not in the final 
analysis 
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Trends across time 
Regarding the influence of Trait-Anxiety on QOSL across time, no main effect 
for Time was found. However, a significant interaction effect was found (Wilks’ 
Lambda=.89; F(12,558)= 2.18, p=.012; partial eta squared=.04; Figure 1). This 
indicates that QOSL scores varied accordingly to the diagnosis (BC or BBP) and 
scores on Trait-Anxiety (high versus low/moderate). Women with BC reported 
less QOSL across time independent of their score on Trait-Anxiety, while women 
with BBP showed an improvement on QOSL scores across time. High-scorers on 
Trait-Anxiety had lower scores on QOSL across all time points, irrespective of 
their diagnosis (BBP or BC), compared to women with low or moderate scores. 
Women in the BBP group (scoring low or moderately on Trait-Anxiety) scored 
higher on QOSL than women in the BC group at Time-5 (t(203)=2.01, p=.046). 
When the group was stratified according to age, fitting the menopausal status, no 
significant interaction effect was found between age and type of diagnosis. 
Also the influence of type of surgery on QOSL across time was 
examined. A significant effect for Time was found (Wilks’ Lambda=.783; 
F(4,96)=6.653, p<.0001, partial eta squared=.217; Figure 2). QOSL decreased 
across time. Mean scores on Time-1 (15.21 ± 3.10) significantly differed from 
Time-2 (14.40 ± 3.27; p=.043), Time-3 (14.17 ± 3.41; p=<.0001), Time-4 (14.03 
± 3.17; p<.0001), and Time-5 (14.08 ± 3.47; p=.002). On average, women with 
BCT scored lower on QOSL compared with MTC. However, these differences 
were at no measurement point significant. No interaction effect was found. 
With regard to SF, a significant effect for Time was found (Wilks’ 
Lambda=.88; F(3,80) = 3.63, p=.016; partial eta squared =.12; Figure 3). Women 
tend to show an increase in SF across time. Post hoc tests indicated that mean 
scores on Time-2 (26.19 ± 20.58) were statistically different from Time-5 (30.36 
± 21.82; p=.038). Women with MTC had higher SF-scores compared with women 
with BTC at all time points, except for Time-3. However, differences were at no 
point significant. No interaction effect was found.  
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Figure 2. Mean scores on QOSL across time for women with BBP and BC. Women were 
divided in four groups according to diagnosis (benign or breast cancer) and trait anxiety 
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Figure 3. Mean scores on QOSL across time for women with BCT and MTC. Higher 
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Figure 4. Mean scores on SF across time for women with BCT and MTC. Higher mean 

































































The aim of this prospective study was to examine the determinants of QOSL, SF, 
and SE in women with early stage BC at six and 12 months after surgical 
treatment. This study adds to the common knowledge information about sexuality 
before diagnosis, it compares sexual issues of women with early stage BC with 
women with BBP. Furthermore, this study employs a broad view on sexuality by 
describing distinct but also related concepts, i.e. QOSL, SF, and SE. To the best 
of our knowledge, this is the first prospective study examining the role of 
personality in sexuality in women with early stage BC.  
The QOSL model explained at least 42% of the variance, with the 
common significant predictors: QOSL before diagnosis and personality 
characteristics. QOSL before diagnosis was a significant predictor of QOSL at 
both time points. It is assumed that QOSL is related to the quality of the partnered 
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relationship. It seems that QOSL before diagnosis is buffering for QOSL after 
surgical treatment. As such, this finding is consistent with Ganz et al. [9]. Trait-
Anxiety was a predictor of QOSL at Time-4, while Agreeableness (i.e., the 
inclination towards interpersonal trust and consideration of others) predicted 
QOSL at Time-5. The period after surgical treatment is a very dynamic one, in 
which women are confronted with various taxing adaptational tasks. 
Consequently, it is understandable that different personality factors play a 
prominent role at different time points. For instance, it is quite conceivable that in 
the period around surgical treatment anxiety would contribute more to outcome, 
while the role of agreeableness would be more substantial in the long-term. 
However, this explanation does not do justice to the complexity of the interplay 
between personality and situation. Consistent with findings from other studies: 
QOSL, SF or SE were not related to type of surgery [9, 36] or body image [16]. 
However, other studies found that chemotherapy was related to greater sexual 
problems [9, 14] early after surgery and beyond the first year after treatment [16].  
In conclusion, we could demonstrate that mainly personality and 
psychological factors were predictors of QOSL and SE. In addition, we found that 
different factors predicted QOSL, SF, and SE scores at Time-4 and Time-5. 
Consistent with other studies, QOSL and SF were quite stable during the first year 
when women were compared in terms of type of surgery. Burwell et al. [16] 
found that women experienced considerably more sexual problems in various 
MOS Sexual Functioning-domains, i.e.,  Interest and Arousal, compared with 
MOS Sexual Functioning-scores after surgery, which is consistent with our 
results. We also found that the number of women in the BC group who were not 
or just a little bothered by sexual difficulties decreased compared with scores 
before diagnosis.  
This study has some limitations. The current sample consists of a 
relatively homogeneous sample, in which only women with early stage BC are 
included, which limits generalizability. It was not possible to include levels of SF 
and SE before the diagnosis was known. Several studies included information on 
the presence of menopause resulting from adjuvant therapy [17], or included 
specific physical problems (e.g., vaginal dryness) women experienced. We did 
not assess these aspects. It is likely that they would be good predictors of SF.  
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Future prospective studies should include a broad range of predictors in 
order to fully understand the determinants of sexual health. In addition, 
investigations should have a follow-up period longer than 12 months. 
Furthermore, wide-ranging concepts should be used in order to assess sexual 
health. Several studies have examined to what extent women remain sexually 
active, the frequency of sexual intercourse or specific physical problems women 
experience during sexual intercourse. Although these assessments are relevant, it 
may also be important to include measures that focus on relevant subjective 
experiences. Although this study did find that clinical factors were less relevant 
than other constructs, future studies are still needed to draw more definite 
conclusions, especially, because our study did not include, for instance, current 
treatment status, co-morbidity, menopausal status, and vaginal dryness. In 
addition, studies have not included the partners’ view of the sexual relationship. 
The inclusion of this kind of information could shed more light on the interaction 
between partners. Now, assessments are solely based on the experiences of the 
women with early stage BC and are, therefore, unilateral.  
Understanding specific aspects of QOSL and SF that affect women with 
breast cancer across time is relevant for oncologists, nurse practitioners, and 
medical psychologists. For instance, when women are diagnosed with BC, women 
should be informed about the possible consequences with respect to sexual health 
and body image. Discussing sexual issues with women with BC is of utmost 
importance. However, a majority of health professionals find it difficult to discuss 
the subject. Therefore, it is important that they are aware of the problems 
experienced in this patient group. In this way, they could normalize problems that 
are the result of diagnosis and subsequent treatment of BC.  
In summary, the findings from this study indicate that mainly personality 
and psychological factors have an impact on patients’ sexuality after surgical 
treatment. Clinical factors, even type of surgery, did not contribute substantially 
to the prediction of QOSL, SF, or SE. More knowledge about the experiences of 
women with BC with regard to sexuality will help professionals to identify 
women who are at risk of experiencing sexual problems and to support them 
adequately. Knowledge in this field will help clinicians realize the impact of 
cancer on sexuality. 
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General discussion and clinical implications 




The aim of this thesis was to examine the psychosocial outcomes of women with 
early stage BC in a longitudinal follow-up study. In the first part of this chapter, 
the main findings of the separate studies are summarized. Subsequently, potential 
implications of the findings for clinical practice are discussed. Finally, some 
general methodological considerations combined with recommendations for 




Quality of life in women with early stage BC 
The majority of earlier studies have examined health status (HS) instead of the 
broader concept quality of life (QOL). Although the debate on conceptualisation 
of patient-centred outcomes is not settled yet, the focus of the first part of the 
thesis (Part A) was to shift focus from functioning or, in other words, what 
persons can or cannot do in their daily life, to the evaluation of patients of their 
functioning [1]. Currently, only a few questionnaires are developed in such a way 
that they focus on QOL, i.e., instruments that are focussing on the individual’s 
subjective perception.  
In this thesis, the main focus was on QOL. The WHOQOL instruments 
are generic and cross-culturally developed questionnaires and assess QOL. The 
WHOQOL-100 was not tested psychometrically in breast cancer patients. 
Therefore, the aim of chapter 2 was to examine the psychometric properties of the 
WHOQOL-100 in this particular population. Results showed that the WHOQOL-
100 can be effectively used in women with early stage breast cancer (BC). In 
chapter 3, the objective was to examine which QOL domains and facets 
contributed most to patients’ overall QOL during the first year after surgical 
treatment. Different facets contributed to overall QOL over time. However, the 
consistently predominant contributors to overall QOL during the first year after 
surgical treatment were scores on Positive Feelings, reflecting the amount of 
happiness and enjoyment in life, and scores on Personal Relationship, reflecting 
satisfaction with relationships with family and friends.  
 




In the literature on depressive symptoms, various risk factors have been 
examined. However, previous studies differ substantially with regard to their 
study design, sample size, concepts assessed, and populations examined, as well 
as factors under consideration. Due to these discrepancies, there are striking 
inconsistencies regarding the role of biopsychosocial factors and their association 
with depressive symptoms. Former studies that focused on rather limited sets of 
predictors found that depression has a detrimental impact on patients’ lives [2-4], 
adversely affects compliance with medical treatment [5], significantly influences 
recovery from treatment [6], and may reduce survival length [7-9]. In addition, 
women with depression experience more side-effects of treatment [10]. 
Consequently, there is a need for studies examining a broad range of factors 
reflecting socio-demographic, clinical, social as well as psychological variables, 
including personality traits. Chapter 4 focused on such a broad range of predictors 
of depressive symptoms 12 months after surgical treatment. Depressive symptoms 
at 12 months after surgical treatment were predicted by lower scores on 
agreeableness (i.e., a tendency to be compassionate and cooperative rather than 
suspicious and antagonistic towards others), higher scores on neuroticism (i.e., the 
tendency to experience negative emotions, such as anger, anxiety, or depression), 
depressive symptoms at Time-1, fatigue at Time-1, and type of surgery (breast 
conserving therapy; BCT).  
Recent studies have shown that clinical factors predict whether women 
receive a re-excision after BCT [11-15]. Few studies have examined the 
consequences of a second surgery [16]. Re-excisions may negatively affect 
aesthetic outcomes, and subsequently affect QOL [16, 17]. Recently, it was found 
that the risk of local recurrence progressively increases with the number of re-
excisions required to obtain clear margins. However, to what extent additional 
surgical treatment is negatively affecting women with early stage BC has not been 
studied yet. Therefore, the aim of chapter 5 was to examine the relationship 
between the number of surgical treatments and psychosocial outcomes (i.e., state 
anxiety, fatigue, depressive symptoms, and aspects of QOL). We did not find 
differences between women who had one operation, compared with women who 
had additional surgical treatment. Initially, scores on the outcome measures did 




improve over time. However, after controlling for clinical factors, only anxiety 
scores significantly improved over time. 
 
Social outcomes 
There is still a limited body of knowledge regarding the question whether, in line 
with a decreasing social network, perceived social support also diminishes across 
time, and what role personality plays in this relationship. Therefore, in chapter 6 
the role of personality factors was examined in the relationship between stress 
(i.e., being diagnosed with early stage BC) and QOL. Results showed that 
agreeableness was positively associated with perceived social support at 12 and 
24 months after diagnosis or surgical treatment, while trait anxiety (i.e., the 
tendency to respond to situations perceived as threatening with a rise in anxiety 
intensity) was negatively associated. Besides personality factors, fatigue and 
having a job substantially influenced the way women with early stage BC 
perceive social support. Having a job was negatively associated with perceived 
social support at two years after surgical treatment.  
Sexuality is also part of the social domain. The number of studies 
reporting on sexual issues in women with early stage BC is rather scarce. Most 
studies are cross-sectional and focus on the extent in which women remain 
sexually active, the frequency of sexual intercourse, or specific physical problems 
women experience during sexual intercourse in relation to treatment. However, it 
may also be important to include measures that focus on the subjective 
experiences of these women. Therefore, the objective of chapter 7 was to examine 
quality of sexual life (QOSL), sexual functioning (SF), and sexual enjoyment 
(SE) after diagnosis and surgical treatment. This study adds to the common 
knowledge information about sexuality before diagnosis, it compares sexual 
issues of women with early stage BC with women with BBP. Furthermore, this 
study employs a broad view on sexuality by describing distinct but also related 
concepts, i.e. QOSL, SF, and SE. Personality was related to QOSL at 6 and 12 
months after surgical treatment. Trait anxiety predicted QOSL at 6 months after 
treatment and agreeableness predicted QOSL at 12 months after treatment. 
Consistent with findings from other studies were the following outcomes: QOSL, 
SF or SE were not related to type of surgery [18, 19] or body image [20]. 
However, other studies found that chemotherapy was related to greater sexual 
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problems early after surgery [19, 21] and beyond the first year after treatment 
[20]. The findings from the present study indicate that mainly personality and 
psychological factors have an impact on patients’ sexuality after surgical 
treatment. Clinical factors, even type of surgery, did not contribute substantially 




Weaknesses of the current study 
The work presented in this thesis has a number of limitations. First, the current 
study consisted of a rather homogeneous group of women with early stage BC 
(T1 and T2 stage). It may be that women with a more advanced cancer (T3 and 
T4 stage) would experience a greater threat to survival [22] and, therefore, would 
experience more psychosocial problems. As advanced BC was not present in this 
sample, our results may not be generalised to that particular population, to cancer 
in general, or to women with recurrent breast cancer. In addition, the population 
of older women with BC (75+ years) is rapidly growing. However, few studies 
have examined the specific psychosocial problems these women are facing. In 
this study, we have decided to study a population with a clear therapeutic plan. As 
a consequence, we did not focus on this population, since therapy in older women 
varies. However, in the future this group will be an important target population. 
Second, studies like the current one often show relatively high attrition [23]. Our 
study had 63.7% of the women with early stage BC in the study at one-year after 
surgical treatment. This may have influenced our results. However, in general, 
women with BC who dropped out of the study did not differ from women 
remaining in the study, except for age. Women remaining in the study were 
significantly younger. The opposite was found for women with benign breast 
problems. Third, the sample size at one-year after diagnosis or surgical treatment 
was relatively small in analyses where all assessment points were used (i.e., 
repeated measures). This may also affect our results. It is not clear why women 
missed the assessment on a particular time point or why women dropped out from 
the study. Fourth, this study reported on self-reported outcomes, for instance, 
depressive symptoms. It would be interesting to combine self-reported outcomes 
with clinical interviews. Finally, some important factors, for instance, co-




morbidity, menopausal status, specific symptoms (i.e., vaginal dryness), and 
information whether any of the women had received treatment for mental health 
problems, have not been included. Future studies on early stage BC should further 
address these issues. Therefore, the results should be interpreted with caution and 
replication is desirable.  
 
Strengths of the current study 
Despite these limitations, the work presented in this thesis has a number of 
strengths. Most studies of cancer patients examined psychological status at one 
time point [2], whereas our findings are based on prospective longitudinal follow-
up research. Moreover, this study included a baseline assessment, i.e., an 
assessment before diagnosis was known. This baseline assessment was used as 
reference point in most studies reported in this thesis. Strength is furthermore that 
women with benign breast problems were also included. Women with benign 
breast problems were included as a control group in several studies in this thesis, 
for instance, in the chapter on quality of sexual life, sexual functioning, and 
sexual enjoyment (Chapter 7). Finally, the data was collected in several hospitals, 
which may improve generalisability of the results. 
 
Implications for clinical practice and future research 
Understanding the specific aspects of psychosocial outcomes in women with early 
stage BC is relevant for oncologists, nurse practitioners, and medical 
psychologists. For instance, when women are diagnosed with BC, women should 
be informed about the possible physical and psychological consequences this 
disease or treatment may have.  
QOL is an important concept, since it can inform surgeons and patients in 
the decision-making process of determining which treatment options to use. 
Following the results of the first part of the thesis, the WHOQOL-100 is suitable 
for use in women with breast problems (Chapter 2). The WHOQOL-100 can be 
used in clinical practice to assess subjectively experienced QOL or can be used 
for research purposes to determine the QOL of this population. Since our study 
did not examine the sensitivity and specificity of the WHOQOL-100, future 
studies could address this issue. Chapter 3 adds knowledge to our understanding 
of which factors determine the overall QOL scores of women with early stage 
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BC. Knowledge about these factors will allow health professionals to further 
adjust follow-up management to the needs of women with early stage BC.  Our 
results showed that women may benefit from a more multidisciplinary treatment: 
not only focussing on the medical aspects, but also discussing the psychological, 
social, and environmental aspects of BC [24]. Methodologically, our findings 
showed that assessment instruments, which use a composite score, have an 
important drawback, i.e. important information about the different factors related 
to QOL over time is lost when composite scores are used. 
In the second part of this thesis, the focus was on addressing 
psychological problems in women with early stage breast cancer. In chapter 4, 
predictors of depressive symptoms one year after surgical treatment were 
examined. The current study showed that some patients have an increased risk of 
developing depressive symptoms. Since, depression has a detrimental impact on 
patients’ lives [2-4], it adversely affects compliance with medical treatment [5], 
significantly influences recovery from treatment [6], and may reduce survival 
length [7-9]. In addition, due to the fact that women with depression experience 
more side-effects of treatment [10], identification of women with depressive 
symptoms is particularly important. As a consequence, BC patients should be 
evaluated for the presence of depressive symptoms. The CES-D is easy to 
administer to screen for depressive symptoms and has well established cut-off 
values. In this study, we have shown that certain personality factors may have a 
profound impact on levels of functioning and/or well-being of women with early 
stage BC. Therefore, it seems appropriate to screen women on personality factors 
at the start of the diagnostic process. In this study, we used the NEO-FFI and 
STAI-Trait to assess personality. Although the NEO-FFI contains 60 items, it 
seems feasible that women complete these questionnaires once at the start of the 
diagnostic process. In clinical practice, screening may ideally be part of the care 
process. Screening could be done by nurse practitioners or other health 
professionals. Women who are at risk for developing depressive symptoms could 
be monitored more closely. The need for screening is supported by the National 
Program Cancer Control [Nationaal Programma Kankerbestrijding]. Currently, 
guidelines are developed for the detection of psychosocial problems. Although it 
is not clear whether women with, for instance, high scores on neuroticism tend to 
have a negative way of perceiving their situation or whether their situation is 




worse compared with low-scorers, it is important to take into account that there is 
an association with their functioning. In chapter 5, the relationship between 
second surgery and psychological outcomes (i.e., state anxiety, fatigue, depressive 
symptoms, and aspects of QOL were examined. This study showed that, in 
general, women who had one operation did not differ from women who had a 
second operation. After controlling for clinical factors, only anxiety scores 
significantly improved over time. This study contributes to the debate whether 
women who receive a second surgery are at a disadvantage compared with 
women who are ‘effectively’ treated. The group of women who received a second 
surgery was a rather heterogeneous group. Women may receive a second surgery 
when the margin of tissue around the tumor is not cancer-free or when 
complications occur. In addition, women differed in the treatment they had 
received. Some women received BCT twice or women were converted from BCT 
to MTC. Given the relatively small sample size, it was not possible to divide the 
sample and examine whether differences exists between the different subgroups. 
It would be interesting for future studies to further address this issue.  
In the final part of this thesis, we have addressed the social aspects of 
QOL. The aim of chapter 6 was to examine the relationships between personality 
and perceived availability of social support (PASS) and satisfaction with received 
social support (SRSS) in early stage BC patients. In addition, the role of PASS 
and/or SRSS was examined in the link between diagnosis and QOL. As social 
support is related to QOL, it seems important to discuss this issue with patients 
and their family. Awareness of what patients need during and after treatment 
could guide significant others to provide the care needed. In Chapter 7, the quality 
of sexual life and sexual functioning of women with early stage BC and benign 
breast problems were examined. Due to the sensitive nature of this topic, many 
patients are reluctant to discuss sexual difficulties with health professionals or to 
seek help for their problems. This sensitivity should also be acknowledged in the 
group of health professionals who may also find it difficult to discuss this subject. 
Partly due to this sensitivity, this topic has not yet received considerable attention 
by both health professionals and researchers. However, our study has shown that 
it is import to discuss sexual issues with these women, because one quarter of our 
sample was bothered by the presence of sexual difficulties at 6 and 12 months 
after surgical treatment. First, by studying this topic and subsequently informing 
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both health professionals and patients, we make them aware of the problems that 
may be experienced. They can address the sexual concerns by integrating them 
into routine clinical practice information about the areas of sexual functioning that 
may be impaired by treatment. This can normalize the discussion of sexual issues 
for health professionals, as well as the patient and his or her partner. Furthermore, 
health professionals can use these data to provide reassurance to their patients that 
the majority of women treated for BC do quite well following the completion of 
their treatment. Second, more knowledge about the experiences of women with 
BC with regard to sexuality will help professionals to identify women who are at 
risk of experiencing sexual problems and to support them more adequately. 
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(Summary in Dutch) 
 




Borstkanker is de meest voorkomende kanker bij vrouwen en de voornaamste 
doodsoorzaak in deze groep. Geschat wordt dat één op de negen vrouwen 
gedurende haar leven borstkanker zal krijgen. Borstkanker komt vooral voor bij 
Westerse vrouwen van 50 jaar en ouder. Het aantal vrouwen dat borstkanker 
overleeft groeiende is, heeft de diagnose een grote invloed op het psychosociaal 
functioneren. In dit proefschrift zal de psychosociale invloed van borstkanker 
worden onderzocht. 
De meeste vrouwen in ontwikkelde landen die gediagnosticeerd worden 
met borstkanker in het vroege stadium zullen chirurgisch worden behandeld. Er 
zijn twee soorten chirurgie mogelijk: (i) de borstamputatie waarbij de hele borst 
wordt verwijderd en (ii) de borstbesparende operatie waarbij alleen de tumor en 
het omringende weefsel wordt verwijderd. Deze behandeling wordt gevolgd door 
radiotherapie. Een borstbesparende operatie is overigens alleen mogelijk wanneer 
de tumor kleiner is dan 5 cm en de tumor in verhouding tot de omvang van de 
borst niet te groot is.  
Bij beide ingrepen zal meestal onderzoek plaatsvinden naar eventuele 
lymfeklieruitzaaiingen. Bij voorkeur gebeurt dit met de schildwachtklier-
procedure. De schildwachtklier is een lymfeklier die direct lymfeafvloed ontvangt 
in het gebied in de borst waar de tumor zich bevindt. Wanneer de tumor via de 
lymfevaten uitzaait, komen tumorcellen meestal eerst in de schildwachtklier 
terecht. De schildwachtklier wordt opgespoord met behulp van een licht 
radioactieve stof. Als blijkt dat één of meer klieren uit de oksel is aangedaan, 
wordt het verwijderen van alle okselklieren geadviseerd. Hier is vaak een tweede 
operatie voor nodig (okselklierdissectie).  
Afhankelijk van de tumorgrootte, mate van differentiatie van de tumor en 
de aanwezigheid van metastasen, zal adjuvante behandeling (chemotherapie, 
hormoontherapie, radiotherapie) worden aanbevolen. Elke vorm van adjuvante 
behandeling kan onafhankelijk van elkaar of in combinaties worden ingezet 
gedurende de behandelperiode.  
Het aantal prospectieve follow-up studies dat zich richt op psychosociale 
uitkomsten bij vrouwen met borstkanker in het vroege stadium is beperkt. Het 
onderzoek in deze dissertatie is een prospectief follow-up onderzoek bij vrouwen 
die uiteindelijk de keuze hebben tussen een borstsparende operatie en een 
borstamputatie. Vrouwen met een voelbare afwijking in de borst of een afwijking 
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op de screening-borstfoto van het bevolkingsonderzoek werden gevraagd om mee 
te doen aan de studie. Voordat de diagnose bekend was, vulden de deelnemende 
vrouwen een set vragenlijsten in. Deze set bestond uit twee 
persoonlijkheidsvragenlijsten (NEO-FFI, STAI-trait), alsmede vragenlijsten 
betreffende de aanwezigheid van depressieve symptomen (CES-D) en 
vermoeidheid (FAS). Daarnaast werd een vragenlijst ingevuld die kwaliteit van 
leven meet (WHOQOL-100). Vrouwen met de diagnose borstkanker vulden 
daarenboven een vragenlijst in die de ziektespecifieke gezondheidstoestand meet 
(EORTC QLQ BR 23). Tot twee jaar na de diagnose en behandelingen kregen de 
vrouwen nog verschillende sets met de bovenstaande vragenlijsten thuisgestuurd.  
 
Kwaliteit van leven 
Kwaliteit van leven is een belangrijke uitkomstmaat binnen de oncologie 
geworden. Het aantal onderzoeken dat pretendeert kwaliteit van leven te 
bestuderen, is de laatste jaren enorm gegroeid. In het eerste deel van dit 
proefschrift staat dit thema dan ook centraal. Echter, wanneer een kritische 
houding wordt aangenomen, dan kan geconcludeerd worden dat de meeste 
onderzoeken zich, ondanks dat ze pretenderen gericht te zijn op kwaliteit van 
leven, meer richten op gerelateerde concepten, zoals gezondheidstoestand. Er is 
om die reden een sterke behoefte aan meetinstrumenten die daadwerkelijk 
kwaliteit van leven meten. Een vragenlijst die de persoonlijke evaluatie van het 
fysieke, psychische en sociale functioneren meet, is de 
Wereldgezondheidsorganisatie Kwaliteit van Leven vragenlijst (WHOQOL-100). 
Deze cross-culturele, generieke vragenlijst is in het verleden al in diverse 
onderzoeken gebruikt, maar over de psychometrisch kwaliteiten in de specifieke 
doelgroep vrouwen met een palpabele afwijking in de borst, was nog weinig 
bekend. In hoofdstuk 2 werden daarom deze eigenschappen onderzocht in diverse 
populaties: vrouwen met borstkanker, vrouwen met benigne borstproblematiek en 
vrouwen die meer dan vijf jaar geleden zijn behandeld aan borstkanker. Uit deze 
studie bleek dat de WHOQOL-100 een betrouwbaar en valide instrument was om 
kwaliteit van leven in deze groepen te meten. In hoofdstuk 3 werden de relaties 
tussen de domeinen en facetten van kwaliteit van leven enerzijds en algemene 
kwaliteit van leven anderzijds onderzocht. De hypothese was dat de domeinen en 
facetten die belangrijk zijn voor vrouwen met borstkanker over de tijd zouden 




verschillen. Deze hypothese werd bevestigd. De facetten Positieve Gevoelens en 
Persoonlijke Relaties bleken belangrijke factoren te zijn op bijna alle 
meetmomenten, terwijl andere facetten, zoals Seksuele Activiteit, op een bepaald 
tijdstip (een half jaar na operatie) een significante relatie had met kwaliteit van 
leven. Instrumenten voor het vaststellen van kwaliteit van leven kunnen somtijds 
aspecten van kwaliteit van leven meten die niet sterk of in het geheel niet 
beïnvloed worden door een bepaalde interventie. Gebruik van een samengestelde 
totaalscore kan dan het zicht ontnemen op wel degelijk aanwezige duidelijke 
effecten. De bevinding dat vooral die specifieke facetten van kwaliteit van leven, 
die het hebben van positieve gevoelens en het waarderen van persoonlijke relaties 
en seksuele activiteit weerspiegelen, van belang zijn voor vrouwen met 
borstkanker, onderstreept dat een gedetailleerde, meer fijnmazigere beschrijving 
op domein- en facetniveau in bepaalde gevallen te verkiezen is boven een 
globalere benadering bestaande uit het berekenen van één totaalscore voor 
kwaliteit van leven. 
 
Uitkomsten op psychologisch gebied 
Verschillende onderzoeken hebben aangetoond dat een meerderheid van de 
vrouwen die gediagnosticeerd werden met borstkanker redelijk goed omgaan met 
deze ziekte. Echter, er is ook een groep vrouwen die ernstige psychologische 
problemen ervaren, zowel direct volgend op de diagnosestelling als tijdens en na 
de behandeling. De emotionele consequenties van borstkanker, met name 
depressieve klachten, hebben relatief veel aandacht gekregen in de 
wetenschappelijke literatuur. De prevalentie van depressie en depressieve 
symptomen varieert van 1.5% tot 50%, afhankelijk van de onderzoekspopulatie, 
de gehanteerde definitie van depressie en de wijze waarop depressie gemeten 
werd. De meerderheid van de onderzoeken vond dat 20 tot 30% van de vrouwen 
verhoogd scoren op depressieve symptomen. Depressieve klachten lijken het 
meest voor te komen in de eerste 6 maanden na de diagnose. Bestaande literatuur 
heeft aangetoond dat socio-demografische, klinische en persoonlijkheids-
kenmerken een voorspellende waarde hebben ten aanzien van depressieve 
klachten bij vrouwen met borstkanker. Echter, onderzoek tot nu toe heeft zich 
gericht op beperkte sets van factoren. In hoofdstuk 4 is daarom gekozen voor een 
brede aanpak. Persoonlijkheidstrekken, zoals neuroticisme en altruïsme spelen 
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een substantiële bij het ontwikkelen van depressieve klachten. Daarnaast speelt de 
emotionele gesteldheid vóór de diagnose een belangrijke rol. Vermoeidheid had 
eveneens een negatief effect op depressieve klachten. Tot slot werd in deze studie 
gevonden dat vrouwen met een borstbesparende operatie een groter risico liepen 
om één jaar na de operatie depressief te worden. In hoofdstuk 5 werd onderzocht 
in hoeverre vrouwen die een tweede operatie ondergaan meer psychosociale 
problemen hebben dan vrouwen die vrouwen die slechts één maal werden 
geopereerd. Hoewel chirurgen streven om vrouwen zo min mogelijk chirurgisch 
te behandelen, is dit in de praktijk niet altijd mogelijk. Sommige vrouwen hebben 
aanvankelijk een borstbesparende operatie ondergaan, maar als blijkt dat het 
weefsel rond de tumor niet vrij is van kankercellen, wordt vaak besloten om 
nogmaals te opereren. Tot op heden zijn er een beperkt aantal onderzoeken 
geweest die hebben gekeken naar welke klinische factoren bijdragen aan de 
noodzaak tot een heroperatie (re-excisie). Onduidelijk was of er een relatie bestaat 
tussen een tweede operatie en de psychologische uitkomsten. Uit onze studie 
bleek dat vrouwen die twee keer zijn geopereerd niet per definitie meer 
problemen ervaren dan vrouwen die eenmalig onder het mes zijn gegaan.  
 
Uitkomsten op sociaal gebied 
In hoofdstuk 6 stond sociale steun centraal. De relaties tussen persoonlijkheid en 
de mate waarin vrouwen de beschikbaarheid van sociale steun ervaren en 
tevreden zijn met de ontvangen steun werden onderzocht. Persoonlijkheids-
kenmerken, zoals trekangst en altruïsme, speelden een rol in de mate waarin 
vrouwen tevreden waren met de beschikbare en verkregen steun. Hoogscoorders 
op trekangst en laagscoorders op altruïsme scoorden lager op ontvangen sociale 
steun. Ook vermoeidheid en het hebben van een baan speelde een rol bij het 
bepalen van de determinanten van sociale steun. Sociale steun heeft een 
mediërende rol in de relatie tussen een stressvolle gebeurtenis (diagnose) en 
kwaliteit van leven.  
Verschillende onderzoeken hebben aangetoond dat borstkanker een 
negatieve invloed kan hebben op het seksueel functioneren van vrouwen. 
Ondanks dat seksualiteit wordt beschouwd als een belangrijk aspect van kwaliteit 
van leven, zijn er tot op heden relatief weinig studies die dit thema uitvoerig, op 
systematische wijze hebben onderzocht. Veel studies op dit gebied zijn cross-




sectioneel en leggen eenzijdig de nadruk op de rol van chirurgische behandeling 
of chemotherapie op seksueel functioneren en seksuele activiteit. Kennis ten 
aanzien van de kwaliteit van het seksuele leven is eveneens noodzakelijk, 
aangezien er een discrepantie kan bestaan tussen de aanwezigheid van seksuele 
problemen en hoe de persoon daarmee omgaat. In hoofdstuk 7 van dit proefschrift 
is het seksuele leven na behandeling onderwerp van studie geweest. 
Geconcludeerd werd dat vrouwen, gemiddeld genomen, in de loop van de tijd 
minder tevreden werden over de kwaliteit van hun seksuele leven. 
Persoonlijkheidskenmerken (trekangst, extraversie en altruïsme), leeftijd, het 
hebben van een partner en vermoeidheid beïnvloeden het seksuele leven van 








Langs deze weg wil ik iedereen bedanken die heeft bijgedragen aan het tot stand 
komen van dit proefschrift.  
In het bijzonder bedank ik mijn promotoren: Guus van Heck, Jolanda de 
Vries en Jan Anne Roukema. De afgelopen jaren heb ik enorm genoten van onze 
samenwerking en ben erg blij dat wij deze samenwerking voortzetten. Ik 
waardeer het vertrouwen dat jullie in mij hebben en de vrijheid die ik van jullie 
krijg in mijn werk. 
De leden van de manuscriptcommissie: prof. dr. Johan Denollet, prof. dr. 
Hanneke de Haes, prof. dr. Maarten von Meyenfeldt, prof. dr. Robbert Sanderman 
en Dr. Lideke van der Steeg dank ik voor het beoordelen van dit proefschrift. Een 
extra woord van dank ben ik verschuldigd aan Lideke, zonder jouw medewerking 
had ik nu nog niet op het podium gestaan. 
Rinus Verkooijen heeft mij met veel enthousiasme geholpen bij de lay-
out van dit proefschrift, bedankt. Tot slot bedank ik de maker van het schilderij 
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